# Chapter 78: Major or Mild Neurocognitive Disorder Due to Parkinson’s Disease

# The Biological and Neurological Basis of Neurocognitive Disorder Due to Parkinson’s Disease

## Introduction

Major or Mild Neurocognitive Disorder (NCD) Due to Parkinson’s Disease (PD) represents one of the most significant and disabling non-motor aspects of this common neurodegenerative condition (McKinlay, 2013; Poewe, 2008). While Parkinson's disease is clinically defined by its cardinal motor symptoms—bradykinesia, rigidity, resting tremor, and postural instability—it is now unequivocally understood as a complex, multisystem disorder with a wide spectrum of non-motor manifestations (Jankovic, 2008; Krishna et al., 2018; Poewe, 2008). Among these, cognitive impairment is nearly ubiquitous, affecting a substantial portion of patients even at the time of diagnosis and progressing to dementia in up to 80% of individuals over the course of their illness (Rotaru et al., 2023; Aarsland et al., 2003; Press, 2004). This cognitive decline ranges from subtle, domain-specific deficits, classified as Mild Neurocognitive Disorder (or Mild Cognitive Impairment, PD-MCI), to a global deterioration of intellectual functions that interferes with daily life, classified as Major Neurocognitive Disorder (or Parkinson’s disease dementia, PDD) (Presečki et al., 2014; Reichenberg & Seligman, 2016; Aarsland et al., 2005).

The biological underpinnings of PD-NCD are profoundly heterogeneous and extend far beyond the canonical pathology of dopamine depletion in the nigrostriatal pathway (Gerlach & Riederer, 1993; Marino et al., 2019). The emergence of cognitive dysfunction reflects a widespread neurodegenerative process involving multiple neurotransmitter systems, the progressive accumulation of misfolded α-synuclein protein, and the disruption of large-scale neural networks that subserve higher cortical functions (Barone, 2009; Emre, 2003). The traditional view of PD as a pure motor disorder has been supplanted by a model that recognizes a long prodromal or "pre-motor" phase, where non-motor symptoms such as olfactory dysfunction, REM sleep behavior disorder (RBD), constipation, and depression may precede the onset of parkinsonism by years or even decades (Savica et al., 2010; Hawkes, 2008; Gaig & Tolosa, 2009). These early symptoms provide crucial clues to the underlying pathophysiology, suggesting that the disease process begins in the lower brainstem, enteric nervous system, and olfactory bulb before ascending to the substantia nigra and eventually the cerebral cortex (Braak & Del Tredici, 2008; Saito & Murayama, 2012).

Dementia in PD is clinically distinguished from Dementia with Lewy Bodies (DLB) by the "one-year rule," which states that in PDD, dementia develops in the context of well-established parkinsonism (i.e., more than one year after motor onset), whereas in DLB, dementia occurs before or concurrently with parkinsonism (Seppi & Rascol, 2007; McKeith et al., 2005). Despite this clinical distinction, PDD and DLB are now widely considered to be part of the same neuropathological continuum of Lewy body disease (LBD), sharing core clinical features and underlying α-synuclein pathology (Aarsland et al., 2005; Boeve, 2009; Ince, 2011).

This chapter provides a comprehensive examination of the biological and neurological mechanisms that underlie the development of mild and major neurocognitive disorders in Parkinson's disease. We will explore the critical roles of multiple neurotransmitter systems, the molecular and genetic factors driving neurodegeneration, the structural and functional brain changes revealed by neuroimaging, and the implications of these biological substrates for diagnosis, treatment, and future research. Understanding this complex neurobiology is paramount for developing effective therapies that can not only manage symptoms but also modify the course of this devastating aspect of Parkinson's disease.

## Neurobiological Systems

The cognitive deficits observed in PD-NCD are not the result of a single pathological process but rather a complex interplay of dysfunctions across multiple neurobiological systems. While the loss of dopamine is central to the motor symptoms of PD, the cognitive and behavioral manifestations arise from a more widespread neurodegeneration that implicates cholinergic, noradrenergic, and serotonergic pathways, which become progressively compromised as the disease advances (Barone, 2009; Pérez-Lloret & Barrantes, 2016).

### Dopaminergic Systems and Cognition

The foundational pathology of PD is the progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc), leading to profound dopamine deficiency in the dorsal striatum (caudate and putamen) (Gerlach & Riederer, 1993; Marín et al., 2018; Eckert et al., 2007). This nigrostriatal pathway is a key component of the motor loop of the basal ganglia-thalamocortical circuits, and its degeneration is directly responsible for the cardinal motor signs of PD (Marsden, 1984; Bergman & Deuschl, 2002). However, the basal ganglia are also integral to non-motor circuits, including associative and limbic loops that are critical for cognition and emotion (Pillon et al., 1996; Yanagisawa, 1998).

Cognitive impairment in early PD, particularly executive dysfunction (e.g., deficits in planning, set-shifting, and working memory), is strongly linked to the degeneration of dopaminergic projections beyond the nigrostriatal system (Levin & Katzen, 2005; Poletti & Moustafa, 2013). The mesocortical pathway, originating from the ventral tegmental area (VTA) and projecting to the prefrontal cortex (PFC), is crucial for executive functions (Narayanan et al., 2013; Yokochi, 2007). Depletion of dopamine in the PFC disrupts the modulation of cortical and subcortical networks, leading to the "dysexecutive syndrome" characteristic of PD-MCI (Bédard et al., 2003; Emre, 2003). This frontal-like cognitive profile is a core feature of what has been termed "subcortical dementia" (Cummings, 1988; Mayeux et al., 1983).

The mesolimbic pathway, also originating in the VTA and projecting to limbic structures like the nucleus accumbens and amygdala, is involved in motivation, reward processing, and emotional regulation (Fibiger, 1984; Yokochi, 2007). Dysfunction in this system is thought to contribute to apathy and anhedonia, common neuropsychiatric symptoms in PD that are closely intertwined with cognitive performance (Mamikonyan & Weintraub, 2015; Starkstein, 2009). The variable response of these cognitive and behavioral symptoms to levodopa therapy underscores the complexity of dopamine's role; while some executive functions may improve, dopaminergic overstimulation of relatively preserved ventral striatal pathways can lead to adverse effects like impulse control disorders (ICDs) or psychosis (Mestre et al., 2013; Weintraub et al., 2008; Leentjens & van den Heuvel, 2015).

### Cholinergic System Dysfunction

While dopaminergic deficits initiate many of the early cognitive changes, the transition to PDD is most robustly correlated with a profound and widespread cholinergic deficit (Pérez-Lloret & Barrantes, 2016; Emre, 2003). The primary source of cortical cholinergic innervation is the nucleus basalis of Meynert (NbM), a structure that undergoes significant neuronal loss and Lewy body pathology in PDD and DLB (Hornykiewicz & Kish, 1984; Mann & Yates, 1983). This cholinergic denervation is more severe in PDD than in PD patients without dementia and even exceeds that seen in Alzheimer's disease (AD) in some cortical areas (Aarsland et al., 2003; Jellinger, 2014).

The loss of cortical acetylcholine is strongly associated with attentional deficits, fluctuations in consciousness, and the development of visual hallucinations—core features of the Lewy body dementias (Bohnen et al., 2024; Perry et al., 1990). Furthermore, cholinergic deficits contribute significantly to impairments in memory and executive function (Bédard et al., 1999; Emre, 2003). The pedunculopontine nucleus (PPN), another key cholinergic nucleus in the brainstem, also degenerates in PD and is implicated in both gait dysfunction and attentional control, providing a link between motor and non-motor symptoms (Chambers et al., 2020; Pérez-Lloret & Barrantes, 2016). The critical role of the cholinergic system in PDD is substantiated by the modest but significant efficacy of cholinesterase inhibitors, such as rivastigmine, which are approved for the symptomatic treatment of dementia in PD (Rotaru et al., 2023; Emre et al., 2004; Aarsland, 2006).

### Noradrenergic and Serotonergic Systems

The neurodegenerative process in PD also affects other monoaminergic systems, which contribute significantly to the neuropsychiatric and cognitive landscape of the disorder (Barone, 2009; Poewe, 2008). The locus coeruleus (LC), the brain's primary source of norepinephrine, is one of the first sites to be affected by Lewy pathology, often preceding involvement of the substantia nigra (Braak & Del Tredici, 2008; Del Tredici & Braak, 2012). The resulting widespread noradrenergic denervation has been linked to a range of non-motor symptoms, including depression, apathy, fatigue, and cognitive deficits, particularly in attention and executive function (Szot et al., 2011; Kano et al., 2011). The noradrenergic system plays a crucial role in arousal, vigilance, and modulating cognitive flexibility, and its dysfunction likely contributes to the "bradyphrenia" or slowing of thought seen in PD (Grimbergen et al., 2009; Narayanan et al., 2013).

Similarly, the serotonergic system, originating in the dorsal raphe nuclei, is also compromised in PD (Grosch et al., 2016; Politis et al., 2010). Serotonin is a key regulator of mood, anxiety, and sleep-wake cycles. Degeneration of serotonergic neurons is a major biological substrate for depression and anxiety disorders, which are highly prevalent in PD and are themselves risk factors for cognitive decline and dementia (Schuster, 2014; Mollenhauer & Weintraub, 2017; van der Steen et al., 2019). Furthermore, serotonergic dysfunction has been implicated in the pathophysiology of PD psychosis and L-dopa-induced dyskinesias, highlighting the complex interactions between monoamine systems in the disease (Bosboom & Wolters, 2004; Faggiani, 2014). The widespread involvement of these non-dopaminergic systems explains why many cognitive and psychiatric symptoms are poorly responsive to dopamine replacement therapy and underscores the need for multi-target therapeutic approaches (Antonini et al., 2023; Barone, 2009).

## Genetic and Molecular Basis

At the core of the neurodegenerative process in PD and its associated cognitive disorders is a cascade of molecular and cellular events, driven by a combination of genetic predispositions and environmental factors (Bonifati, 2003; Johnson et al., 2018). The central molecular event is the misfolding and aggregation of the presynaptic protein α-synuclein, but this occurs in the context of other critical cellular dysfunctions, including mitochondrial impairment, oxidative stress, neuroinflammation, and failures in protein degradation pathways (Sarkar et al., 2016; Ritu Soni et al., 2023).

### Alpha-Synuclein and Lewy Body Pathology

The defining neuropathological hallmark of PD is the presence of intracellular proteinaceous inclusions known as Lewy bodies (LBs) and Lewy neurites (LNs) in surviving neurons (Gerlach & Riederer, 1993; Dickson, 2005; Goedert et al., 2003). The primary component of these aggregates is a misfolded and fibrillar form of α-synuclein (Spillantini et al., 1997; Yang et al., 2022). The discovery that mutations and multiplications in the α-synuclein gene (`SNCA`) cause autosomal dominant forms of PD provided conclusive evidence for its causal role in the disease (Chiba‐Falek & Nussbaum, 2003; He et al., 2007).

The progression of cognitive decline to dementia in PD is strongly associated with the extent and distribution of Lewy pathology (Apaydın et al., 2002; Jendroska, 1997). According to the staging scheme proposed by Braak and colleagues, α-synuclein pathology is hypothesized to originate in the olfactory bulb and the dorsal motor nucleus of the vagus in the lower brainstem (Stage 1-2), corresponding to the pre-motor phase of PD (Braak & Del Tredici, 2008; Wolters & Braak, 2006). The pathology then ascends through the brainstem to affect the locus coeruleus and substantia nigra (Stage 3-4), leading to the onset of motor symptoms (Saito & Murayama, 2012; Braak & Del Tredici, 2005). In later stages, the pathology spreads to limbic and neocortical areas (Stage 5-6), which correlates with the development of cognitive impairment and dementia (Hasegawa, 2007; Adachi & Hanajima, 2022). This stereotypical progression has fueled the "prion-like hypothesis," which posits that misfolded α-synuclein acts as a seed, propagating from cell to cell along neuroanatomical pathways and templating the misfolding of native α-synuclein in recipient cells (Giubilei & Orzi, 2014; Mou et al., 2019; Bellucci et al., 2015).

### Other Genetic Factors

While `SNCA` mutations are rare, research has identified several other genes that cause monogenic forms of PD or increase disease risk, providing invaluable insights into the underlying molecular pathways (Quadri, 2013; 정선주, 2011).

Mutations in `LRRK2` (leucine-rich repeat kinase 2) are the most common cause of both familial and sporadic late-onset PD (Saunders‐Pullman et al., 2019). LRRK2 is a large, complex kinase implicated in multiple cellular processes, including vesicle trafficking, autophagy, and immune responses (Zhang, 2019; Hoang, 2014). Pathogenic mutations, most commonly G2019S, enhance its kinase activity, suggesting that LRRK2 inhibitors could be a viable therapeutic strategy.

Autosomal recessive, early-onset PD is most frequently caused by mutations in `PARKIN` (gene `PARK2`), `PINK1`, and `DJ-1` (gene `PARK7`) (Bonifati, 2003; Khan et al., 2003; Kurian & Abela, 2021). These genes are crucial for mitochondrial quality control (Kroemer & Blomgren, 2007; Schneider & Klein, 2014). PINK1 acts as a sensor for mitochondrial damage, and upon depolarization, it accumulates on the outer mitochondrial membrane where it recruits and activates Parkin, an E3 ubiquitin ligase (Miklya et al., 2007). This initiates the process of mitophagy, the selective degradation of damaged mitochondria via the autophagy pathway (Sarah E.M. et al., 2012). Loss-of-function mutations in these genes lead to the accumulation of dysfunctional mitochondria, increased oxidative stress, and ultimately, neuronal death (Narendra et al., 2019). Interestingly, classic Lewy body pathology is often absent in `PARKIN`-associated PD, suggesting alternative pathways to dopaminergic neurodegeneration (Doherty et al., 2013).

Mutations in the `GBA` (glucocerebrosidase) gene, which cause the lysosomal storage disorder Gaucher's disease, represent the most significant genetic risk factor for developing PD (Beccari et al., 2011). `GBA` mutation carriers have an increased risk of PD and tend to have an earlier onset and a higher likelihood of developing cognitive impairment and dementia (Barrett, 2017; Aarsland et al., 2008). The GCase enzyme is involved in lysosomal function, and its deficiency is thought to impair the clearance of α-synuclein, creating a bidirectional pathogenic loop between the two proteins.

### Cellular and Synaptic Mechanisms

The convergence of genetic and pathological findings points to several key cellular mechanisms that drive neurodegeneration and cognitive decline in PD.

**Mitochondrial Dysfunction and Oxidative Stress:** There is extensive evidence for impaired mitochondrial complex I activity and increased oxidative stress in the PD brain (Sarkar et al., 2016; Ogawa & Mori, 1995). Dopaminergic neurons are particularly vulnerable due to their high energy demands, extensive axonal arborizations, and the inherent oxidative stress generated from dopamine metabolism itself (Trimmer et al., 1996; Ruberg et al., 1997). The link between `PINK1`/`PARKIN` and mitophagy solidifies the central role of mitochondrial dysfunction in PD pathogenesis (Kroemer & Blomgren, 2007; Sarah E.M. et al., 2012).

**Protein Degradation Failure:** The accumulation of α-synuclein aggregates points to a failure of the cell's primary protein degradation systems: the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP) (Bayliss et al., 2011). `PARKIN` mutations directly implicate the UPS, while `GBA` mutations highlight the role of lysosomal dysfunction. Aggregated α-synuclein itself can inhibit both pathways, creating a vicious cycle of protein accumulation and cellular toxicity (Gustavsson, 2015; Johnson et al., 2018).

**Neuroinflammation:** Post-mortem studies and in vivo imaging consistently show evidence of chronic neuroinflammation, characterized by the activation of microglia and astrocytes, in the brains of PD patients (Rogers & Kovelowski, 2003; Mollenhauer & Weintraub, 2017; Rocha et al., 2014). Inflammatory mediators can promote α-synuclein aggregation, increase oxidative stress, and directly contribute to neuronal death (Gao et al., 2008; Jiang, 2013). This inflammatory response may be triggered by neuronal death, environmental factors, or even signals from the gut microbiome, and it is considered a key "aggravator" of the disease process (Johnson et al., 2018; Padilha Guedes & Silva, 2010).

**Synaptic and Axonal Dysfunction:** A growing body of evidence suggests that synaptic and axonal terminals are the earliest sites of pathology in PD (Bellucci et al., 2015; Nakamura, 2022). Misfolded α-synuclein can impair synaptic vesicle release, disrupt axonal transport, and lead to a "dying-back" axonopathy, where the distal axon degenerates before the neuronal cell body dies (Grosch et al., 2016; Xie, 2011). This synaptic dysfunction contributes not only to motor symptoms but also to the disruption of cortical and subcortical circuits underlying cognitive processes (Cordeiro et al., 2023).

## References

1. Supriya Krishna, Sandhya Prasad, Rohit Goel, & Bijay Krishna Prasad (2018). PARKINSON’S DISEASE- A REVIEW. Journal of Evolution of Medical and Dental Sciences. https://doi.org/10.14260/jemds/2018/295
2. Shôji Nakamura (2022). Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder. Frontiers in Bioscience-Scholar. https://doi.org/10.31083/j.fbs1401004
3. M. Gerlach, & Peter Riederer (1993). The Pathophysiological Basis of Parkinson’s Disease. Milestones in drug therapy. https://doi.org/10.1007/978-3-0348-6348-3_2
4. Peter G. Fuhr, D Maritz, J Bernatik, & Steck Aj (1995). [Initial symptomatology of Parkinson disease].. PubMed
5. Parra Medina Luis Enrique, Arankowsky Sandoval Gloria, Salazar Ceballos Jorge Efraín, & Góngora Alfaro José Luis (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología
6. Dijana Š tefanec, Zrinka Puharić, Ružica Mrkonjić, Sabina Bis, & Jasmin Marjan-Š tefoković (2016). „Javnozdravstveni značaj Parkinsonove bolesti-prikaz slučaja“. Hrvatski časopis za javno zdravstvo
7. Hayet Sahli, Lilia Seddik, & Philippe Rémy (2018). [Non-motor symptoms of Parkinson disease and their management].. PubMed
8. Daniel Marín, Hans Carmona, Melissa Ibarra, & Manuela Gámez (2018). Enfermedad de Parkinson: fisiopatología, diagnóstico y tratamiento. Salud UIS. https://doi.org/10.18273/revsal.v50n1-2018008
9. Julia C. Greenland, & Roger A. Barker (2018). The Differential Diagnosis of Parkinson’s Disease. Codon Publications eBooks. https://doi.org/10.15586/codonpublications.parkinsonsdisease.2018.ch6
10. Reijo J. Marttila (1983). Diagnosis and epidemiology of Parkinson's disease. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1983.tb01512.x
11. Jean‐Pierre Schuster (2014). Dépression et maladie de Parkinson. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.274
12. Yoshikuni Mizuno (1997). [Concept and diagnostic criteria of Parkinson's disease and parkinsonism].. PubMed
13. Christof Stumpf (1983). Antiparkinsonmittel. https://doi.org/10.1007/978-3-7091-3384-2_14
14. B Mignot, & H Ollat (1982). [Parkinson disease and depression (author's transl)].. PubMed
15. Joseph Jankovic (2008). Parkinson's disease: clinical features and diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2007.131045
16. Iraís Viveros-Martínez, Cristofer Zarate-Calderon, Donají Chi-Castañeda, Porfirio Carrillo, Gonzalo Emiliano Aranda‐Abreu, Armando J. Martínez, Jorge Manzo, Genaro A. Coria‐Ávila, & Luis I. García (2024). Characterizing Secondary and Atypical Parkinsonisms: Defining Features and Clinical Variability. Neuroglia. https://doi.org/10.3390/neuroglia5040030
17. Barbara Starovasnik, & Alenka Sever (2004). Motnje kognitivnih sposobnosti pri bolnikih s Parkinsonovo boleznijo. Psihološka obzorja. https://doi.org/10.20419/2004.13.149
18. Manju A. Kurian, & Lucia Abela (2021). DNAJC6 Parkinson Disease
19. Jonathan T. Butler, & Christopher Tolleson (2014). New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527313666140917104850
20. Ashok Chakraborty, & Anil Diwan (2022). Depression and Parkinson's disease: a Chicken-Egg story. AIMS neuroscience. https://doi.org/10.3934/neuroscience.2022027
21. Cecilia Peralta (2013). [Neuropsychiatric non motor symptoms of Parkinson's disease].. PubMed
22. Lilia Rotaru, Oxana Grosu, & Stanislav Groppa (2023). Current level of knowledge about Parkinson’s disease cognitive impairment: review. The Moldovan Medical Journal. https://doi.org/10.52418/moldovan-med-j.66-2.23.15
23. Lance M. McCracken, John V. Hindle, Angeliki Bogosian, Neil P. Robertson, G. Meco, & Ewald M. Hennig (2020). Advances in Peripheral Neuropathy in Parkinson’s Disease
24. Josep Valls‐Solé (2005). Role of Electrophysiology in Diagnosis and Research in Atypical Parkinsonian Disorders. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:409
25. Rishika Meadwle (2021). Parkinson’s Disease: Progressive Nervous System Disorder that Affects Movements. International Journal of Physical Medicine & Rehabilitation
26. Brian Bell (2008). Depression and Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2008.04.01.67
27. D Sharang, A. J. Vyavahare, & Anuja Bokhare (2025). Enhancing Parkinson’s Disease Diagnosis Using Machine Learning: A Comparative Study. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-6366739/v1
28. Rosane Sampaio Santos, Carlos Henrique Ferreira Camargo, Edna Márcia da Silva Abdulmassih, & Hélio Afonso Ghizoni Teive (2015). Dysphagia in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/60983
29. Franciele da Trindade Flores (2009). EQUILÍBRIO CORPORAL DE INDIVÍDUOS COM DOENÇADE PARKINSON
30. Marialuisa Quadri (2013). Finding Genes for Parkinsonism
31. Klaus Seppi, & Olivier Rascol (2007). Dementia with Lewy bodies and Parkinson disease with dementia. Neurology. https://doi.org/10.1212/01.wnl.0000269667.17041.66
32. Daniel Z. Press (2004). Parkinson's Disease Dementia — A First Step?. New England Journal of Medicine. https://doi.org/10.1056/nejme048305
33. Rodolfo Savica, Walter A. Rocca, & J. Eric Ahlskog (2010). When Does Parkinson Disease Start?. Archives of Neurology. https://doi.org/10.1001/archneurol.2010.135
34. Matthew Menza (2010). Psychiatric Symptoms Associated With Parkinson Disease
35. Yuko Saito, & Shigeo Murayama (2012). [Braak's hypothesis and non-motor symptoms of Parkinson disease].. PubMed
36. Sandrine Greffard, & Marc Verny (2012). Quels diagnostics envisager chez un patient âgé présentant l'association d'un syndrome parkinsonien et de troubles cognitifs ? What diagnosis would you consider in case of parkinsonism and cognitive impairment in the elderly?
37. Giuseppe Nicoletti (2010). Sporadic Parkinsonism. BMC Geriatrics. https://doi.org/10.1186/1471-2318-10-s1-l40
38. Iria Rodríguez Constenla, Iria Cabo, Paula Bellas Lamas, & Ernesto M. Cebrián Pérez (2010). Trastornos cognitivos y neuropsiquiátricos en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009737
39. Gerhard Ransmayr (2015). Cognitive impairment in Parkinson's disease.. PubMed
40. Richard Camicioli (2002). Identification of parkinsonism and Parkinson's disease. Drugs of today. https://doi.org/10.1358/dot.2002.38.10.740195
41. Yoshio Tsuboi, Virgilio H. Evidente, & Zbigniew K. Wszołek (2005). Clinical Diagnosis of Familial Atypical Parkinsonian Disorders. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:375
42. Paola Presečki, Igor Filipčić, Goran Arbanas, & Ninoslav Mimica (2014). Neurocognitive disorders in DSM-5
43. Linda J. Keilman, M Harris, & Sharon Bronner (2021). 300 - Increasing Complexity Awareness of Parkinson Disease Psychosis: Risk Factors, Symptoms, Diagnosing &amp; Management. International Psychogeriatrics. https://doi.org/10.1017/s1041610221001514
44. Toshikazu Kondo (1997). [Brain tumor and parkinsonism].. PubMed
45. David L. Brody (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
46. Vincenzo Bonifati (2003). Autosomal recessive, early-onset Parkinson’s disease
47. Brit Mollenhauer, & Daniel Weintraub (2017). The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700737114
48. Joseph Rogers, & Carl J. Kovelowski (2003). Inflammatory Mechanisms in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-297-5_21
49. Yeojin Bang, Juhee Lim, & Hyun Jin Choi (2021). Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson’s disease: clues to early diagnosis and effective treatment. Archives of Pharmacal Research. https://doi.org/10.1007/s12272-021-01337-3
50. María‐Jesús Sobrido, J J Dias-Silva, & B Quintáns (2009). [Behavioral disorders in Parkinson's disease. Genetic, pharmacological and medico-legal aspects].
51. María Jesús Sobrido, Juan José Dias Silva, & Beatriz Quintans Castro (2009). Trastornos del comportamiento en la enfermedad de Parkinson. Aspectos genéticos, farmacológicos y médico-legales. Revista de Neurología. https://doi.org/10.33588/rn.48s01.2008730
52. Thomas Eckert, Dennis J. Zgaljardic, & David Eidelberg (2007). Parkinson’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0010
53. Sayaka Taniguchi, & Atsushi Takeda (2015). I. New Insights into Symptoms in Parkinson's Disease Including Non Motor Featrures. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.104.1546
54. Regina Galabov (2011). Olfaktorische Störungen bei neurodegenerativen Erkrankungen
55. Hye Mi Lee, & Seong‐Beom Koh (2015). Many Faces of Parkinson's Disease: Non-Motor of Parkinson's Disease
56. 余舒扬, & Wei Zhang (2012). 帕金森病认知障碍的异质性. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2012.06.018
57. R. J. Marttila, & U. K. Rinne (1988). Parkinson's disease and essential tremor in families of patients with early-onset Parkinson's disease.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.51.3.429
58. Katiane Roversi, Natália Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, & Sébastien Talbot (2021). Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.759679
59. Peter Hedera, & Joseph H. Friedman (2014). Can fall of blood pressure prevent falls in Parkinson disease?. Neurology. https://doi.org/10.1212/wnl.0000000000000370
60. Bhaskar Ghosh, Amar Mishra, & Prosenjit Sengupta (2005). Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.. PubMed
61. David J. Burn, & Alison J. Yarnall (2015). Motor symptoms and phenotype in patients with Parkinson’s disease dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199681648.003.0007
62. LI Yang-yan (2015). Research status of pathogenesis of non-motor symptoms of Parkinson disease. Acta Medicinae Sinica
63. Jing Du, & Zongliang Gao (2014). Recent advance in cognitive impairment in Parkinson's disease. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2014.08.025
64. 정선주 (2011). 파킨슨병의 유전 인자. 대한의사협회지
65. S. J. Huber, Donald L. Freidenberg, Edwin C. Shuttleworth, George W. Paulson, & J A Christy (1989). Neuropsychological impairments associated with severity of Parkinson's disease. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.1.2.154
66. Cristina Sánchez Castañeda (2009). Structural brain changes, cognitive deficits and visual hallucinations in dementia with lewy bodies and parkinson's disease with dementia. TDX (Tesis Doctorals en Xarxa)
67. Deivendran Kalirathinam, Dr Suresh D Vaidya, & Aqsa Nazeer (2014). Analyze The Effect of Dual Task Hand Activities In Parkinsons Patients. IOSR Journal of Nursing and health Science. https://doi.org/10.9790/1959-03515766
68. Barbara Schildkrout (2014). Disease #48: Parkinson's Disease. https://doi.org/10.1002/9781394260447.ch76
69. Qiying Sun, & Beisha Tang (2017). α-Syn-PMCA in cerebrospinal fluid has diagnostic potential in Parkinson’s disease. Journal of Xiangya Medicine. https://doi.org/10.21037/jxym.2017.12.03
70. Héctor Riquelme-Heras (2021). Multicausality as an Increase in the Latency Period for the Diagnosis of Parkinson's Disease in Primary Care: A Case Report. Journal of Clinical and Medical Research. https://doi.org/10.37191/mapsci-2582-4333-3(3)-067
71. O Hornykiewicz, & Stephen J. Kish (1984). Neurochemical Basis of Dementia in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046382
72. Fumihito Yoshii (2012). [Pain and sensory disturbance in Parkinson disease].. PubMed
73. Melissa J. Armstrong, & Michael S. Okun (2020). Diagnosis and Treatment of Parkinson Disease. JAMA. https://doi.org/10.1001/jama.2019.22360
74. Florence Chang, & Keith A. Josephs (2013). Levodopa Responsiveness in Adult-onset Lower Limb Dystonia is Associated with the Development of Parkinson's Disease.. PubMed. https://doi.org/10.7916/d8vd6x5m
75. Jörg B. Schulz, R. Benecke, R. Dodel, K. Eggert, W. Fogel, M. Gerlach, H. Reichmann, P. Riederer, A. Schwartz, & J. Winkler (2005). Strukturierte Diagnostik bei Parkinson-Syndromen. Aktuelle Neurologie. Sup./Aktuelle Neurologie. Supplement. https://doi.org/10.1055/s-2005-866880
76. Inga Liepelt (2007). Neuropsychologische Auffälligkeiten in der Frühphase des Morbus Parkinson. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-987454
77. Lijun Zuo, & Wei Zhang (2016). Fatigue in Parkinson's disease: a review. https://doi.org/10.3760/cma.j.issn.0254-9026.2016.04.022
78. John V. Hindle (2010). Ageing, neurodegeneration and Parkinson's disease. Age and Ageing. https://doi.org/10.1093/ageing/afp223
79. Ranjita Betarbet, & J. Timothy Greenamyre (2007). Rotenone Model for Parkinson’s Disease. CRC Press eBooks. https://doi.org/10.3109/9781420019223-25
80. Georg Ebersbach (2002). Parkinson-Syndrom und zerebrovaskuläre Morbidität. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57512-9_6
81. Wahyu Dwi Hantoro, Indarwati Setyaningsih, & Mochammad Was’an (2019). Patofisiologi parkinsonism pasca trauma kepala. https://doi.org/10.22146/bns.v18i2.54995
82. E Arunraj (2013). Study of Autonomic Nervous System Dysfunction in Parkinson’s Patients.
83. Ladan Ghazi Saidi (2020). Visuospatial and Executive Deficits in Parkinson’s Disease: A Review. Acta Scientific Neurology. https://doi.org/10.31080/asne.2020.03.0172
84. Liliana Cuibus, & Marcel Pereanu (2012). Vegetative Disorders in Parkinson's Disease. Acta Medica Transilvanica
85. John M. Morgan, & Kapil D. Sethi (2007). Differential Diagnosis. CRC Press eBooks. https://doi.org/10.3109/9781420019995-7
86. Christian Geny (2009). Démence parkinsonienne et démence à corps de Lewy. Neurologie com. https://doi.org/10.1684/nro.2009.0075
87. William C. Koller, & Erwin B. Montgomery (1997). Issues in the early diagnosis of Parkinson's disease. Neurology. https://doi.org/10.1212/wnl.49.1_suppl_1.s10
88. О. В. Яковлева, & О С Левин (2021). Speech and behavioral contaminations as non-epileptic automatic behavior in Parkinson’s disease. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro202112110258
89. R. R. Tyutina, A A Pilipovich, В Л Голубев, & A B Danilov (2020). Microbiota and Parkinson's disease (overview). Medical alphabet. https://doi.org/10.33667/2078-5631-2020-1-10-14
90. Rajib Dutta (2021). Role of neuron specific enolase as a biomarker in Parkinson’s disease. Journal of Neuroscience and Neurological Disorders. https://doi.org/10.29328/journal.jnnd.1001052
91. Lorena Cuenca‐Bermejo, Ana-Luisa Gil-Martínez, Lorena Cano-Fernandez, Consuelo Sánchez-Rodrigo, Cristina Estrada, Emiliano Fernández‐Villalba, & María Trinidad Herrero (2019). Parkinson's disease: a short story of 200 years.. PubMed. https://doi.org/10.14670/hh-18-073
92. Wolfgang H. Oertel, Dávid Vadász, Vincent Ries, Geert Mayer, Karla Eggert, Martina Krenzer, Marcus M. Unger, Günter U. Höglinger, Brit Mollenhauer, Frie﻿de﻿ri﻿ke Sixel-Döring, Claudia Trenkwalder, & Candan Depboylu (2013). Prodromale Marker der Parkinson-Krankheit. Aktuelle Neurologie. https://doi.org/10.1055/s-0033-1355379
93. J Sigwald, & J. Damagnez (1952). Dyskinésies de la langue: Manifestations post-encephalitiques associées ou non à un syndrome parkinsonien. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x1952000200006
94. Cecil Todes (1984). Idiopathic Parkinson's disease and depression: a psychosomatic view.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.47.3.298
95. William J. Weiner (2008). Early diagnosis of Parkinson's disease and initiation of treatment.. Reviews in neurological diseases
96. Sakshi, & Pooja Anand (2024). Parkinson’s New Advancements in Diagnosis and Treatment: A Review. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2024/75485.19997
97. Gutknecht (2002). Einfluss von Begleitsymptomen und Begleiterkrankungen auf Behandlungsstrategien beim idiopathischen Parkinsonsyndrom. Praxis. https://doi.org/10.1024/0369-8394.91.10.419
98. Alice Poisson (2014). Les hallucinations dans la maladie de Parkinson. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.276
99. M Gonce, & A. Barbeau (2023). CURRENT TREATMENT ON PARKINSON'S DISEASE. International Research Journal of Modernization in Engineering Technology and Science. https://doi.org/10.56726/irjmets36198
100. Arvind Kumar (2022). Herbal Moieties and its effect on Parkinsonism: A New Prospective. YMER Digital. https://doi.org/10.37896/ymer21.08/41
101. Yves Agid, & J. Blin (2007). Nerve Cell Death in Degenerative Diseases of the Central Nervous System: Clinical Aspects. Novartis Foundation symposium. https://doi.org/10.1002/9780470513422.ch2
102. El Sayed El Sayed, Amany A. Eissa, Shahira Nofal, & Engy Elmorsy (2018). Parkinson's disease: A Review about Pathogenesis, Pharmaceutical Treatment and Experimental Models. Journal of Advanced Pharmacy Research. https://doi.org/10.21608/aprh.2018.8013
103. Sushil Kumar Garg, Kiran Bala, Hardeep Singh Malhotra, Aldrin Anthony, & Siddharth Maheshwari (2022). Non-motor Dysfunction in Idiopathic Parkinson’s Disease - An Indian Perspective. Acta Scientific Neurology. https://doi.org/10.31080/asne.2022.05.0524
104. B. Pillon, Bruno Dubois, & Yves Agid (1996). Testing cognition may contribute to the diagnosis of movement disorders. Neurology. https://doi.org/10.1212/wnl.46.2.329
105. Matthew Menza, Roseanne D. Dobkin, & Humberto Marín (2006). Cognitive and psychiatric aspects of Parkinson’s disease: treatment recommendations. Aging Health. https://doi.org/10.2217/1745509x.2.1.87
106. Yutaka Suzuki (2012). Mild Cognitive Impairment. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.71.385
107. Alex Rajput, Ryan J. Uitti, Sniya Sudhakar, & B. Rozdilsky (1989). Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Annals of Neurology. https://doi.org/10.1002/ana.410250612
108. Ilona Csóti, & Ferenc Fornádi (2010). Differential diagnosis of atypical Parkinsonian syndromes
109. Tanaya Mishra, Nitish Kamble, Amitabh Bhattacharya, Ravi Yadav, Dwarakanath Srinivas, & Pramod Kumar Pal (2024). Impact of Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease. Journal of Movement Disorders. https://doi.org/10.14802/jmd.23247
110. Пиллипович Анна Александровна, П У Гойтемирова, Ноздрюхина Наталия Васильевна, Струценко Алла Анатольевна, Гарабова Наида Исагаджиевна, Чебоксаров Дмитрий Васильевич, & Бунтина Мария Александровна (2013). Немоторные проявления болезни Паркинсона. Электронный научно-образовательный вестник «Здоровье и образование в XXI веке»
111. Fatai Kunle Salawu, & A B Olokoba (2015). Excessive Daytime Sleepiness and Unintended Sleep Episodes Associated with Parkinson’s Disease. Oman Medical Journal. https://doi.org/10.5001/omj.2015.02
112. Jennifer Rich (2001). Degenerative Central Nervous System (CNS) Disease. Pediatrics in Review. https://doi.org/10.1542/pir.22.5.175
113. Nir Giladi, & Eldad Melamed (2000). The role of functional neurosurgery in Parkinson's disease.. PubMed
114. Jaunilson Francisco Da Cruz, & Luciana El Bainy Correa Da Cruz (2020). EXERCÍCIOS FÍSICOS PARA PARKINSON.. Fiep Bulletin - online. https://doi.org/10.16887/90.a1.8
115. Adrian Massey, Matthew K. Boag, Annie Magnier, Dharah P. C. F. Bispo, Tien K. Khoo, & Dean L. Pountney (2022). Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms232112928
116. A O Akhmadulina, О С Левин, & М Г Полуэктов (2020). Restless legs syndrome in Parkinson’s disease. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro202012010280
117. Н. Б. Чеснокова, Т. А. Павленко, & M. V. Ugrumov (2017). Ophthalmic disorders as a manifestation of Parkinson's disease. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro201711791124-131
118. Perry Schuster (2010). Restriktive Valvulopathie im Rahmen einer Behandlung mit Dopaminagonisten
119. Suharti Suharti (2020). Patofisiologi Penurunan Kognitif pada Penyakit Parkinson. UMI Medical Journal. https://doi.org/10.33096/umj.v5i1.76
120. Ildikó Miklya, Patricia Göltl, Florencia Hafenscher, & Noémi Pencz (2007). The Role of PARKIN in Parkinson’s Disease. CRC Press eBooks. https://doi.org/10.3109/9781420019223-17
121. Mutsumi Iijima (2018). Odor dysfunction in Parkinson’s disease and neurodegenerative diseases. Journal of Japan Association on Odor Environment. https://doi.org/10.2171/jao.49.370
122. Hans‐Michael Meinck, & Peter A. Ringleb (2012). Parkinson-Syndrom und andere Bewegungsstoerungen
123. Josef Finsterer (2011). Parkinson's syndrome and Parkinson's disease in mitochondrial disorders. Movement Disorders. https://doi.org/10.1002/mds.23651
124. Amin Cervantes‐Arriaga, & Mayela Rodríguez‐Violante (2011). Disfunción no motora en la enfermedad de Parkinson: una enfermedad neurológica con manifestaciones multisistémicas. Medicina Interna de México
125. Nelly Fabre, C Brefel-Courbon, & O Rascol (1997). [Parkinson "plus"].. PubMed
126. 丁铭臣 (1992). 神经系统疾病专题讲座：第十讲 巴金森病进展. 中级医刊
127. Sri Yenni Trisnawati, Purwa Samatra Dewa Putu Gde, Lely Setyawati Kurniawan, Astari Arum Cendani Goller, & Valentina Tjandra Dewi (2022). GEJALA PSIKOTIK PADA PENYAKIT PARKINSON: SEBUAH LAPORAN KASUS DAN TINJAUAN PUSTAKA. Callosum Neurology. https://doi.org/10.29342/cnj.v4i2.152
128. Derek P. Narendra, Risa Isonaka, Diana Nguyen, Alice B. Schindler, Angela Kokkinis, Debra Ehrlich, Tanya Bardakjian, David S. Goldstein, Tsao‐Wei Liang, & Pedro Gonzalez‐Alegre (2019). Peripheral synucleinopathy in a <i>DJ1</i> patient with Parkinson disease, cataracts, and hearing loss. Neurology. https://doi.org/10.1212/wnl.0000000000007614
129. Thierry Gallarda (2004). [Depression and organic brain diseases in the elderly].. Gériatrie et Psychologie Neuropsychiatrie du Viellissement
130. Ruth Sander (2015). Search for early indicators of Parkinson’s disease. Nursing Older People. https://doi.org/10.7748/nop.27.4.13.s16
131. Iris Reuter, S. Mehnert, Matthias Oechsner, & Martin Engelhardt (2011). Cognitive Rehabilitation in Parkinson's Disease Using Neuropsychological Training, Transfer Training and Sports Therapy. InTech eBooks. https://doi.org/10.5772/17685
132. Mun Yin Yen, Ketut Tirtayasa, & Dewa Putu Sutjana (2013). RATIONAL MANAGEMENT OF PARKINSON’S DISEASE
133. G. Arthur, & M. Jeff (2011). Pesticides and Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/16479
134. Yang Yang, Yang Shi, Manuel Schweighauser, Xianjun Zhang, Abhay Kotecha, Alexey G. Murzin, Holly J. Garringer, Patrick W. Cullinane, Yuko Saito, Tatiana Foroud, Thomas T. Warner, Kazuko Hasegawa, Rubén Vidal, Shigeo Murayama, Tamás Révész, Bernardino Ghetti, Masato Hasegawa, Tammaryn Lashley, Sjors H. W. Scheres, & Michel Goedert (2022). Cryo-EM structures of α-synuclein filaments from Parkinson’s disease and dementia with Lewy bodies. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2022.07.12.499706
135. Janice Wong, & Lili‐Naz Hazrati (2013). Parkinson’s disease, parkinsonism, and traumatic brain injury. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408363.2013.844678
136. Eduardo Tolosa, Marı́a José Martı́, & Yaroslau Compta (2012). Dystonic symptoms associated with parkinsonian disorders. CRC Press eBooks. https://doi.org/10.3109/9781841848525-21
137. Jeniffer Maricruz Muentes Solorzano, Johanna Katherine Lucas Quijije, Tania del Rocío Menéndez Pin, & Jonathan Vinicio Cornejo Vera (2020). Causas y efectos de los pacientes diagnosticados con el mal de Parkinson. RECIMUNDO. https://doi.org/10.26820/recimundo/4.(4).octubre.2020.496-508
138. Naomi P. Visanji, & Connie Marras (2015). The relevance of pre-motor symptoms in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2015.1083423
139. Neil Gordon (2015). Intractable or refractory epilepsy. Journal of Pediatric Neurology. https://doi.org/10.1055/s-0035-1557217
140. Roddiel Merino Yan, Miriam Marañón Cardonne, Enrique Juan Marañón Reyes, & Antonio García Leyva (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
141. Daniel Benharroch (2024). Drug Induced Parkinsonism As It Compares With Parkinson Disease. Advances In Clinical And Medical Research. https://doi.org/10.52793/acmr.2024.5(2)-76
142. Victoria Mery Canales, & Carlos J Uri Clavería (2008). Manifestaciones no motoras en la enfermedad de Parkinson. REVISTA MÉDICAS UIS
143. Yvette Bordelon, & Adrienne M. Keener (2016). Parkinsonism. Seminars in Neurology. https://doi.org/10.1055/s-0036-1585097
144. Hans Christian Ring (1993). Psychological and social problems of Parkinson's disease.. PubMed
145. Viktor Kholin, Karaban' In, Sergiy Kryzhanovskiy, N.V. Karasevich, Н А Мельник, Maryna Khodakovska, Hanna Shershanova, & N. O. Movchun (2024). Cognitive disorders in Parkinson's disease. Ageing & Longevity. https://doi.org/10.47855/jal9020-2024-5-6
146. Terry Rolan (2006). Sleep and Parkinson's disease.. Missouri medicine
147. John C. Morgan, Shyamal H. Mehta, & Kapil D. Sethi (2013). Differential diagnosis. CRC Press eBooks. https://doi.org/10.1201/b14361-6
148. Christina Vaughan, & Jennifer G. Goldman (2012). Psychosis and Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_6
149. Nadja Gustavsson (2015). Unfolding the role of the UPR in Parkinson’s disease
150. Alberto Albanese (2006). Can falls be prevented in Parkinson's disease?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2006.108324
151. Joseph H. Friedman, & Hubert H. Fernandez (2000). THE NONMOTOR PROBLEMS OF PARKINSONʼS DISEASE. The Neurologist. https://doi.org/10.1097/00127893-200006010-00004
152. Rachel Saunders‐Pullman, Deborah Raymond, & Sonya Elango (2019). LRRK2 Parkinson Disease
153. Javier Martín‐Núñez (2021). Associations between kinesiophobia, performance and functionality in patients with freezing of gait and Parkinson. European journal of health research. https://doi.org/10.32457/ejhr.v7i1.1395
154. 柳澤 信夫 (1994). Parkinson's disease.Diagnosis and advance in medical care.2.Advance in pathosis and diagnosis.1.Initial symptoms and diagnosis of Parkinson's disease.. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.83.539
155. Helena Maria Van Oers (2019). Correlates of psychiatric and psychological distress in patients with Parkinson’s disease. https://doi.org/10.36811/jphsm.2019.110010
156. Pavithra K.Pavithra, Antonette Rhea, Dhanraj M.Dhanraj, & Pravinya Pravinya P (2018). Prosthodontic Management of a Patient with Parkinson’s disease- A Case Report. Journal of Young Pharmacists. https://doi.org/10.5530/jyp.2018.10.84
157. Unknown (2010). Care and management of the patient with advanced dementia. CRC Press eBooks. https://doi.org/10.1201/b13196-50
158. Н. В. Федорова, Ekaterina Bril, Т К Кулуа, & A. Mikhaylova (2021). Progressive supranuclear palsy. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro2021121051111
159. Neilys González Benítez (2018). La neutrosofía para tratar la incertidumbre de trastornos mentales en la tercera edad
160. Syeda Arshiya Farheen, Pooja Shah, Manpreet Gill, Sumayya Ayaz, Satneet Singh, Archana Adikey, Venkatesh Sreeram, Rizwan Ahmed, Mariyah Hussain, & Saeed Ahmed (2017). Translational Science of Psychosis in Parkinsons Disease. Clinical Depression. https://doi.org/10.4172/2572-0791.1000102
161. Deepak Shrivastava (2022). Pharmacological Agents Used in Various Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003093381-28
162. Clifford W. Shults (2003). Treatments of Parkinson Disease. Archives of Neurology. https://doi.org/10.1001/archneur.60.12.1680
163. 葛原 茂樹 (2005). 痴呆診療：診断と治療の進歩 老年期痴呆の診断. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.94.1482
164. Bradley F. Boeve (2015). Parkinsonism-Related Dementiasa. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0036
165. Stewart A. Factor, Eric Molho, Gerald D. Podskalny, & Diane Brown (1995). Parkinson's disease: drug-induced psychiatric states.. PubMed
166. Zheng-Hao Huang, Hsiang‐Cheng Chen, Yu‐Ching Chou, Cheng‐Li Lin, Chia‐Hung Kao, Hsin‐Yi Lo, Tse-Yen Yang, & Feng‐Cheng Liu (2018). Does nephrotic syndrome without chronic kidney disease increase the risk of Parkinson’s disease and secondary parkinsonism? A nationwide population-based study in Taiwan. BMJ Open. https://doi.org/10.1136/bmjopen-2017-020821
167. Robert L. Rodnitzky (1999). THE PARKINSONISMS. The Neurologist. https://doi.org/10.1097/00127893-199911000-00002
168. David de Noreña Martínez, David Ezpeleta, & Germán Latorre González (2022). Enfermedades neurológicas y juego. Kranion. https://doi.org/10.24875/kranion.m22000027
169. Jinwei Zhang (2019). LRRK2 Signalling Pathways in Parkinson’s Disease. Archives in Neurology & Neuroscience. https://doi.org/10.33552/ann.2019.02.000540
170. Mark W. Mahowald, Michel Cramer Bornemann, & Carlos H. Schenck (2004). Parasomnias. Seminars in Neurology. https://doi.org/10.1055/s-2004-835064
171. Fanshi Zhang, Ai‐Di Luo, Shusheng Liao, Mei Liu, Jun Zhang, & Zucai Xu (2024). Progress of non‐motor symptoms in early‐onset Parkinson's disease. Ibrain. https://doi.org/10.1002/ibra.12180
172. Richard Appleton, & Rajat Das Gupta (2018). Cerebral palsy: not always what it seems. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2018-315633
173. Hasan Belli, Mahir Akbudak, Cenk Ural, & Filiz Kulacaoğlu (2012). Solitary lesion in ponto-mesencephalic area related secondary mania: a case report.. PubMed
174. Brandon Barton, S. Elizabeth Zauber, & Christopher G. Goetz (2009). Movement Disorders Caused by Medical Disease. Seminars in Neurology. https://doi.org/10.1055/s-0029-1213731
175. Jessica Kandl, & Jaime Eaglin Moore (2022). Parkinson Disease. Journal of Singing. https://doi.org/10.53830/xagk4962
176. John Harrison, Isabel Stow, & Adrian M. Owen (2001). Parkinson’s disease. CRC Press eBooks. https://doi.org/10.3109/9780203213193-13
177. Dennis W. Dickson, & Carolyn Orr (2011). Neuropathology of Dementia in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch14
178. David A. Oakley, Nick Ward, Peter W. Halligan, & R. S. J. Frackowiak (2003). Differential brain activations for malingered and subjectively ‘real’ paralysis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198515548.003.0021
179. Tien K. Khoo, & David J. Burn (2009). Non-motor symptoms may herald Parkinson's disease.. PubMed
180. George Wilson, Charles Rupp, & Harvey Bartle (1943). EMOTIONAL FACTORS IN ORGANIC DISEASE OF THE CENTRAL NERVOUS SYSTEM. American Journal of Psychiatry. https://doi.org/10.1176/ajp.99.6.788
181. Robert L. Rodnitzky (2000). Diagnosis of parkinsonism in the elderly. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511585012.003
182. Epameinondas Lyros, Lambros Messinis, & Panagiotis Papathanasopoulos (2008). Clinical correlates of mental dysfunction in Parkinson's disease without dementia. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-7-s1-s262
183. Werner Poewe (2008). Non‐motor symptoms in Parkinson’s disease. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2008.02056.x
184. Hans‐Christoph Steinhausen, & Christopher Gillberg (2006). Brain disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543807.002
185. Awadhesh Kumar Baranwal, & Sujit Kumar (2021). AN APPLIED PHYSIOLOGY OF PARKINSON’S DISEASE – AN OLD AGE NEUROLOGICAL DISORDER. Journal of Emerging Technologies and Innovative Research
186. Ian R. Mackenzie (2005). Neuropathology of Atypical Parkinsonian Disorders. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:033
187. Gonzalo J. Revuelta, Guttalu K. Kumaraswamy, & Carol F. Lippa (2015). Pathological correlates of dementia in Parkinson’s disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199681648.003.0015
188. Darius K.‐S. Chan (2001). Parkinson disease and its differentials. Diagnoses made easy.. PubMed
189. Maria L. Moro‐de‐Casillas, & David E. Riley (2012). Insomnia in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_17
190. Bonnie Levin, Rachel Tomer, & Gustavo Rey (1992). Cognitive Impairments in Parkinson’s Disease. Neurologic Clinics. https://doi.org/10.1016/s0733-8619(18)30222-6
191. Andreas Straube, & Iris Reuter (2000). Parkinson-Syndrom und Sport. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-1017559
192. Unknown (2020). Exploring the clinical burden of OFF periods in Parkinson disease. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2020.88517
193. Ümit Özgür Akdemir, & Lütfiye Özlem Atay (2016). Nuclear Medicine Applications in Movement Disorders. Nuclear Medicine Seminars. https://doi.org/10.4274/nts.2016.021
194. Ümit Özgür Akdemir, & Lütfiye Özlem Atay (2017). Nuclear Medicine Applications in Movement Disorders. Nuclear Medicine Seminars. https://doi.org/10.4274/nts.021
195. Maja Antulić (2019). Komplementarni fizioterapijski pristupi kod osoba s Parkinsonovom bolesti
196. Wendy R. Galpern, & Anthony E. Lang (2006). Interface between tauopathies and synucleinopathies: A tale of two proteins. Annals of Neurology. https://doi.org/10.1002/ana.20819
197. Victor Ponomariov, & Е В Мазуренко (2012). Диагностика болезни Паркинсона на ранних стадиях заболевания. Медицинские новости
198. Jon Stone, Suvankar Pal, D. Blackburn, Markus Reuber, Parvez Thekkumpurath, & Alan Carson (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
199. Adriana Jiménez, Diana Organista‐Juárez, Luísa Rocha, Enrique Estudillo, Verónica Fernández-Sánchez, Mónica Alethia Cureño-Díaz, Mara A. Guzmán‐Ruiz, & Rosalinda Guevara‐Guzmán (2024). Dysfunction of olfactory structures: A conserved mechanism of neurodegeneration?. Brain Behavior and Immunity Integrative. https://doi.org/10.1016/j.bbii.2024.100053
200. Franco Giubilei, & Francesco Orzi (2014). Hetrogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039829201344
201. Nabeel Ali, Amna Syeda, Tenzin Topgyal, Naseem A. Gaur, & Asimul Islam (2021). Parkinson’s Disease: A Current Perspectives on Parkinson’s Disease and Key Bioactive Natural Compounds as Future Potential Drug Candidates. Current Drug Targets. https://doi.org/10.2174/1389450122666210623115505
202. Jacqueline Bayliss, Romana Stark, Alex Reichenbach, & B. Zane (2011). Gut Hormones Restrict Neurodegeneration in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/28028
203. Jayakrishna S Madabushi, Mayank Gupta, Brett Pearce, & Nihit Gupta (2023). Parkinson’s Disease: Diagnostic Challenges Amidst Transdiagnostic and Overlapping Mental Health Symptoms. Cureus. https://doi.org/10.7759/cureus.36661
204. Katie Kompoliti, & Christopher G. Goetz (2005). Approach to the patient presenting with parkinsonism. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.038
205. J. R. Gilmour (1901). The Psycho-pathology of Ideas of Negation [Psicopatologia delle idee di Negazione]. (Il Manicomio, No. 3, 1900.) De Sancte. Journal of Mental Science. https://doi.org/10.1192/bjp.47.198.593-a
206. Mjid Oukhrib, Lahcen Tamegart, Hafida El Ghachi, Abdelali Ben Maloui, Bilal El‐Mansoury, Mohamed Chraa, & Halima Gamrani (2023). Epidemiology of Parkinson's Disease. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5156-4.ch001
207. Prabavathy Subramanian, & Vinodhan Palanisamy (2023). Neurocognitive Disorder. Pondicherry Journal of Nursing. https://doi.org/10.5005/jp-journals-10084-13167
208. M. Adida (2010). Insight in bipolar disorder. Frontiers in Neuroscience. https://doi.org/10.3389/conf.fnins.2010.12.00009
209. Peter Kempster, D. R. Williams, Marianna Selikhova, JL Holton, T. Révész, & Andrew J. Lees (2007). Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain. https://doi.org/10.1093/brain/awm142
210. Christopher H. Hawkes (2008). The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?. Movement Disorders. https://doi.org/10.1002/mds.22242
211. Christopher W. Hess, & Blair Ford (2012). Pain in Parkinson’s Disease: Pathophysiology, Classification, and Clinical Approach. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_24
212. Yasuko Toyoshima, Hitoshi Takahashi, Shinnichi Katada, Naoyuki Kojima, Mari Tada, Takashi Tani, Ryoko Koike, Takanori Nozawa, Izumi Aida, Takashi Nakajima, Osamu Onodera, & Akiyoshi Kakita (2021). Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients. Neuropathology. https://doi.org/10.1111/neup.12777
213. Igor D. Grachev (2013). Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-305380
214. Luiz Fernando A. T. Pedrão, Pâmela Medeiros, Estela C. Leandro, & Bárbara Falquetto (2024). Parkinson’s disease models and death signaling: what do we know until now?. Frontiers in Neuroanatomy. https://doi.org/10.3389/fnana.2024.1419108
215. David G. Gunn, Sharon L. Naismith, & Simon J.G. Lewis (2010). Sleep Disturbances in Parkinson Disease and Their Potential Role in Heterogeneity. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988709358591
216. Juvaria Azmath (2020). Case Study on Parkinson’s Disease. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2020.31178
217. Shigeki Kuzuhara (2004). Clinical features of Parkinson's disease in the elderly. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. https://doi.org/10.3143/geriatrics.41.245
218. Robert Wartenberg (1952). Head-dropping Test. BMJ. https://doi.org/10.1136/bmj.1.4760.687
219. Antônio Lúcio Teixeira, Fernando Machado Vilhena Dias, Arthur Kümmer, Doyle, Harsanyi, Cardoso, & Leonardo F. Fontenelle (2011). Psychiatric disorders in primary focal dystonia and in Parkinson&amp;rsquo;s disease. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s17507
220. Yassar Alamri (2015). Mental health and Parkinson’s disease: from the cradle to the grave. British Journal of General Practice. https://doi.org/10.3399/bjgp15x684985
221. Rizwan Akhtar, & Tomoo Mano (2019). High serum neurofilament light chain predicts a worse fate in early parkinsonism. Neurology. https://doi.org/10.1212/wnl.0000000000007194
222. Rogério Donizeti Reis, Marcos Antônio Batista, & José Vitor da Silva (2019). Doença de Parkinson: representação material da vulnerabilidade humana no contexto do cuidador familiar. Revista Brasileira de Bioética. https://doi.org/10.26512/rbb.v14iedsup.26453
223. Yara Masoud Tuhami (2018). Evidence that Parkinson's disease is partly an Autoimmune Disease
224. Evangelos Oikonomou, & T. Paparrigopoulos (2015). [Neuropsychiatric manifestations in Parkinson's disease].. PubMed
225. Dario Arnaldi, Silvia Morbelli, Elisa Morrone, Claudio Campus, & Flavio Nobili (2012). Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.. PubMed
226. Jason Wilbur (2023). Dementia: Dementia Types.. PubMed
227. Timothy F. Hoban (2001). Sleep-related rhythmic movement disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511711947.030
228. G.V. Dhruva Kumar, V. Deepa, N. Vineela, & G. Emmanuel (2022). Detection of Parkinson’s disease using LightGBM Classifier. 2022 6th International Conference on Computing Methodologies and Communication (ICCMC). https://doi.org/10.1109/iccmc53470.2022.9753909
229. Marta Di Salvo (2018). Neuroinfiammazione e morbo di Parkinson: ruolo della Pea-Oxa
230. Ludivine Ritz, Anne‐Lise Pitel, François Vabret, Francis Eustache, & Hélène Beaunieux (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
231. Max Schmauß (2022). Depression und Parkinson-Erkrankung. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-1683-1840
232. Audrey McKinlay (2013). A review of cognitive and other non-motor problems in Parkinson’s disease. Aging Health. https://doi.org/10.2217/ahe.12.84
233. Dennis W. Dickson (2005). Neuropathology of Parkinson's disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.040
234. Karen Frei (2020). Abnormalities of smooth pursuit in Parkinson’s disease: A systematic review. Clinical Parkinsonism & Related Disorders. https://doi.org/10.1016/j.prdoa.2020.100085
235. Katerina Markopoulou, & Bruce A. Chase (2010). Olfaction in <i>Parkin</i> -associated Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e31820882ee
236. Julita Szarpak, Paulina Drożak, Michał Piwoński, Hubert Wróblewski, & Justyna Morylowska-Topolska (2022). Should patients with Parkinson’s disease only visit a neurologist’s office? - a narrative review of neuropsychiatric disorders among people with Parkinson’s disease. Current Problems of Psychiatry. https://doi.org/10.2478/cpp-2022-0021
237. Ransmayr (2007). Klinik des Morbus Parkinson. Therapeutische Umschau. https://doi.org/10.1024/0040-5930.64.1.5
238. Ryan J. Uitti (1998). Tremor: how to determine if the patient has Parkinson's disease.. PubMed
239. Bingchen Li, Haowei Ti, & Chang Liu (2024). Massage techniques to treat Parkinson’s spasm symptoms. Advances in Computer and Engineering Technology Research. https://doi.org/10.61935/acetr.3.1.2024.p165
240. Matthew Majeske, Violeta Nistor, & Charles H. Kellner (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
241. Giuseppe Limongelli, Raffaella D‘Alessandro, Valeria Maddaloni, Alessandra Rea, Anna Sárközy, & William J. McKenna (2013). Skeletal muscle involvement in cardiomyopathies. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0b013e3283641c69
242. Geoffrey A. Kerchner, & Michael Rosenbloom (2014). Frontotemporal Neurocognitive Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg65
243. George Winokur (1970). Genetic Findings and Methodological Considerations in Manic Depressive Disease. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000193237
244. Erik Ch. Wolters, & Heiko Braak (2006). Parkinson’s disease: premotor clinico-pathological correlations. https://doi.org/10.1007/978-3-211-45295-0_47
245. DW Dickson (2005). Molecular neuropathology of parkinsonism. CRC Press eBooks. https://doi.org/10.1201/b14441-6
246. Rodger J. Elble (2020). Do We Belittle Essential Tremor by Calling It a Syndrome Rather Than a Disease? No. Frontiers in Neurology. https://doi.org/10.3389/fneur.2020.586606
247. Dag Aarsland, & Per Svenningsson (2012). Using biomarkers to disentangle different causes of Parkinsonism. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2012-303025
248. Fausto Santeusanio (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
249. Josef Finsterer, Fúlvio A. Scorza, Carla A. Scorza, & Ana C. Fiorini (2021). Parkinson-related neuropathy. Clinics. https://doi.org/10.6061/clinics/2021/e2675
250. Seyed-Amirabbas Ahadiat, & Zeinab Hosseinian (2023). A look back at the prodromal findings in Parkinson’s disease. Bulletin of the National Research Centre/Bulletin of the National Research Center. https://doi.org/10.1186/s42269-023-01143-5
251. Diego Santos‐García, Teresa de Deus, Cristina Tejera Pérez, Irene Expósito-Ruiz, E. Suárez-Castro, Pedro Carpintero, & M Macías-Arribi (2015). Gastroparesia y otros síntomas gastrointestinales en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.6106.2015203
252. Peter J. Nestor (2010). Dementia in Lewy body syndromes. Neurology. https://doi.org/10.1212/wnl.0b013e3181d55f79
253. Fulvio Lauretani, Antonio Saginario, Gian Paolo Ceda, Laura Galuppo, Livia Ruffini, Anna Nardelli, & Marcello Maggio (2014). Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation. Current Drug Targets. https://doi.org/10.2174/1389450115666140826104030
254. Bart Post, Martijn van der Eijk, Marten Munneke, & Bastiaan R. Bloem (2011). Multidisciplinary care for Parkinson’s disease: not if, but how!. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2011.241604rep
255. Hanlin You (2022). The New Developing Treatment of Parkinson’s Disease. SHS Web of Conferences. https://doi.org/10.1051/shsconf/202214401017
256. И В Дамулин, Dmitry Romanov, & I. V Ninoy (2019). FEATURES OF MENTAL DISORDERS IN NEUROLOGICAL DISEASES. Russian Medicine. https://doi.org/10.18821/0869-2106-2019-25-5-6-335-342
257. D. G. Thomson (1883). The Prognosis in Insanity. Journal of Mental Science. https://doi.org/10.1192/bjp.29.126.188
258. V Arul Jayendra Pradeep (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder.
259. Yasuhiro Hasegawa, & A Takahashi (1992). [Progressive autonomic failure with Parkinson's disease].. PubMed
260. Per Borghammer, & Nathalie Van Den Berge (2019). Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-191721
261. Andrés Ceballos-Baumann (2006). Demenz bei Parkinson-Syndromen: Lewy-Körper-Demenz, idiopathisches und andere Parkinson-Syndrome, Normaldruckhydrozephalus. Nervenheilkunde. https://doi.org/10.1055/s-0038-1626818
262. Kapil D. Sethi (2003). Clinical aspects of Parkinson disease. Current Opinion in Internal Medicine. https://doi.org/10.1097/00132980-200302010-00004
263. Kapil D. Sethi (2002). Clinical aspects of Parkinson disease. Current Opinion in Neurology. https://doi.org/10.1097/00019052-200208000-00009
264. Michael Donnelly (2025). Psychological Treatment Considerations for Early versus Late-Stage Parkinson’s Disease. https://doi.org/10.61440/jcpn.2025.v3.43
265. Dag Aarsland, & Jan Larsen (2003). Diagnosis and Treatment of Hallucinations and Delusions in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_28
266. Robertus M. A. de Bie (2016). Beyond Tremor, Slowness, and Stiffness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190607555.003.0004
267. Martin Bareš (2011). Nejčastější chyby a omyly v diagnostice a léčbě Parkinsonovy nemoci. Neurologie pro praxi
268. María Stamelou, Una‐Marie Sheerin, Nicholas Wood, & Kailash P. Bhatia (2014). The entity of parkinsonism and associated lipomatosis. Neurology. https://doi.org/10.1212/wnl.0000000000000937
269. Bi‐Li Chen (2013). Research Progress of Non-motor Symptoms of Parkinson Disease. Medical Recapitulate
270. Florence Chang, & Keith A. Josephs (2013). Levodopa Responsiveness in Adult-onset Lower Limb Dystonia is Associated with the Development of Parkinson’s Disease. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.136
271. C. D. Aring (1962). The Riddle of the Parkinson Syndrome. Archives of Neurology. https://doi.org/10.1001/archneur.1962.00450190003001
272. Helmut Heinsen, & Lea T. Grinberg (2022). Neuropathology of Non-Motor Parkinson’s Disease Symptoms. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.005
273. Sanja Sarka (2018). Stavovi okoline o problemu osoba s Parkinsonovom bolesti
274. 岸 泰宏 (2010). (2)身体疾患と精神疾患，精神症状を見極める！. エマージェンシー・ケア
275. Yuan‐Tso Cheng, & Yan‐Jiang Wang (2020). Tobacco smoking and the reduced risk of Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0000000000009431
276. Ren Ya (2010). Manifestation and treatment of non-motor systoms of Parkinson's disease. Zhongguo shiyong neike zazhi
277. Bilal El‐Mansoury, Abdelali Ben Maloui, Ahmed Draoui, Youssef Ait Hamdan, Mjid Oukhrib, Kamal Smimih, Abdessamad Elmourid, Abdelaati El Khiat, Samira Boulbaroud, Iman Meftah, Miloud Hammoud, Redouane Chatoui, Es‐Said Sabir, Halima Gamrani, & Arumugam R. Jayakumar (2023). Non-Motor Symptoms in Parkinson's Disease. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5156-4.ch003
278. Zbigniew K. Wszołek, & Katerina Markopoulou (1998). Olfactory dysfunction in Parkinson's disease.. PubMed
279. Howard I. Hurtig (2000). What Is Parkinson’s Disease? Neuropathology, Neurochemistry, and Pathophysiology. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-410-8_3
280. Fulvio Lauretani, Paolo Caffarra, Livia Ruffini, Anna Nardelli, Gian Paolo Ceda, Marcello Maggio, & Augusto Scaglioni (2011). Brief practical clinical diagnostic criteria for the neurodegenerative diseases in the elderly. Drugs and Therapy Studies. https://doi.org/10.4081/dts.2011.e6
281. Z. A. Zalyalova, Е А Катунина, & Д. В. Похабов (2025). Parkinson's disease and migraine. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2025-3-98-103
282. Н Ю Новиков, E. S. Brazhnik, & В. Ф. Кичигина (2023). Pathological correlates of cognitive decline in Parkinson’s disease: from molecules to neural networks. Биохимия. https://doi.org/10.31857/s0320972523110180
283. Bart Post, Martijn van der Eijk, Marten Munneke, & Bastiaan R. Bloem (2011). Multidisciplinary care for Parkinson's disease: not if, but how!. Practical Neurology. https://doi.org/10.1136/jnnp.2011.241604
284. Anthony Santiago, & Stewart A. Factor (2003). Levodopa. CRC Press eBooks. https://doi.org/10.1201/9780203912164-21
285. Adrijana Strupar (2017). Sestrinska skrb za bolesnike s Parkinsonovom bolesti
286. Sarah E.M., M. Juliet, & Joseph Paul (2012). Parkinson’s Disease and Parkin: Insights from Park2 Knockout Mice. InTech eBooks. https://doi.org/10.5772/18148
287. Hugo Morales‐Briceño, Amin Cervantes‐Arriaga, & Mayela Rodríguez‐Violante (2011). [Premotor diagnosis of Parkinson's disease].. Gaceta Médica de México
288. Vásquez Celaya Lizbeth, Tamariz Rodríguez Amiel, Gutiérrez Pérez Jaime Rafael, Marín Márquez Gerardo, Toledo Cárdenas Ma. Rebeca, Carrillo Castilla Porfirio, Manzo Denes Jorge, Coria Avila Genaro A, & García Hernández Luis (2019). Enfermedad de Parkinson más allá de lo motor. eNeurobiología
289. Daniel San-Juan Orta, & Juan Del Castillo-Calcáneo (2010). Sueño y enfermedad de Parkinson. Archivos de neurociencias (México, D.F.)
290. Tânia M.S. Novaretti, Nathália Novaretti, & Vítor Tumas (2016). Bipolar disorder, a precursor of Parkinson's disease?. Dementia & Neuropsychologia. https://doi.org/10.1590/s1980-5764-2016dn1004018
291. Joseph H. Friedman (2012). Gait disorders in the elderly.. PubMed
292. Lisette K. Bunting, & Barbara Fitzsimmons (1991). Depression in Parkinsonʼs Disease. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-199106000-00005
293. William J. Weiner (2003). Differential Diagnosis of Parkinsonism. CRC Press eBooks. https://doi.org/10.1201/9780203912164-7
294. Richard Mayeux, & Karen Marder (1996). Putative clinical and genetic antecedents of dementia associated with Parkinson's disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511601187.007
295. Dedi Sutia (2014). HUBUNGAN KADAR ALPHA SYNUCLEIN PLASMA DENGAN PENYAKIT PARKINSON
296. Ajay Kotwal, Ranjana Duggal, Vanita Sharma, Abhinav Gupta, & Anil K Gupta (2022). PERIPHERAL NERVOUS SYSTEM DISORDERS: A DIAGNOSTIC APPROACH. Global Journal For Research Analysis. https://doi.org/10.36106/gjra/7505767
297. Andrew E. Budson, & Maureen K. O’Connor (2021). Which other disorders cause dementia?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0003
298. Heinz Reichmann, & Ülrike Sommer (2001). Demenz beim idiopathischen Parkinson-Syndrom. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-18909
299. William C. Koller (1984). The Diagnosis of Parkinson's Disease. Archives of Internal Medicine. https://doi.org/10.1001/archinte.1984.04400020048005
300. Osman Sinanović (2012). Psychiatric disorders in neurology.. PubMed
301. Angelo Antonini (2009). Non-motor Symptoms in Parkinson’s Disease. European Neurological Review. https://doi.org/10.17925/enr.2009.04.01.25
302. Werner Poewe, & Joseph Jankovic (2014). Preface. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175845.001
303. Che‐Wei Lin, Jeen-Shing Wang, Pau-Choo Chung, Chung‐Yao Hsu, Li-Ming Liou, Yen Kuang Yang, & Ya-Ting Yang (2012). Classification of Parkinson’s Disease Severity Using Heart Rate Variability Analysis. CRC Press eBooks. https://doi.org/10.1201/b12756-27
304. Sáenz Farret Michel, Arias Carrión Oscar, Thalia Estefania Sánchez Correa, Pellene Luis Alejandro, & Federico Micheli (2015). Pisa Syndrome. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000092
305. Claudio Pacchetti, Silvano Cristina, Francesca Mancini, Cira Fundarò, Elisabetta Corengia, E. Martignoni, & Giuseppe Nappi (2000). Sintomi non motori nella malattia di Parkinson: Procedure per la diagnosi, la terapia e la riabilitazione
306. P. Y. Mallikarjun, Nitesh Kumar Singh, Siddavatam Bhavana, Sompalli Swathi, & Vikas Singh (2023). Parkinson’s Disease Prediction Using Machine Learning. https://doi.org/10.46610/jocsaci.2023.v09i01.001
307. Muriel Bonnet (2001). Symptômes de la maladie de Parkinson. Gérontologie et société. https://doi.org/10.3917/gs.097.0129
308. Sol Yakubovich, Simon Israeli‐Korn, Orly Halperin, Gilad Yahalom, Sharon Hassin‐Baer, & Adam Zaidel (2020). Visual self-motion cues are impaired yet overweighted during visual–vestibular integration in Parkinson’s disease. Brain Communications. https://doi.org/10.1093/braincomms/fcaa035
309. Murat Kasap, & Gürler Akpınar (2011). Proteomics Approaches to Parkinson’s Disease and Search for Potential Biomarkers: Review. Turkiye Klinikleri Journal of Medical Sciences. https://doi.org/10.5336/medsci.2010-21522
310. Christine Brefel‐Courbon, & Fabienne Ory‐Magne (2010). La douleur dans la maladie de Parkinson. Neurologie com. https://doi.org/10.1684/nro.2009.0113
311. S. F. Candela, Franco Giubilei, & Francesco Orzi (2013). Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism.. PubMed
312. Ahmet Kokurcan, & Cem Atbaşoğlu (2015). [Differential Diagnosis of Schizophrenia: Psychotic Symptoms in Neurodevelopmental Disorders and Psychotic Disorders due to other Medical Conditions].. PubMed
313. Rafaela Valiengo de Souza (2023). Potenciais evocados auditivos em indivíduos adultos e idosos com doença de Parkinson. https://doi.org/10.11606/d.5.2023.tde-04032024-112221
314. Yoshiaki Kaji, & Koichi Hirata (2012). [Depression and anxiety in Parkinson's disease].. PubMed
315. Carles Gaig, & Eduardo Tolosa (2009). When does Parkinson's disease begin?. Movement Disorders. https://doi.org/10.1002/mds.22672
316. A Abdelgabar, & Jvc Sharma (2003). SLEEP DISORDERS IN PARKINSON'S DISEASE. International Journal of Clinical Practice. https://doi.org/10.1111/j.1742-1241.2003.tb10615.x
317. Zehra Habib, Zoaib Habib Tharwani, & Abdullah Malikzai (2023). Exploring the connection between sleep disorders and neurological diseases: implications for diagnosis and management. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000213
318. PramodK Pal, Abhishek Lenka, Priyantha Herath, & ShivamO Mittal (2018). Sleep disturbances in patients with Parkinson’s disease: It’s time to wake up!. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_16_18
319. Jack Klein (2015). Chronic Pain, Psychopathology, and DSM-5 Somatic Symptom Disorder. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674371506001109
320. Jerzy Leszek (2021). Parkinson’s disease with concomitant generalized anxiety disorder – case report. Medycyna Faktów. https://doi.org/10.24292/01.mf.0421.14
321. Helen Creasey, & G. Anthony Broe (1993). Parkinson's disease. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.1993.tb137825.x
322. 小林俊輔 (2021). Parkinson 病の運動症状は氷山の一角で，ほかに多彩な非運動症状が存在する. 内科
323. Beatriz Ospina, & Jorge Luis Orozco Vélez (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
324. Deepak Garg, Nishka Mehlawat, Yogesh Pal, Akansha Singh, & Vivek Mehta (2023). Comparative Analysis of Machine Learning Algorithms in Parkinson Disease Diagnosis. https://doi.org/10.1109/icacrs58579.2023.10404974
325. Doroteja Lehpamer (2018). "Parkinson plus" sindrom
326. Silu Lu, James P. Shaffery, Yi Pang, Lu‐Tai Tien, & Lir‐Wan Fan (2016). Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson’s Disease. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.1000255
327. Unknown (2003). Nichtmotorische Parkinson-Symptome. Aktuelle Neurologie. Sup./Aktuelle Neurologie. Supplement. https://doi.org/10.1055/s-2003-41784
328. Michael Müntener, & Brigitte Schurch (2004). Neurologic erectile dysfunction. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7945-3_5
329. Charlotte Beal, & Franck Durif (2021). [Atypical parkinsonian syndromes].. PubMed
330. Joseph H. Friedman (2012). Fatigue: A Common Comorbidity in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_27
331. Emese Orban, & Remus Şipoş (2023). Sexual dynamics disorders in Parkinson’s disease. Medic ro. https://doi.org/10.26416/med.151.1.2023.7838
332. 陈生弟, & Chen Chao Wei (2012). 帕金森病非运动症状的识别与处理：从忽视到重视. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2012.06.001
333. Renata Wallner, Adrianna Senczyszyn, Sławomir Budrewićz, & Joanna Rymaszewska (2019). Zaburzenia poznawcze i neuropsychiatryczne w chorobie Parkinsona. Polski Przegląd Neurologiczny. https://doi.org/10.5603/ppn.2019.0018
334. David S. Knopman (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
335. David S. Knopman (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1336
336. Beatriz Muñoz, Valentina Quintana-Peña, Daniela Serrato Alvarez, Jaime Valderrama, Yuri Takeuchi, & Jorge Orozco (2021). Perspectives of Cognitive Impairment and Behavioral Disturbances in Parkinson’s Disease Dementia. IntechOpen eBooks. https://doi.org/10.5772/intechopen.96623
337. Elena Herrera Gómez (2015). Alteraciones cognitivas y lingüísticas en la enfermedad de Parkison
338. Bruno V. Gallo, & Alisabeth C. Hearron (2017). Parkinson’s disease. Routledge eBooks. https://doi.org/10.4324/9781315382760-65
339. Chen Hai-b (2009). Non-motor Symptoms of Parkinson's Disease(review). Zhongguo kangfu lilun yu shijian
340. Franklin H. Silverman, & Barbara Henry (1989). Depression: A Primary Symptom of Parkinson Disease?. Journal of rehabilitation
341. Frédéric Limosin (2014). Maladie de Parkinson : la psychiatrie en première ligne ?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.273
342. Ke Zhou, Peter C.Y. Chow, & SC Lim (2024). A Criminal Case of Hypersexuality and Parkinson’s Disease. Neurology and Neuroscience. https://doi.org/10.33425/2692-7918.1071
343. Gabriela Dogaru, & Ioana Stănescu (2014). TREATMENT AND REHABILITATION IN NON-MOTORS SYMPTOMS OF PARKINSON’S DISEASE. Balneo Research Journal. https://doi.org/10.12680/balneo.2014.1076
344. Zien Zhang, & Yu Zhang (2020). Ocular symptoms and signs related to Parkinson′s disease. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2020.03.015
345. V.V. Enatescu, & V.R. Enatescu (2007). A model for analysis of non verbal parameters in n-dimensional space. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2007.01.1064
346. Manuchair Ebadi, Jon Tippin, Kelvin L. Chou, Bradley A. Erickson, Kevin C. Doerschug, & Decontee M Jimmeh Fletcher (2011). Non-motor Symptoms in Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2011.07.02.113
347. Serap Parlar Kılıç (2010). PARKİNSON HASTALARINDA UYKU BOZUKLUKLARI VE HEMŞİRELİK YÖNETİMİ. Journal of Anatolia Nursing and Health Sciences. https://doi.org/10.17049/ahsbd.81422
348. Baljinder Kaur (2017). CLASSIFICATION ON DEGREE OF HARMING IN PARKINSON DISEASE. International Journal of Advanced Research in Computer Science. https://doi.org/10.26483/ijarcs.v8i8.4668
349. Fernando Vázquez-Sánchez, Elena Rodríguez Martínez, & Adrián Arés Luque (2010). Trastornos urinarios, disfunción sexual e hipersexualidad en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009736
350. Brian Hainline, Lindsey Gurin, & Daniel M. Torres (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
351. Lucija Martinić (2016). Različitosti fizioterapijskih intervencija kod osoba oboljelih od Parkinsonve bolesti
352. Isao Fukunishi, Kiyoshi Hosokawa, & S Ozaki (1991). Depression Antedating the Onset of Parkinson's Disease. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.1991.tb00499.x
353. Sumit Sarkar, James Raymick, & Syed Imam (2016). Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17060904
354. Miquel Baquero (2015). Depressive symptoms in neurodegenerative diseases. World Journal of Clinical Cases. https://doi.org/10.12998/wjcc.v3.i8.682
355. Corneliu Luca, & Tatjana Rundek (2015). Parkinsonism, small vessel disease, and white matter disease. Neurology. https://doi.org/10.1212/wnl.0000000000002091
356. Anat Kesler, & Amos D. Korczyn (2006). Visual disturbances in Parkinson's disease. Practical Neurology. https://doi.org/10.1136/jnnp.2006.088286
357. Tarit Kanti Ghosh (2023). Early Parkinson’s Disease Tremor Characteristics: Identification &amp; Treatment. Journal of Psychiatry Research Reviews & Reports. https://doi.org/10.47363/jpsrr/2023(5)152
358. Charles Maitland (2012). Vestibular Dysfunction. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_25
359. Joong Seok Kim, & Hey Young Sung (2015). Gastrointestinal Dysfunctions in Parkinson’s Disease. Journal of the Korean Neurological Association. https://doi.org/10.17340/jkna.2015.4.1
360. P.I. Luthert (2013). DEMENTIA IN PARKINSON'S DISEASE
361. Richard L. Doty, & Hakan Tekelı (2012). Chapter 9. Olfactory function in Parkinson’s disease. Advances in consciousness research. https://doi.org/10.1075/aicr.85.16dot
362. Zdravko Kolundžić, & Draženka Blaži (2010). The significance of swallowing in patients with Parkinson's disease
363. 水田英二 (2007). ≪パーキンソン病に伴う非運動障害とその治療≫ 認知機能障害の原因，頻度とその治療方法. 内科
364. Thiago da Silva Rocha Paz, Ana Elisa Lemos Silva, Núbia Isabela Macêdo Martins, Vera Lúcia Santos de Brito, Marco Antônio Araújo Leite, & Clynton Lourenço Corrêa (2019). Congelamento da marcha e de membros superiores na doença de Parkinson. Revista Brasileira de Neurologia
365. Federica Provini, Carolina Lombardi, & E Lugaresi (2005). Insomnia in Neurological Diseases. Seminars in Neurology. https://doi.org/10.1055/s-2005-867074
366. H.‐M. Meinck, & P Ringleb (2007). B 2.9.5 Parkinson-Syndrom und andere Bewegungsstoerungen
367. Kristina Kampić, Vladimira Vuletić, & Darko Chudy (2021). Duboka mozgovna stimulacija – prijeoperacijska priprema i procjena pacijenata s Parkinsonovom bolešću. Medicina Fluminensis. https://doi.org/10.21860/medflum2021_365325
368. Bradley C. Hiner (2006). Differential Diagnosis of Parkinson's Disease: A New Blood Test?. Clinical Medicine & Research. https://doi.org/10.3121/cmr.4.4.246
369. David R. Williams (2013). Progressive Supranuclear Palsy and Corticobasal Degeneration. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199609536.003.0014
370. Xinyan Yi, Di Qiao, & Xuan Zhang (2017). Subthalamic nuclei-deep brain stimulation on motor symptoms in Parkinson′s disease. https://doi.org/10.3877/cma.j.issn.2095-123x.2017.02.013
371. Erick García Hernández (2018). Evaluación del efecto neuroprotector de la glibenclamida en un modelo murino de la enfermedad de Parkinson.
372. Shoned Jones, Kelli Torsney, Lily Scourfield, Katie Berryman, & Emily Henderson (2020). Mental Health in Parkinson’s Disease. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594714.011
373. Katsuhiro Toda, & Toshihide Harada (2010). Prevalence, Classification, and Etiology of Pain in Parkinson's Disease: Association between Parkinson's Disease and Fibromyalgia or Chronic Widespread Pain. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.222.1
374. Biddut Deb Nath, Dipti Debnath, Rokeya Pervin, & Md. Akil Hossain (2020). Role of Environmental Toxicants and Inflammation in Parkinson’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780429319310-6
375. Ann‐Kathrine Granérus (2001). [Drug treatment is beneficial also for elderly patients with Parkinson disease. Important to consider also other co-existing diseases].. PubMed
376. K P van Spaendonck, H. J. C. Berger, M.W.I.M. Horstink, & A.R. Cools (1998). [Cognitive deficits in Parkinson's disease].. PubMed
377. Radhakrishnan Mahesh, Dilip K. Pandey, Shvetank Bhatt, & Baldev Gautam (2010). Depression Associated Disorders: Comorbidity, eurobiological and eurobehavioural Link
378. Veysel Tahiroğlu, & İlhami Gülçın (2024). Overview of Some Biochemical Parameters in Parkinson’s Disease. https://doi.org/10.69860/nobel.9786053359357.6
379. Cristina Simonet, Eduardo Tolosa, Ana Cámara, & Francesc Valldeoriola (2019). Emergencies and critical issues in Parkinson’s disease. Practical Neurology. https://doi.org/10.1136/practneurol-2018-002075
380. Emma Emma, Thornton, Róbert, & Vink (2015). Substance P and its tachykinin NK1 receptor： a novel neuroprotective target for Parkinson＇s disease. 中国神经再生研究：英文版
381. Bindiya Gupta (1986). Synthetic Heroin-Induced Parkinsonism. Jefferson Journal of Psychiatry. https://doi.org/10.29046/jjp.004.2.006
382. Stephanie Phan (2013). Primary or secondary? What came first and how to treat?. Mental Health Clinician. https://doi.org/10.9740/mhc.n178411
383. V. Gallo, Honglei Chen, & Neil Pearce (2020). Idiopathic Parkinson’s disease and classification of parkinsonisms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198749493.003.0011
384. Christian Geroin, Carlo Alberto Artusi, Jorik Nonnekes, Camila Aquino, Divyani Garg, Marian L. Dale, Darbe Schlosser, Yijie Lai, Mohammad Alwardat, Mehri Salari, Robin Wolke, Valery Tsinda Labou, Gabriele Imbalzano, Serena Camozzi, Marcelo Merello, Bastiaan R. Bloem, Tamine Capato, Ruth Djaldetti, Karen A. Doherty, ... Michèle Tinazzi (2023). Axial Postural Abnormalities in Parkinsonism: Gaps in Predictors, Pathophysiology, and Management. Movement Disorders. https://doi.org/10.1002/mds.29377
385. Aiperi Almanbekova (2022). Diagnosis and Pharmacological Management of Parkinson’s Disease: A Review. International Journal of Health Sciences and Research. https://doi.org/10.52403/ijhsr.20220215
386. Sérgio Antônio Antoniuk (2013). Debilidad muscular aguda: diagnósticos diferenciales. Revista de Neurología. https://doi.org/10.33588/rn.57s01.2013252
387. Sára Bech, Steven Haugbøl, & Kristian Winge (2017). [Challenges in the differential diagnoses of parkinsonism].. PubMed
388. Yujie Lai (2021). Association of Cognitive Dysfunction with Cardiovascular Autonomic Nerve Abnormalities in Early Parkinson Disease. Psychology and Behavioral Science International Journal. https://doi.org/10.19080/pbsij.2021.17.555954
389. 織茂智之 (2007). 非運動症状と MIBG 心筋シンチグラフィーの意味するもの：早期診断の可能性. 最新医学
390. MASASHI TAKANASHI (2010). パーキンソン病の非運動症状. Juntendō Igaku/Juntendo igaku. https://doi.org/10.14789/pjmj.56.444
391. 久大 立花 (2021). Diagnosis and treatment of old-onset Parkinson's disease. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. https://doi.org/10.3143/geriatrics.58.341
392. James P Battista, & Paul Greene (2015). Improvement of Primary Writing Tremor in Parkinson’s Disease with Carbidopa/Levodopa. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.277
393. 刘文彦, LIU Zheng jun, 丁健青, & 陈生弟 (2011). 帕金森病患者的睡眠障碍. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2011.09.013
394. Kieran Walsh, & Gerry Bennett (2000). Parkinson's disease: a guide for care staff. Nursing and Residential Care. https://doi.org/10.12968/nrec.2000.2.2.74
395. Büşra Sümeyye Arıca Polat (2011). Parkinson hastalığında antiparkinson tedaviye bağlı cinsel işlev bozukluğu ve hiperseksüalite sıklığı parkinson hastalığında antiparkinson tedaviye bağlı cinsel işlev bozukluğu ve hiperseksüalite sıklığı
396. Chris D. Turnbull, & Paul Fitzsimmons (2009). Neuropsychiatric features of Parkinson’s disease. The Journal of the Royal College of Physicians of Edinburgh. https://doi.org/10.4997/jrcpe.2009.407
397. D. N. Parfitt (1934). Psychoses associated with Pernicious Anaemia: With a Report of Two Cases. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.s1-15.57.12
398. Renata Padilha Guedes, & C.G. Silva (2010). Inflammation in the Pathogenesis and Progression of Neurological Diseases. Ciência em Movimento. https://doi.org/10.15602/1983-9480/cmbs.v12n24p35-47
399. О А Аленикова, Likhachev Sa, & O. I. Davidova (2015). CLINICAL RELEVANCE AND PATHOGENESIS OF VISUAL DISTURBANCES IN PARKINSON’S DISEASE. The Neurological Journal. https://doi.org/10.18821/1560-9545-2015-20-3-4-10
400. F. Pan-Montojo, & Heinz Reichmann (2015). Ursache der Parkinson-Krankheit: Braak revisited. Aktuelle Neurologie. https://doi.org/10.1055/s-0034-1387475
401. W R Gibb (1986). IDIOPATHIC PARKINSON'S DISEASE AND THE LEWY BODY DISORDERS. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.1986.tb00136.x
402. Gurutz Linazasoro (2002). Neuroprotection in Parkinson’s disease: love story or mission impossible?. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2.3.403
403. Paul G. Ince (2011). Dementia with Lewy Bodies and Parkinson's Disease Dementia. https://doi.org/10.1002/9781444341256.ch22
404. Claudio Ronco, Peter A. McCullough, Stefan D. Anker, Inder S. Anand, Nadia Aspromonte, Sean M. Bagshaw, Rinaldo Bellomo, Tomás Berl, Ilona Bobek, Dinna N. Cruz, Luciano Daliento, Andrew Davenport, Mikko Haapio, Hans L. Hillege, Andrew A. House, Nevin Katz, Alan S. Maisel, Sunil Mankad, P. Zanco, ... Piotr Ponikowski (2010). Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contributions to nephrology. https://doi.org/10.1159/000313745
405. Unknown (2011). Psychosis in Parkinson′s disease. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.83090
406. Cori Gray, & Craig Stern (2018). Recommendations for the Treatment of Parkinson's Disease. Journal of Contemporary Pharmacy Practice. https://doi.org/10.37901/jcphp16-00031
407. Emese Orban, & Remus Şipoş (2021). Monitorizarea pacientului cu boală Parkinson – o provocare interdisciplinară. Medic ro
408. Cèlia Painous, & Marı́a José Martı́ (2020). &lt;p&gt;Cognitive Impairment in Parkinson’s Disease: What We Know so Far&lt;/p&gt;. Research and Reviews in Parkinsonism. https://doi.org/10.2147/jprls.s263041
409. W R Gibb, & Philip J. Luthert (1994). Dementia in Parkinson’s Disease and Lewy Body Disease. Dementia. https://doi.org/10.1007/978-1-4615-6805-6_45
410. J. Eric Ahlskog (2005). How Do I Know If I Have Parkinson’s Disease?. https://doi.org/10.1093/oso/9780195171938.003.0004
411. Michal Rolinski, & Klaus P. Ebmeier (2011). Tackling dementia in patients with Parkinson's disease.
412. Kirstie N. Anderson, Michael J. Keogh, & Luca Gosse (2025). Sleep Disturbance in Parkinson’s Disease: Consequences for the Brain and Disease Progression – A Narrative Review. Nature and Science of Sleep. https://doi.org/10.2147/nss.s478860
413. Stephen N. Gomperts (2008). Dementia with Lewy Bodies and Parkinson Disease Dementia. Journal watch. https://doi.org/10.1056/jn200803250000001
414. Alejo Nevado‐Holgado, John R. Terry, & Rafał Bogacz (2011). Bifurcation analysis points towards the source of beta neuronal oscillations in Parkinson's disease. https://doi.org/10.1109/cdc.2011.6160899
415. Joel Mack, & Laura Marsh (2017). Parkinson’s Disease: Cognitive Impairment. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20160043
416. Imran Z Haq, Y. Naidu, Prashanth Reddy, & К. Ray Chaudhuri (2010). Narcolepsy in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/ern.10.56
417. Bosheng Ma, Jianying Zhang, Yanlei Cui, & Huanmin Gao (2023). The Anatomy and Clinical Significance of Sensory Disturbance in Parkinson's Disease. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2203056
418. Phillipa J. Lamont (2004). cognitive decline in a young adult with pre-existent developmental delay - what the adult neurologist needs to know. Practical Neurology. https://doi.org/10.1111/j.1474-7766.2004.02-206.x
419. J. Eric Ahlskog (2009). Clinical Diagnosis of Parkinson’s Disease. https://doi.org/10.1093/oso/9780195371772.003.0004
420. Jelena Stamenović, Biljana Živadinović, & Vanja Đurić (2024). Clinical characteristics and treatment of psychosis in Parkinson's disease: A narrative review. Journal of the Chinese Medical Association. https://doi.org/10.1097/jcma.0000000000001146
421. Yun Tian, Jifeng Guo, & Beisha Tang (2018). Attach importance to the comorbidities of Parkinson's disease. https://doi.org/10.3760/cma.j.issn.1008-1372.2018.01.001
422. Naoki Wada (2019). Autonomic Disorders Associated with Parkinson's Disease. The Japanese Journal of Rehabilitation Medicine. https://doi.org/10.2490/jjrmc.56.204
423. Bharti Gaba, Shobhit Kumar, Shadab Md, Sanjula Baboota, Jasjeet Kaur Narang, & Javed Ali (2017). Natural Neuroprotectives for the Management of Parkinson's Disease. https://doi.org/10.1002/9783527803781.ch4
424. Madhavi Thomas, & Joseph Jankovic (2005). Clinical Diagnosis of Vascular Parkinsonism and Nondegenerative Atypical Parkinsonian Disorders. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:393
425. Merle Ruberg, Valentine France‐Lanord, Bernard Brugg, Stéphane Hunot, Philippe Anglade, Philippe Damier, Baptiste Faucheux, & Yves Agid (1997). Parkinson's Disease, Apoptosis, and Oxidative Stress. CRC Press eBooks. https://doi.org/10.1201/9781482292213-42
426. Tanya Simuni, & Kapil D. Sethi (2009). Nonmotor manifestations of Parkinson's disease. Annals of Neurology. https://doi.org/10.1002/ana.21472
427. Esther Suárez San Martín, Jorge Juanes, R. Montero, & Carlos Salvador Aguiar (2012). Demencia frontotemporal asociada al cromosoma 17 y otros síndromes parkinsonianos asociados a demencia. Revista de Neurología. https://doi.org/10.33588/rn.54s04.2012520
428. Lon S. Schneider, & updated by M. T. Abou‐Saleh (2002). Neurochemistry. https://doi.org/10.1002/0470846410.ch72
429. Jasmine Kalyani (2021). Clinical Study on the Incidence of Pain in Parkinson's Disease. Journal of Neurology and Neuroscience
430. Bruno Dubois (1997). Troubles cognitifs de la maladie de Parkinson. Médecine thérapeutique
431. Ioana-Cristina Neagoe (2018). THE PART PLAYED BY KINESIOTHERAPY IN THE PROPHYLAXIS AND TREATMENT OF THE PARKINSON’S DISEASE PATIENT:. Studia Universitatis Vasile Goldis Physical Education and Physical Therapy Series
432. Yoshiharu Arii, Kazuyuki Kawamura, & Toshio Inui (2014). Parkinson's disease with Sick Sinus Syndrome : A case report
433. А А Ларина, O S Shapoval'iants, Н. В. Мазурина, & Е. А. Трошина (2012). [Diagnostics and treatment of polyglandular syndrome of adults].. PubMed
434. Calabrese, & Skodda (2005). Kognitive Störungen bei Parkinsonpatienten. Praxis. https://doi.org/10.1024/0369-8394.94.42.1647
435. Andrew J. Lees (2005). Atypical Parkinsonism. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:495
436. Lourie W Reichenberg, & Linda Seligman (2016). Neurocognitive Disorders. https://doi.org/10.1002/9781394259465.ch18
437. Ilona Csóti, W. Fogel, Sebastian Schade, Alfons Schnitzler, Martin Südmeyer, Christian Winkler, & Jürgen Winkler (2013). Schmerz bei Parkinson-Patienten. Aktuelle Neurologie. https://doi.org/10.1055/s-0033-1343339
438. Darren R. Gitelman, & Tanya Simuni (2012). Imaging studies as biomarkers of Parkinson’s disease. Imaging in Medicine. https://doi.org/10.2217/iim.12.15
439. Gerald M. Fenichel (2005). Psychomotor Retardation and Regression
440. Hubert H. Fernandez, Néstor Gálvez-Jiménez, & Hubert H. Fernandez (2012). Nonmotor complications of Parkinson disease. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.79.s2a.03
441. Eduardo Tolosa, Miguel Coelho, & Marisol Gallardo (2003). DAT imaging in drug-induced and psychogenic parkinsonism. Movement Disorders. https://doi.org/10.1002/mds.10575
442. Sarah M. Tisel, & Bryan T. Klassen (2021). Hypokinetic Movement Disorders: Parkinson Disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0069
443. Richard A. Walsh (2016). Parkinson’s Disease with an Unusual Tremor. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190607555.003.0009
444. Kátia Policarpo de Sousa Luz, & Virgínia Maria Mendes Oliveira Coronago (2017). A Doença de Parkinson na pessoa Idosa e a Relação com sua Qualidade de Vida. ID on line REVISTA DE PSICOLOGIA. https://doi.org/10.14295/idonline.v11i35.720
445. Maria Isabel Buil Mur, María Pilar Cuartero Usan, Andrea Cuello Ferrando, Vanesa Náger Obón, Ester Lacuey Barrachina, & Nuria Blasco Pérez (2021). El Parkinson y la fisioterapia, artículo monográfico.. Revista Sanitaria de Investigación
446. Michaela Johnson, Benjamin Stecher, Viviane Labrie, Lena Brundin, & Patrik Brundin (2018). Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis. Trends in Neurosciences. https://doi.org/10.1016/j.tins.2018.09.007
447. Janina Grosch, Jürgen Winkler, & Zacharias Kohl (2016). Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2016.00293
448. Marina Čeprnja, & Vladimira Vuletić (2020). Biochemical Markers in Parkinson's Disease. Neurology - Research & Surgery. https://doi.org/10.33425/2641-4333.1032
449. Leonardo Caixeta, & Renata Teles Vieira (2008). Demência na doença de Parkinson. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462008005000016
450. Leonardo Caixeta, & Renata Teles Vieira (2008). Demência na doença de Parkinson. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462008000400013
451. Monty Silverdale, Christopher Kobylecki, Lewis Kass‐Iliyya, Pablo Martínez‐Martín, Michael Lawton, Sarah Cotterill, К. Ray Chaudhuri, Huw R. Morris, Fahd Baig, Nigel Williams, Leon Hubbard, Joshua Shulman, & Donald G. Grosset (2018). A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease. Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2018.06.001
452. Yansheng Du, Yuan Zhang, & Qingbo Zhou (2019). Research progress on blood pressure regulation disorder in Parkinson′s disease. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2019.10.010
453. H.C. Fibiger (1984). The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046230
454. N Milutinovich (1968). [Experience with the diagnosis of cerebral palsy].. PubMed
455. Liliana Cuibus, & Marcel Pereanu (2012). Olfactory System - Implication for Parkinson's Disease. Acta Medica Transilvanica
456. E. Cobos, Nieves Martín Begué, Silvia Muñoz Quiñones, & Jorge Arruga Ginebreda (2011). Alteraciones morfologícas del disco óptico. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears
457. Barbara Jasińska‐Myga, & Jarosław Sławek (2006). Depresja w chorobie Parkinsona
458. Unknown (1936). PROGNOSIS AND TREATMENT. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.s1-17.66.189-a
459. C. D. Marsden (1984). Which Motor Disorder in Parkinson's Disease Indicates the True Motor Function of the Basal Ganglia?. Novartis Foundation symposium. https://doi.org/10.1002/9780470720882.ch12
460. Craig A. Taylor (2003). Neuropsychiatry. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.023
461. Kamil Mohd Ariff, & Zailinawati Abu Hassan (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals)
462. Tsuyoshi Ogata, Ryuji Sakakibara, Fuyuki Tateno, Yohei Tsuyusaki, Hiromi Tateno, Yosuke Aiba, Masahiko Kishi, Tsutomu Inaoka, Hitoshi Terada, Hirokazu Doi, & Yasuo Suzuki (2016). Mild Cognitive Impairment as the Initial Manifestation of Progressive Supranuclear Palsy. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.14001
463. Robert Vink, & E. W. Thornton (2015). Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson′s disease. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.165505
464. Madhu Gupta (2024). Nervous System-I. https://doi.org/10.58532/nbennurebch11
465. Verma VK, Uraiya D, Kumar A, Tripathi N, & Dhoan P (2017). A study of the correlation of non-motor symptoms of Parkinson’s disease and Parkinson plus syndrome with duration of the disease. International Journal of Medical Research and Review. https://doi.org/10.17511/ijmrr.2017.i08.07
466. Todd Sherer, Ranjita Betarbet, & J. Timothy Greenamyre (2001). Pesticides and Parkinson’s Disease. The Scientific World JOURNAL. https://doi.org/10.1100/tsw.2001.35
467. Stéphane Thobois, & Emmanuel Broussolle (2005). [Circumstances of Parkinson's disease diagnosis].. PubMed
468. Porat Katz Bs (2009). [Sleep disorders and cognitive impairment: the cause and reaction].. PubMed
469. Kailash P. Bhatia (2002). Other extrapyramidal syndromes: parkinsonism-plus and other forms of secondary parkinsonism. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316134993.035
470. Simón Gómez-López, Víctor Jaimes, Cervia Margarita Palencia Gutiérrez, Martha Valladares Hernández, & Alba Guerrero (2013). PARÁLISIS CEREBRAL INFANTIL
471. Rade Vukmir, James Valeriano, & Austin Oblack (2023). Brain Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.027
472. Е А Труфанов (2013). Дифференциальная диагностика болезни Паркинсона и мультисистемной атрофии. Международный неврологический журнал
473. Doug Hobson (2003). Clinical Manifestations of Parkinson's Disease and Parkinsonism. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100003188
474. Jarosław Sławek, Barbara Jasińska‐Myga, & Dariusz Wieczorek (2006). Zaburzenia poznawcze w chorobie Parkinsona. Polski Przegląd Neurologiczny
475. Jan Fröberg (2002). Parkinson's Disease: Current Scientific Understanding and John's Story. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-20021001-08
476. Houman Homayoun (2018). Parkinson Disease. Annals of Internal Medicine. https://doi.org/10.7326/aitc201809040
477. María José Catalán‐Alonso, & Javier del Val (2001). Psicosis inducida por farmacos dopaminomimeticos en la enfermedad de Parkinson idiopatica: ¿primer sintoma de deterioro cognitivo?. Revista de Neurología. https://doi.org/10.33588/rn.3211.2000161
478. Hyo-Keun Lee (2020). Biomechanical Perspectives on the Relationship between Gait Dysfunction and Non-motor Symptoms in Parkinson’s Disease. Journal of The Korean Society of Living Environmental System. https://doi.org/10.21086/ksles.2020.10.27.5.673
479. Ketut Widyastuti, & Anak Agung Ayu Putri Laksmidewi (2018). LAPORAN KASUS PARKINSON DISEASE DEMENTIA: ASPEK NEUROKOGNITIF DAN HALUSINASI VISUAL. Callosum Neurology. https://doi.org/10.29342/cnj.v1i1.8
480. Andrew Tarulli (2016). Parkinsonism. Neurology. https://doi.org/10.1007/978-3-319-29632-6_13
481. Бирк Энгманн (2011). Bipolar Affective Disorder and Parkinson's Disease. Case Reports in Medicine. https://doi.org/10.1155/2011/154165
482. José Miguel Velázquez Pérez, & Carlos Marsal Alonso (2009). Trastornos del movimiento inducidos por fármacos. Revista de Neurología. https://doi.org/10.33588/rn.48s01.2009039
483. Vinoth Kanna Selvaraj, & Bhanu Keshavamurthy (2016). Sleep Dysfunction in Parkinson's Disease. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. https://doi.org/10.7860/jcdr/2016/16446.7208
484. Nandakumar S. Narayanan, Robert L. Rodnitzky, & Manuchair Ebadi (2013). Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2013-0004
485. Taha Khan (2014). First-principle data-driven models for assessment of motor disorders in Parkinson’s disease
486. P Anju, Aleena Varghese, Ashly Roy, S. Suresh, Emily Joy, & R. Sunder (2020). Recent Survey on Parkinson Disease Diagnose using Deep Learning Mechanism. https://doi.org/10.1109/icimia48430.2020.9074896
487. R. Benecke (2005). Clinical differential diagnosis of parkinsonism. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-916289
488. Oscar S. Gershanik (2002). [Dementia and cognitive impairment in Parkinson disease].. PubMed
489. Manuchair Ebadi, Jon Tippin, Kelvin L. Chou, Bradley A. Erickson, Kevin C. Doerschug, & Decontee M Jimmeh Fletcher (2012). Non-motor Symptoms in Parkinson’s Disease. European Neurological Review. https://doi.org/10.17925/enr.2012.07.01.35
490. George Konstantakopoulos (2019). Insight across mental disorders: A multifaceted metacognitive phenomenon. Psychiatriki. https://doi.org/10.22365/jpsych.2019.301.13
491. Ana Teresa Peixinho, Ana Azevedo, & Rita Moiron Simões (2006). Alterações neuropsiquiátricas da doença de Parkinson. https://doi.org/10.25752/psi.6037
492. Harsh Pandey, Arjun Shivnani, Aryaman Chauhan, Aditya Singh, & Pauras Khadakban (2021). Application of AI for Analysis of Parkinson’s Disease. International Journal of Soft Computing and Engineering. https://doi.org/10.35940/ijsce.a3527.0911121
493. Abdul Qayyum, Sara Varanese, Bernardo Perfetti, Alessandro Di, Keisuke Suzuki, Tomoyuki Miyamoto, Masayuki Miyamoto, Masaoki Iwanami, Koichi Hirata, Raquel Rodriguez Fernandez, José António, Muñiz Casado, Christopher A. Lieu, Vikram Shivkumar, Timothy P. Gilmour, Kala Venkiteswaran, Mark J. Nolt, Milind Deogaonkar, Thyagarajan Subramanian, ... Samo Ribarič (2011). Symptoms of Parkinson's Disease. InTech eBooks. https://doi.org/10.5772/953
494. Andrii Domanskyi, & Piotr Chmielarz (2021). Alpha-synuclein preformed fibrils: a tool to understand Parkinson’s disease and develop disease modifying therapy. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.310686
495. Sonja Schumacher (2012). Veränderungen somatosensorischer Funktionen bei asymptomatischen PINK1-Mutationsträgern und asymptomatischen PARKIN-Mutationsträgern im Vergleich zu gesunden Kontrollen
496. Gabriela Romero Esquiliano, Ignacio Méndez Ramírez, Armando Tello Valdés, & Carlos A. Torner Aguilar (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.)
497. Arif Dalvi, Kelly E. Lyons, & Rajesh Pahwa (2006). Secondary Dystonia. CRC Press eBooks. https://doi.org/10.3109/9781420019988-19
498. Arthur H. Crosbie (1920). The Treatment of Gonorrhea in the Male. Boston Medical and Surgical Journal. https://doi.org/10.1056/nejm192001291820504
499. Miriam Aguerri Matute, Rosa María Matute Gómez, Eva Monge Pelegrín, Nuria Garín Portero, Gloria Cucalón Leciñena, & Paloma Latorre Orte (2021). Actuación interdisciplinar en el paciente con trastorno neurodegenerativo:: Enfermedad de parkinson.. Revista Sanitaria de Investigación
500. Edson Bor‐Seng‐Shu, Kelson James Almeida, Daniel Ciampi de Andrade, Erich Talamoni Fonoff, Manoel Jacobsen Teixeira, & Egberto Reis Barbosa (2012). Echogenicity of the substantia nigra region in Parkinson's disease. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2012000200016
501. M.L.G.T Inácio, A.V.G.T Inácio, M.L.S Araújo, & Luciana Maria Silva de Seixas Maia (2018). Olfactory Dysfunction Related to Parkinson Evil. International Journal of Central Nervous System Disease. https://doi.org/10.28933/ijcnsd-2018-05-0803
502. Almudena López Eugenio (2017). Depresión y factores de riesgo cardiovasculares en enfermedad de Parkinson: signos de alarma (fragilidad) en la séptima década de la vida. Proyecto de investigación:
503. Sindhu Tolani (2021). Impact of Major Depressive Disorder on Psychiatric Comorbidity of Females in Low Income Countries. Clinical and Experimental Psychology. https://doi.org/10.35248/2471-2701.21.7.244
504. J. Eric Ahlskog (2005). Parkinson’s Disease: Changes in the Brain and Beyond. https://doi.org/10.1093/oso/9780195171938.003.0003
505. Saikat Datta (2019). Parkinson's Disease and current medical management strategies
506. Heiko Braak, & Kelly Del Tredici (2008). Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology. https://doi.org/10.1212/01.wnl.0000312279.49272.9f
507. Elan D. Louis, & David A. Bennett (2007). Mild Parkinsonian signs: An overview of an emerging concept. Movement Disorders. https://doi.org/10.1002/mds.21433
508. James J. Amos, & Jaspreet Chahal (2010). Management of psychiatric syndromes due to endocrine and metabolic diseases. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511776878.021
509. Gérard Saïd (2012). Diabetic Neuropathies. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0024020
510. J. Matthias Wenderlein (2008). Treatment of idiopathic Parkinson's syndrome: Is the Risk of Parkinson's Syndrome Reducible?. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2008.0054a
511. David C. Steffens, Dan G. Blazer, & John L. Beyer (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
512. Francesco Panza, Vincenza Frisardi, Cristiano Capurso, Alessia D’Introno, Anna M. Colacicco, Davide Seripa, Alberto Pilotto, Gianluigi Vendemiale, Antonio Capurso, & Vincenzo Solfrizzi (2009). POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2009.02236.x
513. Ahmed A. Moustafa, & Michele Poletti (2013). Neural and behavioral substrates of subtypes of Parkinson’s disease. Frontiers in Systems Neuroscience. https://doi.org/10.3389/fnsys.2013.00117
514. Junya Ebina, Satoru Ebihara, & Osamu Kano (2022). Similarities, differences and overlaps between frailty and Parkinson's disease. Geriatrics and gerontology international/Geriatrics & gerontology international. https://doi.org/10.1111/ggi.14362
515. Ivy F. Tso, Jinsoo Chun, & Patricia J. Deldin (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
516. Yash Khare, & Pratima Singh (2023). CNN –based Spiral drawing classifier to detect Early-Stage Parkinson’s Disease. Journal of Physics Conference Series. https://doi.org/10.1088/1742-6596/2570/1/012026
517. Gbenga Shogbesan, Harry W. Schroeder, Domnique Newallo, & Lance T. Hall (2023). Molecular Imaging of Parkinson’s Disease. Exon Publications eBooks. https://doi.org/10.36255/molecular-imaging-of-parkinsons-disease
518. L. Stefanini (2015). Évolution de l'impulsivité et des troubles du contrôle des impulsions après stimulation cérébrale profonde des noyaux sous thalamiques dans la maladie de Parkinson idiopathique
519. Emese Orban, & Remus Şipoş (2021). Monitoring the patient with Parkinson’s disease – interdisciplinary challenge. Medic ro. https://doi.org/10.26416/med.143.5.2021.5505
520. Unknown (2017). Brief Psychotic Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n218
521. Vijay Raj B. V., & Arikketh Devi (2022). Design and Development of Efficient Model to Predict Neurodegenerative Disorders Using Advanced LSTM: A Review of Literature. International Journal of Case Studies in Business IT and Education. https://doi.org/10.47992/ijcsbe.2581.6942.0177
522. Paolo Barone (2009). Neurotransmission in Parkinson’s disease: beyond dopamine. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2009.02900.x
523. Glória Maria Almeida Souza Tedrus, Lineu Corrêa Fonseca, Grace Helena Letro, Alexandre Souza Bossoni, & Samara Adriana Bastos (2009). Dementia and mild cognitive impairment in Parkinson's disease. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2009000600038
524. Madson Alan Maximiano‐Barreto, & André Fernando de Oliveira Fermoseli (2017). A importância do acompanhamento Psicológico sobre os indivíduos portadores de Doença de Parkinson e Parkinsonismo usuários de l-dopa. Caderno de Graduação - Ciências Humanas e Sociais - UNIT - ALAGOAS
525. wilmer jose rojas sanchez (2021). MEJORANDO LA CALIDAD DE VIDA EN LA ENFERMEDAD DE PARKINSON DESDE LA MEDICINA BIORREGULADORA DE SISTEMAS, UNA NUEVA PERSPECTIVA, REPORTE DE CASO CLINICO. https://doi.org/10.31219/osf.io/5hqg9
526. Reuven Sandyk (1983). Parkinsonism secondary to neurosyphilis. A case report.. PubMed
527. Werner Poewe, & Elisabeth Luginger (1999). Depression in Parkinson's disease: impediments to recognition and treatment options.. PubMed
528. Angela E. P. Bouwmans (2017). Transcranial sonography in parkinsonian disorders. https://doi.org/10.26481/dis.20170126ab
529. Po‐Heng Tsai, & Ganesh Gopalakrishna (2022). Mood Disorders in Parkinson’s Disease. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.010
530. Urszula Fiszer (2013). Atypowy zespół parkinsonowski - pierwotne postępujące zatrzymanie chodu? Opis przypadku
531. Abraham Olufemi Asuku, Maryam Tayo Ayinla, Tobiloba Samuel Olajide, Ebele Joan Ajagun, Kaosara Oyinola Ganiyu, Yusuf Olamilekan Hamza, Ayodeji Johnson Ajibare, & Taoheed Adedeji Abdulsalam (2024). Diagnosis and Biomarkers of Parkinson's Disease. CRC Press eBooks. https://doi.org/10.1201/9781003402893-15
532. Ji Won Han, Yebin D. Ahn, Won‐Seok Kim, Cheol Min Shin, Seong Jin Jeong, Yoo Sung Song, Yun Jung Bae, & Jong‐Min Kim (2018). Psychiatric Manifestation in Patients with Parkinson's Disease. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2018.33.e300
533. Elizabet Deljak (2019). Ocjenske ljestvice za Parkinsonovu bolest
534. Bernhard Bornschein, Uwe Siebert, & Richard Dodel (2004). Zusammenhang zwischen Dyskinesien und gesundheitsbezogener Lebensqualitaet bei Patienten mit M. Parkinson. Aktuelle Neurologie. https://doi.org/10.1055/s-2004-833286
535. Blair Ford, Elan D. Louis, Paul Greene, & Stanley Fahn (1996). Oral and genital pain syndromes in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.870110411
536. Junad Khan (2016). Neuropathic pain. The Journal of Indian Prosthodontic Society. https://doi.org/10.4103/0972-4052.179317
537. Anjan Chatterjee, & Karen Marder (2004). Basal Ganglia Disease And Depression. https://doi.org/10.1093/oso/9780195152746.003.0028
538. Ana Blázquez (2025). Nuevos retos en la atención a la discapacidad intelectual en población infantil y juvenil. Revista de Psiquiatría Infanto-Juvenil. https://doi.org/10.31766/revpsij.v42n1a1
539. Richard A. Awad (2011). Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson’s disease. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v17.i46.5035
540. Putu Agus Grantika, Wayan Westa, & D. P. G. Purwa Samatra (2015). ASPEK PSIKIATRI PADA PENYAKIT PARKINSON. Medicina-buenos Aires
541. Matthew J. Barrett (2017). Risk Factors for Psychosis in Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2017.13.02.78
542. Matthew J. Barrett (2017). Risk Factors for Psychosis in Parkinson’s Disease. US Endocrinology. https://doi.org/10.17925/use.2017.13.02.78
543. Harshad B. Patel, Ankit Patel, Saira Mushtaq, Fasiha Haq, & Shakeel Raza (2011). Aripiprazole-Induced Parkinsonism in a Child. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.10l01081
544. B. Robottom, & William J. Weiner (2009). Parkinsons Disease Dementia. Current Psychiatry Reviews. https://doi.org/10.2174/157340009788971128
545. Sabine Spielberger, & Werner Poewe (2013). Overview of Parkinsonism and Approach to Differential Diagnosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199609536.003.0008
546. Jeongjae Lee, Young Eun Kim, Joong Seob Lee, Suk Yun Kang, Min Seung Kim, In Hee Kwak, Jaeseol Park, Jung Yeon Nam, & Hyeo‐Il Ma (2024). Olfactory and Gustatory Function in Early-stage Parkinson’s Disease: Implication for Cognitive Association. Journal of Movement Disorders. https://doi.org/10.14802/jmd.23243
547. Alina Zorina Stroe, Eda M. Ciorabai, Camelia Pantu, Alexandru Floris Stuparu, Lavinia Muja, Diana Vranau, Silviu Docu Axelerad, & Any Docu Axelerad (2023). Unveiling the Mind: A Comprehensive Review of Psychiatric Disorders in Parkinson’s Disease. Ars medica tomitana. https://doi.org/10.2478/arsm-2023-0007
548. Alessandra Solida (2002). Acute dopaminergic challenge tests to assess postural/kinetic tremor of different origin: a case report. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.73.2.206
549. Rahul P Kotian, & Prakashini Koteshwar (2022). Introduction: Types of Parkinson’s Disease. https://doi.org/10.1007/978-981-19-5001-8_8
550. Guido Kroemer, & Klas Blomgren (2007). Mitochondrial Cell Death Control in Familial Parkinson Disease. PLoS Biology. https://doi.org/10.1371/journal.pbio.0050206
551. Yumi Mitsuyama (1984). Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.47.9.953
552. Quyen Q. Hoang (2014). Pathway for Parkinson disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1324284111
553. Unknown (2019). Parkinson's Disease. Definitions. https://doi.org/10.32388/494828
554. Satoshi Seki, Naoki Yoshimura, & Osamu Nishizawa (2008). Pathologies of the basal ganglia, such as Parkinson’s and Huntington’s disease. CRC Press eBooks. https://doi.org/10.3109/9781439805046-27
555. Janusz Błaszczyk (1998). Motor deficiency in Parkinson's disease. Acta Neurobiologiae Experimentalis. https://doi.org/10.55782/ane-1998-1262
556. R. W. Ryall (1989). Affective and manic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511526923.013
557. Kelly E. Lyons, & Rajesh Pahwa (2011). The impact and management of nonmotor symptoms of Parkinson's disease.. PubMed
558. Joaquín A. Vizcarra, Anthony E. Lang, Kapil D. Sethi, & Alberto J. Espay (2015). Vascular <scp>P</scp>arkinsonism: <scp>D</scp>econstructing a <scp>S</scp>yndrome. Movement Disorders. https://doi.org/10.1002/mds.26263
559. Keisuke Suzuki, Masayuki Miyamoto, & Koichi Hirata (2017). Sleep Disturbances in Neurodegenerative Diseases. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.106.309
560. Shannon Chiu, & Jeremy K. Cutsforth‐Gregory (2021). Atypical Parkinsonian Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0070
561. Robert C. Bransfield, & Kenneth J. Friedman (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
562. Kenneth A. Flowers, I Pearce, & J. Pearce (1984). Recognition memory in Parkinson's disease.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.47.11.1174
563. Mayur Pandya, Cynthia S. Kubu, & Monique Giroux (2008). Parkinson disease: Not just a movement disorder. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.75a.07005
564. A Jáuregui-Barrutia, B Tijero-Merino, Juan Carlos Gómez‐Esteban, & J.J. Zarranz (2010). [Sleep disorders in Parkinson's disease: REM sleep behaviour disorder and restless legs syndrome].
565. Sidney Carter (1964). DIAGNOSIS AND TREATMENT: MANAGEMENT OF THE CHILD WHO HAS HAD ONE CONVULSION. PEDIATRICS. https://doi.org/10.1542/peds.33.3.431
566. Yiming Hu, & Wenzhuo Zhang (2023). Sleep disorders in Parkinson's patients. Highlights in Science Engineering and Technology. https://doi.org/10.54097/hset.v36i.5676
567. Michael H. Silber (2013). Sleep Dysfunction in Parkinson’s Plus Syndrome. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199795161.003.0052
568. Diego Santos‐García, Ángel Aneiros Díaz, Mercedes Macías Arribi, Miguel A. Llaneza González, Javier Abella Corral, & Helena Santos Canelles (2010). Síntomas sensoriales en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009742
569. К. Ray Chaudhuri, & Pablo Martínez‐Martín (2004). Clinical assessment of nocturnal disability in Parkinson’s disease. Neurology. https://doi.org/10.1212/wnl.63.8_suppl_3.s17
570. Jashlyn Lijo.J, Priscilla Mary James, & Haja Sherief.S (2020). Case Report on Young Onset Parkinson's Disease. International Journal of Research
571. Mohamed Echchakery, Mounia Amane, Morad Guennouni, Omari Mohamed, Soraia El Baz, Abderrahmane Achbani, Laila Midhat, Houda Nassah, Abdelmohcine Aimrane, Ahmed Draoui, Taoufik Rokni, Lahcen Elmoumou, & Asmae Lamarani Hanchi (2023). Diagnostic Biomarkers of Parkinson's Disease. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5156-4.ch005
572. Zitan Song, & Wei Huang (2014). Researches of cognitive disorders and electroencephalogram in patients with Parkinson's disease. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2014.10.024
573. Matthew B. Stern, & Andrew Siderowf (2010). Chapter 3 Clinical features: motor and nonmotor. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199550630.003.0003
574. Arif Dalvi, Kelly E. Lyons, & Rajesh Pahwa (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
575. Dong Hui-ji (2012). The Characters of Depression and Sleep Disruption between Parkinson and Major Depression. Medicine and Philosophy
576. Kathleen Lewis, Kanimozhi Natesan, B. Dhanalakshmi, & K. Jaisharma (2021). Role of attribute selection on tuning the learning performance of Parkinson’s data using various intelligent classifiers. International Journal of Advanced Technology and Engineering Exploration. https://doi.org/10.19101/ijatee.2021.874039
577. Marie-Reine Autissier (2008). Maladie de Parkinson: traitement et conseils officinaux. HAL (Le Centre pour la Communication Scientifique Directe)
578. Ying-Sheue Chen (2012). Association between chronic insomnia and depression in elderly adults. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.04.001
579. Tiemei Zhang, Shuyang Yu, Peng Guo, Yang Du, Yang Hu, Ying‐shan Piao, Lijun Zuo, Tenghong Lian, Ruidan Wang, Qiu-Jin Yu, Zhao Jin, & Wei Zhang (2016). Nonmotor symptoms in patients with Parkinson disease. Medicine. https://doi.org/10.1097/md.0000000000005400
580. Robert G. Robinson, Erán Chemerinski, & Ricardo E. Jorge (1999). Pathophysiology of Secondary Depressions in the Elderly. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198879901200306
581. Werner Poewe (2006). The need for neuroprotective therapies in Parkinson’s disease. Neurology. https://doi.org/10.1212/wnl.66.10_suppl_4.s2
582. Olaf Rose (2016). Parkinson’s Disease: Basic knowledge.. PubMed
583. W Danielczyk (1982). [3 crises in Parkinson disease].. PubMed
584. Rotem Dan, Filip Růžička, Ondřej Bezdíček, Evžen Růžička, Jan Roth, Josef Vymazal, Gadi Goelman, & Robert Jech (2017). Separate neural representations of depression, anxiety and apathy in Parkinson’s disease. Scientific Reports. https://doi.org/10.1038/s41598-017-12457-6
585. F Howard (1971). Peripheral Neuropathy as a Sign of Systemic Disease. Postgraduate Medicine. https://doi.org/10.1080/00325481.1971.11697594
586. Linyi Li, Shufen Liu, Jian-long Zhuang, Mi-mi Li, Zhengping Huang, Yanhong Chen, Xiangrong Chen, Chunnuan Chen, Shu Lin, & Lichao Ye (2022). Recent research progress on metabolic syndrome and risk of Parkinson’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2022-0093
587. Divya Jyothi Uppari (2015). Huntington's Disease- Neurodegenerative Genetic Disorder. Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
588. Mary V. Seeman (2018). Gambling Disorder in the Context of Parkinson’s Disease. MOJ Addiction Medicine & Therapy. https://doi.org/10.15406/mojamt.2018.05.00081
589. Marina Romanovna Nodel, N. N. Yakhno, Marina Romanovna Nodel, & N. N. Yakhno (2009). NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2009-30
590. Keisuke Suzuki, Hiroaki Fujita, Yuji Watanabe, Takeo Matsubara, Taro Kadowaki, Hirotaka Sakuramoto, Mai Hamaguchi, Narihiro Nozawa, & Koichi Hirata (2019). Leg restlessness preceding the onset of motor symptoms of Parkinson disease. Medicine. https://doi.org/10.1097/md.0000000000016892
591. Lokesh Yadav, Pooja Khosla, Vinus Taneja, & Rishikesh Dessai (2023). Primary adrenal insufficiency presenting with neuropsychiatric illness. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20232447
592. Angelo Antonini, Aron Emmi, & Marta Campagnolo (2023). Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13786
593. Ian Maddocks, Bruce J. Brew, Heather Waddy, & Ian Williams (2005). Parkinson's disease and related disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.019
594. Nancy Klein, H. Wallner, & P.-A. Fischer (2004). Diagnose und Therapie der Depression bei Morbus Parkinson. Journal für Neurologie, Neurochirurgie und Psychiatrie
595. Rottraut Ille, Albert Wabnegger, Petra Schwingenschuh, Petra Katschnig‐Winter, Mariella Kögl-Wallner, Karoline Wenzel, & Anne Schienle (2015). Intact emotion recognition and experience but dysfunctional emotion regulation in idiopathic Parkinson's disease. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2015.12.007
596. Lizbeth Vásquez Celaya, Amiel Tamariz Rodríguez, Jaime Rafael Gutiérrez Pérez, Gerardo Marín Márquez, María Rebeca Toledo‐Cárdenas, Porfirio Carrillo Castilla, Jorge Manzo, Genaro A. Coria‐Ávila, & Luis I. García (2019). Enfermedad de Parkinson más allá de lo motor. eNeurobiología. https://doi.org/10.25009/eb.v10i23.2542
597. Mark Stacy, & Rebekah J. Jakel (2014). Parkinson&amp;rsquo;s disease psychosis. Journal of Parkinsonism and Restless Legs Syndrome. https://doi.org/10.2147/jprls.s40946
598. S Swathilakshmi, D. Vivek, & Aswini EV (2020). Emerging Novel Drugs For Parkinson’s Disease. American Journal Of Pharmacy And Health Research. https://doi.org/10.46624/ajphr.2020.v8.i10.001
599. Helmut Niederhofer (2013). Temporal Limitation and Irreversibility of Brain Development. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2013.0733a
600. Eva L. Feldman, Martin J. Stevens, & James W. Russell (2003). Diabetic Peripheral and Autonomic Neuropathy. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-310-1_24
601. F. Girotti, Riccardo Marano, Licia Grazzi, G. Scigliano, & T. Caraceni (1986). Cognitive impairment in Parkinson's disease.. PubMed
602. Ángel Sesar, Gustavo Fernández‐Pajarín, Begoña Ares, & Alfonso Castro (2021). Do we need to redefine the advanced stage in Parkinson’s disease?. DELETED. https://doi.org/10.24875/rmn.20000119
603. Roger A. Barker, & Clare Redfern (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
604. Vinayak Majhi, Sudip Paul, Goutam Saha, & Jitendra Kumar Verma (2020). Sensor based Detection of Parkinson’s Disease Motor Symptoms. 2021 International Conference on Computational Performance Evaluation (ComPE). https://doi.org/10.1109/compe49325.2020.9200051
605. 김진웅, & 강군용 (2002). 대뇌 기저핵의 기능과 파킨슨 질환. 대한물리치료사학회지 = The journal of Korean academy of physical therapist
606. Deepak M. Sampathu, & Virginia M.‐Y. Lee (2007). Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-963-9_117
607. Edward C Mann (1892). THE DISEASE OF INEBRIETY IN ITS RELATION TO DISEASES OF THE MIND AND NERVOUS SYSTEM.. JAMA. https://doi.org/10.1001/jama.1892.02411130006001b
608. Annamária Takáts (2003). [Diagnostic criteria and differential diagnosis of Parkinson disease].. PubMed
609. Marc‐André Bédard, Maxime Lévesque, Simon Lemay, & F. Paquet (2003). Nondopaminergic Influences on Cognition in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_15
610. Roberto Ceravolo, Carlo Rossi, Lorenzo Kiferle, & Ubaldo Bonuccelli (2010). Nonmotor symptoms in Parkinson‘s disease: the dark side of the moon. Future Neurology. https://doi.org/10.2217/fnl.10.69
611. Charles H. Adler, & Thomas G. Beach (2016). Neuropathological basis of nonmotor manifestations of Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.26605
612. Allan Hugh Cole (2021). Parkinson’s Disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190672928.003.0002
613. Daniel E. Huddleston, Lynn Marie Trotti, Felicia C. Goldstein, & Stewart A. Factor (2012). Nonmotor symptoms in dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-24
614. Orestis Giotakos (2017). Poor insight in psychosis and meta-representation models. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.26386/obrela.v1i1.5
615. Jirada Sringean, Ornanong Udomsirithamrong, & Roongroj Bhidayasiri (2024). Too little or too much nocturnal movements in Parkinson’s disease: A practical guide to managing the unseen. Clinical Parkinsonism & Related Disorders. https://doi.org/10.1016/j.prdoa.2024.100258
616. D. Salat-Foix, & Oksana Suchowersky (2012). The management of gastrointestinal symptoms in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/ern.11.192
617. K. A. Jellinger (2011). Postencephalitic Parkinsonism. https://doi.org/10.1002/9781444341256.ch19
618. Christina L. Erickson, & Naoko Muramatsu (2004). Parkinson's Disease, Depression and Medication Adherence. Journal of Gerontological Social Work. https://doi.org/10.1300/j083v42n03_02
619. Iva Stanković, & Gregor K. Wenning (2014). Neuropsychiatric Manifestations in Atypical Parkinsonian Syndromes. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-09537-0_7
620. Nadeesha Kalyani, Karen A. Sullivan, Gene Moyle, Sandra Brauer, Erica Rose Jeffrey, & Graham Kerr (2019). Effects of dance on cognitive functions, psychological symptoms and health-related quality of life in Parkinson’s disease
621. Urs P. Mosimann, & Ian G. McKeith (2003). Dementia with Lewy bodies and Parkinson's disease dementia - two synucleinopathies
622. Ursula Merschdorf, Daniela Berg, Ilona Csóti, Ferenc Fornádi, Beverly Merz, M. Naumann, Georg Becker, & Tillmann Supprian (2003). Psychopathological Symptoms of Depression in Parkinson’s Disease Compared to Major Depression. Psychopathology. https://doi.org/10.1159/000073446
623. Elizabeth Slow, & Anthony E. Lang (2019). Parkinsonism and Related Disorders. DeckerMed Medicine. https://doi.org/10.2310/im.1178
624. Elizabeth Slow, & Anthony E. Lang (2019). Parkinsonism and Related Disorders. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1178
625. Elizabeth Slow, & Anthony E. Lang (2019). Parkinsonism and Related Disorders. DeckerMed Transitional Year Weekly Curriculum™. https://doi.org/10.2310/tywc.1178
626. M.E. Erro Aguirre, María Moreno García, & Beatriz Zandio Amorena (2010). Bases fisiopatológicas de los síntomas no motores de la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009734
627. Zlatko Trkanjec (2003). News in treatment of Parkinson's disease
628. Jadwiga Wardas, & Barbara Kosmowska (2020). Zaburzenia zachowania fazy snu REM jako wczesny marker choroby Parkinsona. Kosmos. https://doi.org/10.36921/kos.2020_2687
629. Juan Sebastián Theran León, Luis Dulcey, María Alejandra Cala, Stephania Julieth Nariño Anaya, & Juan Pablo Duran Anaya (2023). Debilidad neuromuscular aguda, aproximación diagnóstica y terapéutica de un complejo cuadro clínico de etiología variable.. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v6i6.4222
630. Iris E. Sommer, & Teus van Laar (2019). [Parkinson's disease as a neuropsychiatric disorder].. PubMed
631. Sahil Mehta, ParampreetSingh Kharbanda, & Shivangi Sharma (2015). Neuropsychiatric aspects of Parkinson′s disease. Astrocyte. https://doi.org/10.4103/2349-0977.168248
632. Robert Caslake, Kate Taylor, & Carl Counsell (2009). Parkinson's disease misdiagnosed as stroke. BMJ Case Reports. https://doi.org/10.1136/bcr.07.2008.0558
633. Katharina Klatt‐Schreiner (2022). Endocannabinoide und andere Lipidmediatoren bei Morbus Parkinson-assoziierten Schmerzen : Untersuchung mittels Quantitativer Sensorischer Testung (QST). https://doi.org/10.21248/gups.67483
634. Dora Galeković (2019). Kvaliteta života bolesnika s Parkinsonovom bolešću
635. Carol Frattali, & Joseph R. Duffy (2005). Characterizing and Assessing Speech and Language Disturbances. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:255
636. Do-Young Kwon (2022). Sleep Disturbances in Patients with Parkinson’s Disease. Chronobiology in Medicine. https://doi.org/10.33069/cim.2022.0004
637. Erich O. Richter, & Andrés M. Lozano (2004). Deep Brain Stimulation for Parkinson’s Disease and Movement Disorders. CRC Press eBooks. https://doi.org/10.3109/9780203021651-24
638. Hugh Rickards (2003). The outcome of depressive disorders in the setting of neurological illness. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.74.7.842-a
639. Daiga Heisters (2011). Parkinson's: symptoms, treatments and research. British Journal of Nursing. https://doi.org/10.12968/bjon.2011.20.9.548
640. Yufeng Wang, Qiaojun Peng, & Shaoyue He (2019). Sensory disorders and electrophysiological study in Parkinson′s disease. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2019.05.010
641. Amaia Jáuregui Barrutia, Beatriz Tijero Merino, Juan Carlos Gómez‐Esteban, & Juan José Zarranz Imirizaldu (2010). Trastornos del sueño en la enfermedad de Parkinson: trastorno de conducta del sueño REM y síndrome de piernas inquietas. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2010054
642. Margarita Maria Maramis (2009). Mendiagnosis Gangguan Bipolar pada Fase Depresi sejak dini
643. Joël Belmin (2012). Parkinson's Disease. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119952930.ch63
644. N Shobana (2010). Prevalence of Non-motor Features Across the Various Stages of Idiopathic Parkinson’s Disease and its Correlation with the Severity andDuration of the Disease.
645. Charles H.M. Beck (1980). Normal Aging of the Human Brain Potentiates the Neuropathologies of Parkinson's Disease, Depression, and Alzheimer's Disease: Behavioural Implications. Canadian Journal of Counselling and Psychotherapy
646. María de Lourdes Merighi Tabaquim, & Rui Mateus Joaquim (2013). FUNÇÕES NEUROPSICOLÓGICAS NA PARALISIA CEREBRAL. ARCHIVES OF HEALTH INVESTIGATION
647. David J. Burn (2011). Clinical Features of Dementia Associated with Parkinson's Disease and Dementia with Lewy Bodies. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch12
648. Lei Mou, Wei Ding, & Pedro Fernández-Fúnez (2019). Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology. Journal of Medical Genetics. https://doi.org/10.1136/jmedgenet-2019-106210
649. Young‐Woo Park (1995). Sleepwalking and Sleep Terrors
650. Matthew Feldman, Sarah Marmol, & Jason Margolesky (2022). Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.s360268
651. Antonio Luiz S. Werneck (2010). Doença de Parkinson: Etiopatogenia, Clínica e Terapêutica. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE)
652. D. S. FAIRCHILD (1900). DIAGNOSTIC VALUE OF THE DEEP REFLEXES OF THE LOWER EXTREMITIES.. JAMA. https://doi.org/10.1001/jama.1900.24610140001001
653. Nicolaas I. Bohnen, & Joshua Shulman (2019). Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-191627
654. FRCP Professor Graham Mulley DM, MbChB Professor Clive Bowman BSc, Dr Michal Boyd, & MBChB Dr Sarah Stowe BSc (2014). Major Medical Problems. https://doi.org/10.1002/9781118690345.ch8
655. Sarah Coakeley, Kaylena A. Ehgoetz Martens, & Quincy J. Almeida (2014). Management of anxiety and motor symptoms in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2014.936388
656. Maria Luiza Santos Viana (2024). EPILEPSIA COMO FATOR DE RISCO PARA O DESENVOLVIMENTO DA DOENÇA DE PARKINSON: UMA REVISÃO BIBLIOGRÁFICA. Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida. https://doi.org/10.36692/v16n2-49r
657. Tiago Mestre, Antonio P. Strafella, Teri Thomsen, Valerie Voon, & Janis M. Miyasaki (2013). Diagnosis and treatment of impulse control disorders in patients with movement disorders. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756285613476127
658. Nobuo Yanagisawa (1998). [Motor and cognitive functions of the basal ganglia].. PubMed
659. Alfonso Fasano, Sophie Lehnerer, & Antonio E. Elia (2014). Symptoms of dystonia. https://doi.org/10.2217/ebo.13.269
660. Kelvin L. Chou, & Alice Cronin‐Golomb (2013). Feeling the need … the need for speed (of processing training) in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e3182a82581
661. Unknown (1994). Cognitive-Behavioral Consequences of Epilepsy. Pediatrics in Review. https://doi.org/10.1542/pir.15.9.367
662. Sunil Aggarwal (2018). The Relevance of Exercise with DJ-1 Protein to Reduce Motor Symptoms and Reverse the Early Onset of Idiopathic Parkinson’s Disease. Advances in Pharmacology & Clinical Trials. https://doi.org/10.23880/apct-16000142
663. Fang Wang, & Wei Zhang (2015). [Clinical Features and Pathogenic Mechanisms of Parkinson Disease With Pure Apathy].. PubMed
664. Stepkina Da, В. В. Захаров, & Iakhno Nn (2008). [Cognitive disturbances in the progression of Parkinson's disease].
665. William P. Howlett (2015). Movement Disorders and Motor Neurone Disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316287064.015
666. Andre Y. Son, Alberto Cucca, Shashank Agarwal, Anli Liu, Alessandro Di Rocco, & Milton Biagioni (2017). Are we missing non-motor seizures in Parkinson’s disease? Two case reports. Journal of Clinical Movement Disorders. https://doi.org/10.1186/s40734-017-0061-3
667. Mary V. Seeman (2018). None. MOJ Addiction Medicine & Therapy. https://doi.org/10.15406/mojamt.5.1
668. Semiha Yenişehir, Veli Batur, İlkim Çıtak Karakaya, & Mehmet Gürhan Karakaya (2020). Patient-Reported and Performance-Based Outcome Measures for Functional Mobility and Activity Limitation in Individuals with Parkinson's Disease. Anadolu Kliniği Tıp Bilimleri Dergisi. https://doi.org/10.21673/anadoluklin.622194
669. Juan Carlos Martínez‐Castrillo, Lydia Vela, Javier del Val, & Araceli Alonso‐Cánovas (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
670. Rikinkumar S. Patel, Saher Kamil, Mansi Shah, Narmada Neerja Bhimanadham, & Sundus Imran (2019). Pros and Cons of Marijuana in Treatment of Parkinson's Disease. PMC
671. Veronica Hackethal (2018). Quiz: Drug-Induced Parkinsonism
672. A. Pietzcker (1996). [Medical expert assessment in psychiatry].. PubMed
673. Asako Yoritaka (2014). 1. The Noticeable Early Symptoms of Parkinson's Disease. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.103.1854
674. Ana Belén Segarra, Inmaculada Banegas, Isabel Prieto, & Manuel Ramírez‐Sánchez (2016). Asimetría cerebral y dopamina: más allá de las implicaciones motoras en la enfermedad de Parkinson y hemiparkinsonismo experimental. Revista de Neurología. https://doi.org/10.33588/rn.6309.2016087
675. І. F. Labunets (2020). NEUROPROTECTIVE EFFECTS OF THE PINEAL HORMONE MELATONIN IN ANIMALS WITH EXPERIMENTAL MODELS OF NEURODEGENERATIVE PATHOLOGY. Izdevniecība “Baltija Publishing” eBooks. https://doi.org/10.30525/978-9934-588-44-0/18
676. K Mitra, PK Gangopadhaya, & Sudip Das (2003). Parkinsonism plus syndrome--a review.. PubMed
677. Leora L. Borek, Kelvin L. Chou, & Joseph H. Friedman (2007). Management of the behavioral aspects of Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.6.711
678. Ronald B. Postuma, Jean Gagnon, Sylvie Rompré, & J. Montplaisir (2010). Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e3181ca0166
679. Moon S. Won, Ania Mikos, Mary Hurd, Hubert Fernandez, Thomas A. Eskin, Janet Romrell, & Michael S. Okun (2009). Tardive parkinsonism in a bipolar patient: Post-mortem examination supports a physiological rather than pathological dysfunction. Neurocase. https://doi.org/10.1080/13554790802613033
680. Iago Moura Aguiar, Cicero Felipe Paes de Araújo Costa, André Fernando de Oliveira Fermoseli, Cícera Lourenço Pontes Fon De Jesus, Madson Alan Maximiano‐Barreto, & Theresa Cristina de Albuquerque Siqueira (2018). INFLUENCIA DE PSICOPATOLOGIAS NO DECLÍNIO COGNITIVO E MEMÓRIA EPISÓDICA DE PACIENTES COM DOENÇA DE PARKINSON.
681. Metzer Ws (1992). Phenomenological approach to the correct diagnosis of Parkinson's disease.. PubMed
682. K Hopfensperger, & William C. Koller (1991). Recognizing early Parkinson's disease. Postgraduate Medicine. https://doi.org/10.1080/00325481.1991.11700978
683. María Alicia Lantigua Martell (2019). Marco teórico de la presente investigación. Revista Cubana de Alimentación y Nutrición
684. Martina Sabol (2017). Procjena aktivnosti svakodnevnog života osoba s cerebralnom paralizom
685. Iracema Leroi, & Alistair Burns (2006). Behavioural and psychological symptoms of dementia associated with Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2006.101162
686. Jeremy Cosgrove, & Jane Alty (2018). Cognitive deficits in Parkinson&amp;rsquo;s disease: current perspectives. Journal of Parkinsonism and Restless Legs Syndrome. https://doi.org/10.2147/jprls.s125064
687. A. N. Exton‐Smith, & P. W. Overstall (1979). Central nervous system and special senses. Geriatrics. https://doi.org/10.1007/978-94-011-7191-5_4
688. David J. Burn, & D. Bates (1998). Neurology and the kidney. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.65.6.810
689. Ingeborg Krägeloh‐Mann (2010). Clinical outcome: neurological sequelae following preterm birth. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511712166.004
690. M. Manfredi, Fabrizio Stocchi, & Laura Vacca (1995). Differential diagnosis of parkinsonism.. PubMed
691. Peter Brdiczka (2014). Drugs Can Only Affect Symptoms. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489a
692. Thierry Gallarda (2004). Dépression du sujet âgé et affections organiques cérébrales. Gériatrie et Psychologie Neuropsychiatrie du Viellissement
693. Nicolás López Hernández (2015). Valor diagnóstico combinado de la evaluación olfatoria y el estudio ecográfico transcraneal en el diagnóstico diferencial de los pacientes con enfermedades de parkinson y otros trastornos del movimiento
694. Syed Zohair Husain Rizvi, Vikram Palimar, Chandni Gupta, & Lydia S. Andrade (2024). Spectrum of Non-Motor Symptoms in Parkinson’s Disease — a Review. Annals of Clinical and Experimental Neurology. https://doi.org/10.17816/acen.1001
695. Athira Sasidharan, Dileep KS, & P. V. Giri (2025). An Ayurvedic Approach in Improving the Quality of Life in Atypical Parkinsonism - A Case Report. Journal of Ayurveda and Integrated Medical Sciences. https://doi.org/10.21760/jaims.9.11.40
696. Gilles Fénelon (1997). [Diagnosis and course (under treatment) of Parkinson disease].. PubMed
697. Masayuki Miyazaki, Hiroko Yagihara, Hiromi Fujita, Hodaka Yamakado, Keiji Wada, & Eiko N. Minakawa (2025). CHRONIC SLEEP FRAGMENTATION ACCELERATES THE DEVELOPMENT OF PRODROMAL SYMPTOMS AND PATHOLOGICAL CHANGES IN PARKINSON’ S DISEASE MODEL MICE. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae059.437
698. Alex Iranzo de Riquer, Alberto Bergareche, & Victor Zuchi Campos (2011). Sleep Disorders in Parkinson Disease. The Neurologist. https://doi.org/10.1097/nrl.0b013e31823966f8
699. Sarika Chaudhary, & Nilika Tyagi (2022). A Review on Parkinson’s Disease: Overview and Management. International Journal of Pharmaceutical Sciences Review and Research. https://doi.org/10.47583/ijpsrr.2022.v76i01.004
700. Matthew Chow (2022). Sleep in Parkinson’s Disease Dementia. IntechOpen eBooks. https://doi.org/10.5772/intechopen.99068
701. Jurek Olszewski (2006). [Causes, diagnosis and treatment of neurogenic dysphagia as an interdisciplinary clinical problem].. PubMed
702. Kim Griswold, Paula A. Del Regno, & Roseanne C Berger (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed
703. Christopher Frank, Giovanna Pari, & John P. Rossiter (2006). Approach to diagnosis of Parkinson disease.. PubMed
704. Andrea Bukša (2015). Produljenje vozačke dozvole vozačima starijim od 65 godina
705. Emilio Fernández-Egea, & Peter B. Jones (2023). Schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.065
706. Alastair J.J. Wood, & Donald B. Calne (1993). Treatment of Parkinson's Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm199309303291408
707. О. В. Яковлева, М Г Полуэктов, Е А Lyashenko, & О С Левин (2019). Subjective and objective subtypes of excessive daytime sleepiness in Parkinson's disease. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro201911909244
708. Ulla Ellfolk, Juho Joutsa, Juha O. Rinne, Riitta Parkkola, Pekka Jokinen, & Mira Karrasch (2013). Brain Volumetric Correlates of Memory in Early Parkinson's Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-130276
709. N. N. Koberskaya, & Т. М. Оstroumova (2020). Near-moderate cognitive decline. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2020-2-92-97
710. Egberto Reis Barbosa (2013). Non-motor symptoms in Parkinson's disease. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20130001
711. Paula Garcia Esparcia (2016). Identification of a risk transcriptome and proteome in Parkinson’s disease, Dementia with Lewy bodies and rapidly progressive Dementia with Lewy bodies
712. Isabela Godinho Gonçalves, & Maria Cristina Almeida de Souza (2023). Abordagem geral da doença de Parkinson. Revista Eletrônica Acervo Científico. https://doi.org/10.25248/reac.e12557.2023
713. James E McKinley, & Allen Perkins (2019). Neurologic Conditions: Parkinson Disease.. PubMed
714. J. Eric Ahlskog (2013). Depression. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199977567.003.0029
715. Hira Saleem, Maria Bilal, & Abdul Rafeh Awan (2024). Generalized Fatigue: Why Post-Polio Syndrome Should Be Included as A Differential Diagnosis. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.11113
716. Babatunde Adetunji, Maju Matthews, Biju Basil, & Adegboyega Oyemade (2007). "Bipolar Family". The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0211e
717. Vikas Dhikav, Pankaj Kumar, & Praveen Kumar Anand (2022). Cardiovascular Comorbidities and Cognitive Impairment. OBM Geriatrics. https://doi.org/10.21926/obm.geriatr.2204214
718. Fiona Goudie (2017). Physical and Emotional Problems in Later Life. Routledge eBooks. https://doi.org/10.4324/9781315174075-3
719. Liang Li-w (2011). Premotor Phase of Early Parkinson Disease(review). Zhongguo kangfu lilun yu shijian
720. K. A. Jellinger (2024). Mild cognitive impairment in Parkinson's disease: current view. Frontiers in Cognition. https://doi.org/10.3389/fcogn.2024.1369538
721. Richard Mayeux (1990). Depression in the patient with Parkinson's disease.. PubMed
722. Inga Suttrup, & Tobias Warnecke (2016). Diagnosis of Parkinson’s disease.. PubMed
723. Hisao Tachibana (2013). [Cognitive impairment in Parkinson's disease].. PubMed
724. Julia Ridgeway-Diaz, & Laura Marsh (2022). Parkinson’s Disease and Atypical Parkinsonian Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0017
725. Karim Fifel (2013). Alterations of the circadian timing system in rodent and non human primate models of Parkinson’s disease. HAL (Le Centre pour la Communication Scientifique Directe)
726. Osamu Kano, Ken Ikeda, Derek Cridebring, Takanori Takazawa, Yasuhiro Yoshii, & Yasuo Iwasaki (2011). Neurobiology of Depression and Anxiety in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.4061/2011/143547
727. Simranjit Kaur, Utkarsh Kumar Tripathi, Abhishek Chakladar, Zaid Ahmed, Gaurav Verma, Alexander Martin Alphonse, & Ankan Paul (2023). Atypical Presentation of Neuropsychiatric Variant of Wilson’s Disease and Clinical Improvement with Elemental Zinc Monotherapy. Indian Journal of Clinical Psychiatry.. https://doi.org/10.54169/ijocp.v3i02.81
728. Francisco Cardoso (1995). Tratamento da doença de Parkinson. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x1995000100001
729. Priyadarshi Prajjwal, Herson S Flores Sanga, Kirtish Acharya, Tamara Tango, Jobby John, Rene S.C. Rodriguez, Mohammed Dheyaa Marsool Marsool, Mukhamed Sulaimanov, Aneeqa Ahmed, & Omniat Amir Hussin (2023). Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment. Annals of Medicine and Surgery. https://doi.org/10.1097/ms9.0000000000001142
730. Vaibhav Walia, Ashish Gakkhar, & Munish Garg (2018). Parkinson's Disease. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-5225-5282-6.ch012
731. Fitriyani Fitriyani, & Nanda Tiara Santika (2024). Undiagnosed Type 2 Diabetes Mellitus in A 68 year-old Patient with Parkinson's Disease : An Invisible Risk Factor. https://doi.org/10.23960/jka.v11i1.pp76-82
732. Fakher Rahim, Reem Sayad, Ahmed M. Kedwany, Hager Sayed, Ana Letícia Fornari Caprara, & Jamir Pitton Rissardo (2024). Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review). Medicine International. https://doi.org/10.3892/mi.2024.194
733. Gauri Adhikari, & Ritu Pokhrel (2024). Parkinson’s disease: Causes, Symptoms, Diagnosis, and Treatment. The American journal of patient health info.. https://doi.org/10.69512/ajphi.v1i01.44
734. Roger L. Albin, & William T. Dauer (2012). Parkinson syndrome. Neurology. https://doi.org/10.1212/wnl.0b013e31825dd3d0
735. Rupali Bansal, & Stephen H. Sheldon (2008). Parasomnias in Childhood. CRC Press eBooks. https://doi.org/10.3109/9781420048087-26
736. Vinicius Ricardo Xavier (2019). DOENÇA DE PARKINSON E PRINCIPAIS CAUSAS DE QUEDAS: UMA REVISÃO DE LITERATURA. Anais do EVINCI - UniBrasil
737. Masatoshi Takeda (2003). Neural transplantation to neurodegenerative disorders. Psychogeriatrics. https://doi.org/10.1046/j.1479-8301.2003.00014.x
738. Dipal Patel, Komal Sharma, Chetan Chauhan, & Gunjan Jadon (2014). A CHRONIC, PROGRESSIVE NEUROLOGICAL DISORDER PARKINSON’S DISEASE- MECHANISMS AND TREATMENT. Journal of Drug Delivery and Therapeutics. https://doi.org/10.22270/jddt.v4i1.674
739. H Malaterre, P Lauribe, Francesca Paganelli, B Ramond, & Samuel Wolfe Levy (1992). [Parkinson syndrome, a possible adverse effect of calcium inhibitors].. PubMed
740. Fabiola Beatríz Chasillacta Amores, Grace Pamela López Pérez, Nadihezka Amanda Cusme Torres, & Verónica del Pilar Cantuñi Carpio (2023). Sleep pattern impairment in nursing students according to NANDA. Medwave. https://doi.org/10.5867/medwave.2023.s1.uta111
741. Andreea Slavescu, Lisa Byrne, Amanda Lavan, & Robert Briggs (2022). Hypotensive unawareness in Parkinson's disease-related autonomic dysfunction. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000003329
742. Miriam Rafferty, Erin R. Foster, Angela Roberts, Kevin Smaller, Lynn Johnson, & Rachael Lawson (2024). Stemming the Tide: The Proactive Role of Allied Health Therapy in Parkinson’s Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-230267
743. Amos D. Korczyn (2010). Vascular Contribution to Dementia in Parkinson’s Disease. Neurodegenerative Diseases. https://doi.org/10.1159/000285522
744. Hiroshi Shibasaki, Mark Hallett, Kailash P. Bhatia, Stephen G. Reich, & Bettina Balint (2020). Disorders of Increased Muscle Stiffness or Overactivity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0009
745. Mercedes Lorenzo Peña, María D. Cuenca-López, & J. M. Hernández Guijo (2010). Que nos dice la historia de la enfermedad de Parkinson. Actualidad en farmacología y terapéutica
746. Richard Dodel (2010). Kognitive Störungen bei neurologischen Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628846
747. S Pratibha (2010). Etiology of Late Onset Seizures
748. R. Leiguarda (2003). Distinctive Features of Apraxia in Corticobasal Degeneration and Other Neurological Illnesses. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_10
749. Joseph E.F. Riseman (1956). Differential Diagnosis of Angina Pectoris. Circulation. https://doi.org/10.1161/01.cir.14.3.422
750. Ovidiu Alexinschi, & Emanuel-Andrei Sirițeanu (2024). Affective disorders in Parkinson's disease. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2024.2.13
751. Eliane Michelini Marraccini (2005). Uma vida que se esvai no Parkinson. Revista Latinoamericana de Psicopatologia Fundamental. https://doi.org/10.1590/1415-47142005001005
752. Victorița SUCIU, Laura Caravia, Irina Petrusca, Renee POPOVICI, Andra PINTILIE, & Sebastian DIACONESCU (2025). PARKINSON’S DISEASE (PD) / ATYPICAL PARKINSONIAN SYNDROMES. CLINICAL AND THERAPEUTIC CARACTHERISTICS. Romanian Journal of Medical Rehabilitation Physical Medicine and Balneoclimatology. https://doi.org/10.59277/rjmrpmb.2024.3.12
753. Marianna Selikhova, Peter Kempster, Tamás Révész, Janice L. Holton, & Andrew J. Lees (2012). Neuropathological findings in benign tremulous Parkinsonism. Movement Disorders. https://doi.org/10.1002/mds.25220
754. Frauke Schroeteler (2013). Evidenzbasierte Physiotherapie bei idiopathischem Parkinson-Syndrom. neuroreha. https://doi.org/10.1055/s-0033-1355431
755. Phil Cotterell, Debbie Weight, Sharon Joseph, & Paul Joseph (2019). Complex Parkinson's disease: review and experiences. British Journal of Healthcare Assistants. https://doi.org/10.12968/bjha.2019.13.8.394
756. G. Kuzis, L. Sabe, C. Tiberti, R. Leiguarda, & S E Starkstein (1997). Cognitive Functions in Major Depression and Parkinson Disease. Archives of Neurology. https://doi.org/10.1001/archneur.1997.00550200046009
757. Kailash Bhatia, Carla Cordivari, Mark J. Edwards, Thomas Foltynie, Marwan Hariz, Prasad Korlipara, Patricia Limousin, Niall Quinn, Sarah J. Tabrizi, & Thomas T. Warner (2016). Movement Disorders. Neurology. https://doi.org/10.1002/9781118486160.ch6
758. Heinz Reichmann (2010). Clinical Criteria for the Diagnosis of Parkinson’s Disease. Neurodegenerative Diseases. https://doi.org/10.1159/000314478
759. P. Bustamante, Gonzalo Solas, & K. Grandez (2011). Neurodegenerative Disease Monitoring Using a Portable Wireless Sensor Device. InTech eBooks. https://doi.org/10.5772/29814
760. Kateřina Menšíková (2013). Pre-motorické a non-motorické příznaky Parkinsonovy nemoci a jejich diagnostika
761. Ieva Baužaitė, Viktorija Navickaitė, & Antanas Vaitkus (2024). Persistent Postural-Perceptual Dizziness. Neurologijos seminarai. https://doi.org/10.15388/ns.2024.28.101.3
762. L Ahn Dan, 王晓君, 罗蔚锋, 朱婷鸽, 胡伟东, 毛成洁, & Chun‐Feng Liu (2010). 尿酸对帕金森病患者不同认知功能域影响分析. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2010.06.006
763. Venkateshwarla Rama Raju (2023). Awareness of medical issues in health sciences and in scientific technological education. IP Journal of Nutrition Metabolism and Health Science. https://doi.org/10.18231/j.ijnmhs.2023.018
764. M.W.I.M. Horstink, Marieke C. J. Dekker, Pasquale Montagna, Vincenzo Bonifati, & Bart P. van de Warrenburg (2010). Pallidopyramidal disease: A misnomer?. Movement Disorders. https://doi.org/10.1002/mds.23118
765. Sasmith Menakuru, Mir Inzamam Ali, Mir Inzamam Ali, Sruti Kalla, Sruti Kalla, Abhinav Datti, & Abhinav Datti (2020). Multiple system atrophy in a man misdiagnosed with parkinsonism. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20204915
766. Charles W. Burr (1911). TRANSITORY MENTAL CONFUSION AND DELIRIUM IN OLD AGE. Journal of the American Medical Association. https://doi.org/10.1001/jama.1911.04260120307001
767. Arpit Dwivedi, Srishti Awasthi, Avanish Maurya, Saumya Awasthi, Anurag Mishra, Ashwini Kumar Mishra, Bhavana Dubey, & Ruchi Singh (2023). Parkinson’s Disease: A Systematic Review of Neurodegenerative Disease and Its Management. International Journal of Pharmacy and Pharmaceutical Research. https://doi.org/10.25166/ijppr.2023.27.3.15
768. Guy M. Goodwin (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
769. SEEGIO E. STARKSTEIN, & Robert G. Robinson (1991). Dementia of Depression in Parkinson??s Disease and Stroke. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-199110000-00002
770. julio rotondo, & julio rotondo (2019). Dolor en la enfermedad de Parkinson. Una mirada a un aspecto poco conocido de esta patología. Revista de la Sociedad Española del Dolor. https://doi.org/10.20986/resed.2019.3733/2019
771. Kenneth E. Plotkin (2007). Insomnia Caused by Medical Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-042-7_15
772. W. R. Wayne Martin (2019). Parkinson’s Disease and Aging: Presynaptic Nigrostriatal Function. CRC Press eBooks. https://doi.org/10.4324/9780429284359-6
773. R. Dodel, Sonja Franke, W. H. Oertel, & K. Eggert (2007). Leitlinien für Diagnose und Therapie der Parkinson-Syndrome. Nervenheilkunde. https://doi.org/10.1055/s-0038-1626858
774. Pietro‐Luca Ratti (2014). Troubles du sommeil dans la maladie de Parkinson et les autres synucléinopathies
775. Matthieu Béreau, Vincent Van Waes, Mathieu Servant, Éloi Magnin, Laurent Tatu, & Mathieu Anheim (2023). Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis. Cells. https://doi.org/10.3390/cells12121599
776. William H. Reid, George U. Balis, & Beverly Sutton (1997). The treatment of psychiatric disorders : revised for DSM-IV
777. Samrah Ahmed, Ian Baker, & Christopher Butler (2016). Diagnosing young onset dementia can be challenging.. PubMed
778. Hani T. S. Benamer (2007). Parkinsonism and tremor disorders. A clinical approach. Libyan Journal of Medicine. https://doi.org/10.3402/ljm.v2i2.4698
779. Óscar Bernal-Pacheco, Natlada Limotai, Criscely L. Go, & Hubert H. Fernandez (2012). Nonmotor Manifestations in Parkinson Disease. The Neurologist. https://doi.org/10.1097/nrl.0b013e31823d7abb
780. Αθανασία Αντωνίου (2022). Study of pathogenetic mechanisms of Parkinson's disease in neuronal cellular models. https://doi.org/10.12681/eadd/51615
781. Pooja Kanyadan (2024). Potential Novel Treatments for Parkinson’s Disease. Deleted Journal. https://doi.org/10.62186/001c.92039
782. Rebecca McKnight, Jonathan Price, & John Geddes (2019). Sleep disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0036
783. Rafael J. Salín-Pascual (2012). Sleep, Adenosine and Caffeine as Tools for The Early Diagnosis of Parkinson Disease. The Open Sleep Journal. https://doi.org/10.2174/1874620901205010059
784. Lukas Gattermeyer-Kell, Petra Katschnig‐Winter, Mariella Kögl, & Petra Schwingenschuh (2025). New-onset progressive ataxia in a 66-year-old woman with longstanding Parkinson’s disease – a case report. Case Reports in Neurology. https://doi.org/10.1159/000545411
785. Dana B. Hancock, William K. Scott, & Honglei Chen (2008). Challenges for Epidemiological Research of Pesticide Exposure and Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2008.04.02.48
786. 何延波, & 陈彪 (2007). α-synuclein基因多态性与帕金森病. Chin J Neurol. https://doi.org/10.3760/j.issn:1006-7876.2007.02.018
787. Allan House (1996). Depression associated with stroke. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.8.4.453
788. George T. Capone, Parag Royal, William J. Ares, & Emily Lanningan (2007). Transtornos neuroconductuales en niños, adolescentes y adultos jóvenes con síndrome de Down. Revista Síndrome de Down: Revista española de investigación e información sobre el Síndrome de Down
789. G. Fuchs (2008). Psychosen beim idiopathischen Parkinson–Syndrom – Risikofaktoren für den Verlauf. psychoneuro. https://doi.org/10.1055/s-0028-1087115
790. Pedro Clavero, & María Rodríguez‐Oroz (2007). Trastornos del sueño en la enfermedad de Parkinson y otros trastornos del movimiento. Anales del Sistema Sanitario de Navarra. https://doi.org/10.4321/s1137-66272007000200013
791. Luigi Ferini‐Strambi, Giulia Carli, Francesca Casoni, & Andrea Galbiati (2018). Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?. Frontiers in Neurology. https://doi.org/10.3389/fneur.2018.00551
792. Anette Schrag (2005). Driving in Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.053694
793. R B Godwin-Austen (2002). Dementia and Parkinson's Disease. https://doi.org/10.1002/0470846410.ch50a
794. Julia Das, Lisa Graham, Rosie Morris, Gill Barry, Alan Godfrey, Richard Walker, & Samuel Stuart (2022). Eye Movement in Neurological Disorders. Neuromethods. https://doi.org/10.1007/978-1-0716-2391-6_11
795. James Sweeney (1931). PANCREATITIS AND DIABETES MELLITUS. Endocrinology. https://doi.org/10.1210/endo-15-6-508
796. H. J. Sagar (1996). Psychopharmacology of cognitive impairment in Parkinson's disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511601187.034
797. Carol A. Tamminga, Robert W. Buchanan, & James M. Gold (1998). The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199803003-00004
798. Roland Ebner (2014). Incomplete Description. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488a
799. Elisaveta Sokolov, & К. Ray Chaudhuri (2017). An overview of sleep dysfunction in Parkinson disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199682003.003.0025
800. S. Shorvon (1987). Intensive Neurodiagnostic Monitoring. (Advances in Neurology Vol 46).. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.9.1247-a
801. Achmad Eko Ratno (2017). Perilaku Penemuan Informasi pada Penderita Parkinson. Libri-Net
802. Chloé Laurencin, Téodor Danaila, & Stéphane Thobois (2018). [Parkinson's disease treatment: from honey moon to motor fluctuations].. PubMed
803. Joseph H. Friedman (1998). Behavioral dysfunction in Parkinson's disease.. PubMed
804. Florian Brugger, Roberto Erro, Bettina Balint, Georg Kägi, Paolo Barone, & Kailash P. Bhatia (2015). Why is there motor deterioration in Parkinson’s disease during systemic infections-a hypothetical view. npj Parkinson s Disease. https://doi.org/10.1038/npjparkd.2015.14
805. Christian Johannes Amlang, & Katie Kompoliti (2022). Non‐Parkinsonian movement disorders in the elderly. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch54
806. Jennifer M. Rucci, & Robert E. Feinstein (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
807. Saish Shinde, Shreya Satav, Unnati Shirole, & Sujata Oak (2022). Comprehensive Analysis of Parkinson Disease Prediction using Vocal Parameters. 2022 International Conference on Machine Learning, Big Data, Cloud and Parallel Computing (COM-IT-CON). https://doi.org/10.1109/com-it-con54601.2022.9850857
808. David L. Brody (2019). Parkinsonism. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0020
809. T Dattenberg, Eric Zander, & W Zander (1976). [2 criteria for making differential diagnosis between primarily psychogenic and primarily organic body symptomatology easier].. PubMed
810. Sajjad Salari, & Maryam Bagheri (2019). In vivo, in vitro and pharmacologic models of Parkinson's disease. Physiological Research. https://doi.org/10.33549/physiolres.933895
811. B. Srinivas Teja, T. Tejaswini, P. Dhanush, Soofi Shafiya, & Ramarao Nadendla (2014). NONMOTOR COMPLICATIONS OF PARKINSON DISEASE. Indo American Journal of Pharmaceutical Research
812. Leonardo Caixeta, & Renata Teles Vieira (2008). DEMÊNCIA NA DOENÇA DE PARKINSON E PARKINSONISMO NAS DEMÊNCIAS
813. Eduardo Tolosa, Paolo Barone, & David B. Rye (2004). Parkinson’s disease and sleep. Neurology. https://doi.org/10.1212/wnl.63.8_suppl_3.s1
814. Thomas C. Ely (1906). NEURASTHENIA AS MODIFIED BY MODERN CONDITIONS; AND THEIR PREVENTION.. JAMA. https://doi.org/10.1001/jama.1906.25210220042001k
815. Manmohan Mehndiratta, Rohit Garg, & Sanjay Pandey (2011). Nonmotor symptom complex of Parkinson's disease--an under-recognized entity.. Journal of the Association of Physicians of India
816. Rajesh Pahwa, & Kelly E. Lyons (2010). Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines.. PubMed
817. Kenneth E. Plotkin (2004). Insomnia Caused by Medical and Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_10
818. Sandra Boić (2018). Problemi kretanja i balansa kod osoba s Parkinsonovom bolesti
819. Franziska Albrecht, Joana B. Pereira, Mite Mijalkov, Malin Freidle, Hanna Johansson, Urban Ekman, Eric Westman, & Erika Franzén (2021). Effects of a Highly Challenging Balance Training Program on Motor Function and Brain Structure in Parkinson’s Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-212801
820. Soizic Argaud (2016). Reconnaissance et mimétisme des émotions exprimées sur le visage : vers une compréhension des mécanismes à travers le modèle parkinsonien. https://doi.org/10.13097/archive-ouverte/unige:93815
821. Odile A. van den Heuvel, Ysbrand D. van der Werf, H.J. Groenewegen, E.M.J. Foncke, & Henk W. Berendse (2011). Impulse Control Disorders in Parkinson's Disease. The MIT Press eBooks. https://doi.org/10.7551/mitpress/8595.003.0014
822. Charles W. Burr (1907). TRAUMA OF THE HEAD AS A CAUSE OF INSANITY.. JAMA. https://doi.org/10.1001/jama.1907.25220270033001f
823. María Elena Erro, Itziar Gastón, & Mauricio Chacón Navarro (2008). [Movement disorders in the emergency department].. PubMed
824. Sayed A. M. Amer, & Mohamed Akkad (2016). Correlation between Mild Cognitive Impairment and Functional Status among Elderly. Egyptian Journal of Geriatrics and Gerontology. https://doi.org/10.21608/ejgg.2016.30870
825. William C. Koller, & Sue E. Kase (1986). Muscle Strength Testing in Parkinson’s Disease. European Neurology. https://doi.org/10.1159/000115998
826. Yana Zorkina, Eugene Zubkov, Аnna Morozova, Olga Abramova, O. S. Karimova, & В. П. Чехонин (2020). EFFECTS OF ELECTROCONVULSIVE STIMULATION IN RATS WITH 6-OHDA INDUCED HEMIPARKINSONISM. BIOTECHNOLOGY STATE OF THE ART AND PERSPECTIVES. https://doi.org/10.37747/2312-640x-2020-18-184-186
827. Roberto Erro, Kailash P. Bhatia, & Michèle Tinazzi (2015). Parkinsonism following neuroleptic exposure: A double‐hit hypothesis?. Movement Disorders. https://doi.org/10.1002/mds.26209
828. Abdelaati El Khiat, Bilal El‐Mansoury, Driss Ait Ali, Mohamed El Koutbi, Kamal Kaoutar, Youssef Ait Hamdan, Brahim El Houate, Lahcen Tamegart, Kamal Smimih, Adnane Hakam, Najib Kissani, & Halima Gamrani (2023). Symptomatology and Clinical Features of Parkinson's Disease. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5156-4.ch002
829. Susana Quijano‐Roy, & Marta Gómez‐García de la Banda (2018). Distrofias musculares congénitas. Revista Médica Clínica Las Condes. https://doi.org/10.1016/j.rmclc.2018.08.002
830. Blair Ford, & Ronald F. Pfeiffer (2007). Pain Syndromes and Disorders of Sensation. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:255
831. P R Noverina Eka Putri (2020). Asuhan keperawatan diabetes mellitus tipe 2 dengan ulkus diabetik pada ny. J di upt puskesmas rawat inap sungai pakning
832. Tomasz Litwin, Agnieszka Antos, Jan Bembenek, & Anna Członkowska (2024). Neurological Deterioration in Wilson's Disease—Types, Etiology, Course, and Management. Discovery Medicine. https://doi.org/10.24976/discov.med.202436183.61
833. Nivedita Thakur, Moira Black, S. Nicholas Russo, & Mary Kay Koenig (2022). Neurometabolic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0020
834. Daiga Heisters (2011). Focus on Parkinson's: causes, treatment and support. British Journal of Community Nursing. https://doi.org/10.12968/bjcn.2011.16.4.182
835. Lidiane Andréa Oliveira Lima (2008). Desempenho muscular de indivíduos na fase inicial da doença de Parkinson
836. Graeme JA Macphee, & David A. Stewart (2006). Parkinson's disease. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259806002073
837. Deepak Shrivastava (2022). Does the Patient Have Abnormal Movements at Night?. CRC Press eBooks. https://doi.org/10.1201/9781003093381-11
838. Gabriele Weigel (2014). Critical Additions Required. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488b
839. Murat Emre (2003). What causes mental dysfunction in Parkinson's disease?. Movement Disorders. https://doi.org/10.1002/mds.10565
840. Jenny T. van der Steen, Herma Lennaerts, Danny Hommel, Bertie Augustijn, Marieke Groot, Jeroen Hasselaar, Bastiaan R. Bloem, & Raymond T.C.M. Koopmans (2019). Dementia and Parkinson's Disease: Similar and Divergent Challenges in Providing Palliative Care. Frontiers in Neurology. https://doi.org/10.3389/fneur.2019.00054
841. Ioannis Pantoularis, George Garyfallos, Martha Lobtzianidou, Aristidis Livanos, Ioannis Dasoukis, & Aravella Adamopoulou (2008). Axis I-Axis II comorbidity of borderline personality disorder: gender-related differences. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-7-s1-s226
842. Clara De Groote, Kathy Dujardin, Luc Defebvre, Bérengère Flinois, Virginie Herlin, Nicolas Carrière, & Émilie Wawrziczny (2024). Development of a Screening Tool for Assessing Sexual Difficulties Among Patients with Parkinson’s Disease: The PD-SDS. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-240063
843. Cesar V. Borlongan (2018). Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson’s disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1807276115
844. David S. Goldstein (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-9-200211050-00011
845. Elisabet Mondragón Rezola, Izaskun Arratíbel Echarren, Javier Ruiz Martínez, & J.F. Martí-Massó (2010). Trastornos del sueño en la enfermedad de Parkinson: insomnio y fragmentación del sueño, hipersomnia diurna, alteraciones del ritmo circadiano y síndrome de apnea del sueño. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009735
846. George B. Hassin (1926). PARKINSONIAN STATES. Archives of Neurology And Psychiatry. https://doi.org/10.1001/archneurpsyc.1926.02200200069005
847. Maria I. Dalamagka (2025). Pediatric neurodegenerative disorders and anesthesia considerations. GSC Advanced Research and Reviews. https://doi.org/10.30574/gscarr.2025.22.1.0006
848. Mai-Linh N Tran, Nadine Grace-Abraham, Ecler Jaqua, & Clare Moore (2025). Sleep in Adults: Parasomnias.. PubMed
849. François Tison, & Imad Ghorayeb (2005). [Parkinson's disease and associated disorders].. PubMed
850. Alexander Münchau, & Kailash P. Bhatia (2000). Pharmacological treatment of Parkinson’s disease. Postgraduate Medical Journal. https://doi.org/10.1136/pmj.76.900.602
851. Jan Larsen, Antonie Giæver Beiske, Svein Ivar Bekkelund, Espen Dietrichs, Ole‐Bjørn Tysnes, Steinar T Vilming, & Jan Aasly (2008). Motor symptoms in Parkinson disease. Tidsskrift for Den Norske Laegeforening
852. Vladimir Maletic, & Bernadette DeMuri (2016). Chronic Pain and Depression: Understanding 2 Culprits in Common: Does a Shared Pathophysiology Hold the Key to Managing These Conditions When They Coexist?. Current psychiatry
853. Yasuyuki Okuma (2014). Freezing of Gait and Falls in Parkinson's Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-130282
854. Yelena Bogdanova, & Alice Cronin‐Golomb (2013). Alexithymia and Apathy in Parkinson’s Disease: Neurocognitive Correlates. Behavioural Neurology. https://doi.org/10.1155/2013/682393
855. Smulevich Ab, & Д. В. Романов (2020). Long-term course of negative symptoms in schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198840121.003.0003
856. Müberra Tanrıverdi, Senanur Düzenli, Merve Gündüz, Ayça Arslantürk, & Ayşenur Erekdağ (2024). Investigation of Neurogenic Dysphagia in Different Neurological Diseases. Anadolu Kliniği Tıp Bilimleri Dergisi. https://doi.org/10.21673/anadoluklin.1432672
857. Charles H. Adler (2011). Premotor Symptoms and Early Diagnosis of Parkinson's Disease. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2011.620192
858. Irena Rektorová, Dag Aarsland, К. Ray Chaudhuri, & Antonio P. Strafella (2011). Nonmotor Symptoms of Parkinson's Disease. Parkinson s Disease. https://doi.org/10.4061/2011/351461
859. Koller Wc (1992). How accurately can Parkinson's disease be diagnosed?. Neurology
860. William C. Koller (1992). How accurately can Parkinson's disease be diagnosed?. PubMed
861. Patricia Szot, Allyn Franklin, & Alastair Murray (2011). The Noradrenergic System is a Major Component in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/17094
862. Yaqian Xu (2016). Risk Factors for Parkinson's Disease Dementia. Chin J Geriatrics Res(Electronic Edition). https://doi.org/10.3877/cma.j.issn.2095-8757.2016.01.005
863. Anita Devlin (2003). Paediatric neurological examination. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.9.2.125
864. Elif GOKCAL, & Gulsen BABACAN YILDIZ (2015). Treatment of Motor Symptoms in Idiopathic Parkinson’s Disease. Bezmialem Science. https://doi.org/10.14235/bs.2015.503
865. Sanger Brown (1909). THE INSANE DIATHESIS. Journal of the American Medical Association. https://doi.org/10.1001/jama.1909.25420450001001
866. C S Hoyt, & William V. Good (1995). Acute onset concomitant esotropia: when is it a sign of serious neurological disease?. British Journal of Ophthalmology. https://doi.org/10.1136/bjo.79.5.498
867. Janneke Zinkstok, Fleur P. Velders, R Rieken, Marlies Houben, Ania Fiksinski, Thérèse van Amelsvoort, & Erik Boot (2020). Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome. Tijdschrift voor psychiatrie
868. C. Shakthi, b Sritharan, M. Muthuveeran, M. Manivannan, C. Justin, & D. GanesaPandian (2019). Prevalence of non-motor symptoms in Parkinson’s disease. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20191488
869. Rajib Dutta (2023). Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature. Journal of Neuroscience and Neurological Disorders. https://doi.org/10.29328/journal.jnnd.1001078
870. Г А Старовойтова, А В Горева, T. N. Slobodin, & Ю И Головченко (2015). Особенности эмоциональных нарушений при болезни Паркинсона. Международный неврологический журнал
871. Georg Ebersbach (2010). Langzeitverlauf der Parkinson-Erkrankung. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628776
872. Paul Regal (2013). Neurologic manifestations of <i>E coli</i> infection–induced hemolytic-uremic syndrome in adults. Neurology. https://doi.org/10.1212/01.wnl.0000430450.15615.c3
873. Zeinab Rezaee, Mohammad Marandi, hojjataalah alaei, & Fahimeh Esfarjani (2020). The Effect of Exercise on Parkinson's Disease. The Neuroscience Journal of Shefaye Khatam. https://doi.org/10.52547/shefa.9.1.189
874. Wilma G. Rosen (2018). Assessment of Cognitive Disorders in the Elderly. Routledge eBooks. https://doi.org/10.4324/9780429489464-15
875. P Feudell (1976). [Doubtfullness of the diagnosis diabetic neuropathy].. PubMed
876. Raja Mehanna, & William G. Ondo (2011). Sleep problems in Parkinson’s disease patients. Neurodegenerative Disease Management. https://doi.org/10.2217/nmt.11.33
877. Leonidas Chouliaras, Anya Topiwala, Tamara Cristescu, & Klaus P. Ebmeier (2015). Establishing the cause of memory loss in older people.. PubMed
878. Michael Swash (2007). LIMB-KINETIC APRAXIA IN PARKINSON DISEASE. Neurology. https://doi.org/10.1212/01.wnl.0000281350.34195.75
879. Katherine L. Possin, & Daniel Kaufer (2010). Parkinsonian Dementias. CONTINUUM Lifelong Learning in Neurology. https://doi.org/10.1212/01.con.0000368212.86835.a8
880. Bhomraj Thanvi, Nelson Lo, & Thompson Robinson (2005). Vascular parkinsonism--an important cause of parkinsonism in older people. Age and Ageing. https://doi.org/10.1093/ageing/afi025
881. David Shaffer (1973). Psychiatric Aspects of Brain Injury in Childhood: A Review. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1973.tb15165.x
882. Angelika Hummel (2018). Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
883. К. Ray Chaudhuri, Nataliya Titova, Mubasher A. Qamar, Iulia Murășan, & Cristian Falup‐Pecurariu (2022). The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need. Journal of Personalized Medicine. https://doi.org/10.3390/jpm12121994
884. Rikinkumar S. Patel, Saher Kamil, Mansi Shah, Narmada Neerja Bhimanadham, & Sundus Imran (2019). Pros and Cons of Marijuana in Treatment of Parkinson’s Disease. Cureus. https://doi.org/10.7759/cureus.4813
885. François Tison (1997). Other causes of parkinsonism.. PubMed
886. F. Tuna Burgut, Marina Benaur, & Claire Henchcliffe (2006). Late-life depression: a neuropsychiatric approach. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.1.65
887. A. Jon Stoessl, & J. Rivest (1999). Differential Diagnosis of Parkinsonism. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100000020
888. Abhishek Lenka, Alberto J. Espay, & Michael S. Okun (2024). Parkinsonism or catatonia: That’s the question. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_47_24
889. Kapil D. Sethi, & Shyamal H. Mehta (2012). A clinical primer on restless legs syndrome: what we know, and what we don't know.. PubMed
890. Qian Gui, Jing‐Cai Meng, Mingqiang Shen, Hongxuan Feng, Xiaofeng Dong, Da-Qiang Xu, Wenxin Zhu, Qingzhang Cheng, Lin‐Hui Wang, Guan-Hui Wu, & Yanli Lu (2024). Relationship of Glymphatic Function with Cognitive Impairment, Sleep Disorders, Anxiety and Depression in Patients with Parkinson’s Disease. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s480183
891. Baikuntha Panigrahi, Kanchana Soman Pillai, Divya M. Radhakrishnan, Roopa Rajan, & Achal Srivastava (2024). Fatigue in Parkinson’s disease—A narrative review. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_99_24
892. Shubham Goel, Amrendra Tripathi, Tanupriya Choudhury, & Vivek Kumar (2019). Parkinson's Disease Detection using Soft Computing Technique. https://doi.org/10.1109/smart46866.2019.9117384
893. George Graham (2013). Ordering Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199579563.013.0032
894. Uday Sharma, S Anjali, V Surendra, Nageena Taj, & P M Manjunatha (2019). Parkinson’s Disease: A Brief Outlook
895. Tomotaka Shiraishi, Hidetomo Murakami, & Yasuyuki Iguchi (2019). [Diagnosis and Treatment of Cognitive Impairment in Parkinson's Disease].. PubMed. https://doi.org/10.11477/mf.1416201367
896. Argeo Bämayr (2014). Large Group of Patients Cannot Be Found. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489b
897. Abdullah N Aldweik, Kholod Haj Hussain, & Hamid Alhaj (2023). Can Functional Visual Loss Occur in an Older Adult Patient With a History of Stroke: A Case Report. BJPsych Open. https://doi.org/10.1192/bjo.2023.335
898. Richard A. Armstrong (2016). Visual signs and symptoms of corticobasal degeneration. Clinical and Experimental Optometry. https://doi.org/10.1111/cxo.12429
899. Ronald Kirwa (2021). Therapy on Parkinson’s Disease. Journal of Regenerative Biology and Medicine. https://doi.org/10.37191/mapsci-2582-385x-3(6)-093
900. Emilia J. Sitek, Jan Wójcik, Anna Barczak, & Jarosław Sławek (2015). Diagnostyka neuropsychologiczna w atypowych zespołach parkinsonowskich. Polski Przegląd Neurologiczny
901. Kim Wieczorek Austin, Suzanne Ameringer, Angela Starkweather, Leslie Cloud, Jamie Sturgill, & R. K. Elswick (2016). Biobehavioral Framework of Symptom and Health Outcomes of Uncertainty and Psychological Stress in Parkinson Disease. Journal of Neuroscience Nursing. https://doi.org/10.1097/jnn.0000000000000244
902. Christian Derouesné (2006). Démence à corps de Lewy : nouveau consensus. Gériatrie et Psychologie Neuropsychiatrie du Viellissement
903. Alan Diamond, & Joseph Jankovic (2006). Treatment of advanced Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.8.1181
904. Antoine Laumonnier (2006). [Rehabilitation in the elderly subject with Parkinson's disease].. PubMed
905. Bradley F. Boeve (2009). Early clinical features of the parkinsonian-related dementias. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581410.015
906. Federico Vigevano, & Andrea Bartuli (2002). Infantile epileptic syndromes and metabolic etiologies.. PubMed
907. Gemma Garrido García, & Joan Coderch (2011). ¿El deterioro cognitivo en los primeros episodios de esquizofrenia es generalizado o selectivo?. Alzheimer Realidades e investigación en demencia. https://doi.org/10.5538/1137-1242.2011.48.18
908. Chauhan Mks (2024). Ragatmaka Mantra Therapy: Unveiling an Ancient Science of the Indian System of Medicine. Journal of Natural & Ayurvedic Medicine. https://doi.org/10.23880/jonam-16000438
909. Shatrughna U. Nagrik, Prashant Patil, Deepak M. Nagrik, Vinayak S. Zagare, Priyamala E. Avchar, Samiksha Bahurupi, & Shubhangi Ambhore (2020). Herbal drugs Used on Parkinson Disease. Journal of Drug Delivery and Therapeutics. https://doi.org/10.22270/jddt.v10i4-s.4286
910. Samuel Antonio Freitas (2023). Os transtornos do sono em pacientes com doença de Parkinson estão associados ao risco de morrer ou desenvolver demência?. https://doi.org/10.11606/d.17.2023.tde-30062023-090533
911. S. V. Shtaimets, А. А. Минеева, Ju. V. Lalov, & T. V. Filatenkova (2024). Late diagnosis of chronic inflammatory demyelinating polyneuropathy on the background of misdiagnosed alcoholic polyneuropathy: a clinical case. Medical alphabet. https://doi.org/10.33667/2078-5631-2024-12-30-35
912. Imre Szirmai, & Tibor Kovács (2002). [Parkinson syndrome and cognitive disorders].. PubMed
913. K Hopfensperger, & Koller Wc (1992). Non-parkinsonian tremor.. PubMed
914. Giulio Calia (2013). Taking More Time. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2013.0732a
915. Robert B. Darnell, & Jerome B. Posner (2010). Cerebral Hemisphere Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199772735.003.004
916. Karen Cristina de Carvalho Casotti, Mariana Miie Pecoraro Koga, & Siméia Gaspar Palácio (2009). EFEITOS DO ISOSTRETCHING NA DOR E DEPRESSÃO NA DOENÇA DE PARKINSON: ESTUDO DE CASO
917. Jiali Su, Tao Chen, Shan Zhang, Benchi Cai, & Yanhui Liu (2019). Research progress on non motor symptoms of Parkinson′s disease. Zhongguo yishi zazhi. https://doi.org/10.3760/cma.j.issn.1008-1372.2019.04.042
918. John F. Greden (2003). Physical symptoms of depression: unmet needs.. PubMed
919. Michiko Kimura Bruno, Rohit Dhall, Antoine Duquette, Ihtsham Haq, Lawrence S. Honig, Guillaume Lamotte, Zoltán Mari, Nikolaus R. McFarland, Leila Montaser-Kouhsari, Federico Rodríguez‐Porcel, Jessica Shurer, Junaid Siddiqui, C. Chauncey Spears, Anne‐Marie Wills, Kristophe Diaz, & Lawrence I. Golbe (2024). A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000200345
920. Haleh Mikaeele, Mohammed Ali Arami, Mohammad Marandi, & Khalil Ansarin (2009). Respiratory Problems in Parkinson Disease. Clinical Pulmonary Medicine. https://doi.org/10.1097/cpm.0b013e3181a3b382
921. Catherine Thomas-Antérion, & Pierre Krolak‐Salmon (2010). L'évaluation des fonctions exécutives en pratique courante dans la maladie de Parkinson et les syndromes apparentés. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2010.0073
922. Gustavo Ortiz (2006). Trastornos neurogenéticos y neurometabólicos paroxísticos. Revista de Neurología. https://doi.org/10.33588/rn.42s03.2006027
923. Desislava Marinova, & Maya Danovska (2020). THE MOTOR SYMPTOMS–CHALLENGE IN DIAGNOSIS OF PARKINSON'S DISEASE. Journal of IMAB - Annual Proceeding (Scientific Papers). https://doi.org/10.5272/jimab.2020264.3469
924. Humberto Marín, Matthew Menza, & Roseanne D. Dobkin (2007). Parkinson's Symptoms or Depression? Look for Clinical Signs: How to Sort through Overlapping Symptoms Using DSM-IV-TR Diagnostic Criteria. Current psychiatry
925. Diego Fernandes de Medeiros, Douglas Negrão Wolffenbuttel, Renan Negrão Wolffenbuttel, & Patrick Zawadzki (2018). DIRETRIZES PARA A PRESCRIÇÃO DO EXERCÍCIO: PARKINSON. Seminário de Iniciação Científica e Seminário Integrado de Ensino, Pesquisa e Extensão
926. T. Esch (2013). Neuromolecular Analogies. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2013.0732b
927. Anna Szűcs, Gábor G. Kovács, Narula Lalit, & Halász Péter (2007). Sleep disorders in Parkinson syndromes
928. Michael Donaghy (1991). Diabetic Proximal Neuropathy: Therapy and Prognosis. QJM. https://doi.org/10.1093/oxfordjournals.qjmed.a068548
929. Harrington Tuke (1860). On General Paralysis. Journal of Mental Science. https://doi.org/10.1192/bjp.6.32.198
930. Jan-Hendrik Claasen (2010). Neuroinflammatorische Prozesse beim idiopathischen Parkinson-Syndrom : antiinflammatorische Intervention als mögliche Therapieoption?
931. Ufuk Ergün, Ayla Bozbaş, Ümit Akın, & Levent Ertuğrul İnan (2009). Musical Hallucinations and Parkinson Disease. The Neurologist. https://doi.org/10.1097/nrl.0b013e3181872da7
932. Vanita Kanase, P Pandagale, & Sourbha S. Dani (2022). None. International Journal of Pharmaceutical Sciences and Research. https://doi.org/10.13040/ijpsr.0975-8232.13(6).2230-41
933. Stephen P. Duntley (2004). Insomnia in Primary Sleep Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_12
934. Bradley F. Boeve, & Clifford B. Saper (2006). REM sleep behavior disorder. Neurology. https://doi.org/10.1212/01.wnl.0000209264.61035.bb
935. Carsten Buhmann, Jan Vesper, & Henriette Oelsner (2017). Fahreignung bei Morbus Parkinson. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0043-110051
936. Benzi M. Kluger, & Joseph H. Friedman (2014). Fatigue in Parkinson’s disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199684243.003.0011
937. Amal M. Badawoud, Lashin Saad Ali, Mahmoud S. Abdallah, Ramy M. El Sabaa, Mostafa M. Bahaa, Thanaa A. El‐Masry, Eman Wahsh, Mohamed Yasser, Nashwa Eltantawy, Mamdouh Eldesoqui, & Manal A. Hamouda (2024). The relation between Parkinson’s disease and non-steroidal anti-inflammatories; a systematic review and meta-analysis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2024.1434512
938. Patricia L. Kavanagh, & Karen Marder (2007). Dementia. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:35
939. Agnieszka Stępień, Małgorzata Góral, & Monika Kantorska-Janiec (2008). Mental disorders in paraneoplastic syndromes
940. Syed Arman Rabbani, Boshra Khaled, Huda Khaled, Shrestha Sharma, Faheem Hyder Pottoo, & Asiya Mahtab (2023). Neurochemical Alterations in Parkinson's Disease. CRC Press eBooks. https://doi.org/10.1201/9780429265198-9
941. Lin Chen (2016). Recent advance in autonomic dysneuria in Parkinson's disease. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2016.04.019
942. Yvette AM Grimbergen, J. William Langston, Raymund A.C. Roos, & Bastiaan R. Bloem (2009). Postural instability in Parkinson’s disease: the adrenergic hypothesis and the locus coeruleus. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.9.2.279
943. Sujith Pavan, Arvind Prabhu, & Mamatha Ballal (2023). A descriptive study on symptoms of Parkinson’s disease in an Indian cohort from Karnataka. Biomedicine. https://doi.org/10.51248/.v43i01.2651
944. Diego Candia‐Rivera, Marie Vidailhet, Mario Chávez, & Fabrizio De Vico Fallani (2023). The Coupling between Brain Connectivity and Heartbeat Dynamics Unveils the Altered Interoceptive Mechanisms in Parkinson's Disease. https://doi.org/10.2139/ssrn.4540760
945. Ruth M. Benca (2007). Parasomnias in Adults. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-421-6_20
946. Michael H. Bonnet, & Donna L. Arand (2013). Insomnia. https://doi.org/10.3920/9789086867639_003
947. Ružica Čičak (2018). Fizioterapija u rehabilitaciji osoba oboljelih od Parkinsonove bolesti
948. Leon J. Whitsell (1962). Neurologic complications of diabetes.. PubMed
949. Braunschweiger-Brixel Em, Finck Ga, & Roland Schiffter (1991). [Difficulties and errors in ambulatory therapy of Parkinson disease].. PubMed
950. Orestis Giotakos (2017). Poor insight and psychosis. Psychiatriki. https://doi.org/10.22365/jpsych.2017.284.332
951. Gilles Fénelon (2006). [Psychotic symptoms in Parkinson's disease].. PubMed
952. Rob A. I. de Vos, E.N.H. Jansen, Deniz Yilmazer‐Hanke, Heiko Braak, & Eva Braak (1996). Pathological and clinical features of Parkinson's disease with and without dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511601187.026
953. Priyansha Raj Sinha, & Amit Alexander Charan (2017). Parkinson’s disease: A review article. Deleted Journal
954. Indra Awasthi (2021). Association between Bodily Complaint and Anxiety. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2021.38354
955. Laura K. Teune, & Klaus L. Leenders (2012). Molecular Imaging in Parkinson’s Disease. Neuromethods. https://doi.org/10.1007/7657_2012_51
956. R F Tuchman, Solomon L. Moshé, & I. Rapin (2005). [Neurodevelopmental disorders and epilepsy].. PubMed
957. Joshua Gertler, Lauren Kenney, Adrianna Ratajska, Francesca V. Lopez, Katie Rodriguez, Rachel Schade, & Dawn Bowers (2023). 20 Laterality of Motor Symptom Onset is Not Associated with Cognitive Performance or Mood Symptoms in a Sample of 600 Individuals with Idiopathic Parkinson’s Disease”. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617723006914
958. Giulia Clotilde Vana (2019). Assessment of the heart rate variability in Parkinson's disease
959. Lucía Pérez Macho, & Sergio Borja Andrés (2010). Trastornos digestivos en la enfermedad de Parkinson: atonía gástrica, malabsorción y estreñimiento. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009740
960. Okhunova Diyora Alisherovna (2024). MODERN METHODS FOR PREDICTING COGNITIVE DISORDERS IN PARKINSON'S DISEASE. International Journal of Medical Science and Public Health Research. https://doi.org/10.37547/ijmsphr/volume05issue12-07
961. Barbara Schildkrout (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
962. Piotr Alster, Michał Kutyłowski, & Natalia Madetko‐Alster (2025). Magnetic Resonance Imaging in the Neuroimaging of Progressive Supranuclear Palsy—Parkinsonism Predominant: Limitations and Strengths in Clinical Evaluation. Diagnostics. https://doi.org/10.3390/diagnostics15080945
963. Jae‐Weon Kim, Hyo J. Bae, & Sang Myung Cheon (2010). P1‐042: Orthostatic hypotension and cognitive impairment in Parkinson's disease. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2010.05.589
964. H.-J. Gertz (2001). Dementias in Other Brain Diseases. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_74
965. JAMES W. COKENOWER (1898). NEURO-DEFORMITIES IN CHILDREN FROM AN ORTHOPEDIC STANDPOINT.. JAMA. https://doi.org/10.1001/jama.1898.92450180014001f
966. Mieczysław Pokorski (2013). Breathing and its rehabilitation in Parkinson's disease. BIOPHILIA. https://doi.org/10.14813/ibra.3.25
967. William T. Davis (1944). PARESIS OF RIGHT SUPERIOR OBLIQUE AND OF LEFT SUPERIOR RECTUS MUSCLE. Archives of ophthalmology. https://doi.org/10.1001/archopht.1944.00890110038004
968. Yuming Xu (2018). Early intervention for Parkinson disease. BMJ. https://doi.org/10.3760/cma.j.issn.1671-7368.2018.09.004
969. Georg Ebersbach (2008). Halluzinationen und Psychose bei der Parkinson-Erkrankung. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627132
970. Yuqing Zhang (2021). Investigation of the Effects of SIRT1 and SIRT2 Modulators in Neuroinflammatory Models of Depression. https://doi.org/10.25904/1912/4137
971. B. Boeve (2008). What more can we learn from studying the REM sleep behaviour disorder-Parkinson's disease association?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2008.153551
972. Thomas Verner Moore (1930). THE EMPIRICAL DETERMINATION OF CERTAIN SYNDROMES UNDERLYING PRÆCOX AND MANIC-DEPRESSIVE PSYCHOSES. American Journal of Psychiatry. https://doi.org/10.1176/ajp.86.4.719
973. Werner Poewe (2007). Dysautonomia and cognitive dysfunction in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.21681
974. A. Mékinian, Juliette Tennenbaum, Constance Lahuna, Azzedine Dellal, Nabil Belfeki, Jean Capron, Édouard Januel, Bruno Stankoff, Sonia Alamowitch, & O. Fain (2020). Primary Sjögren's syndrome: central and peripheral nervous system involvements.. PubMed
975. Philip D. Harvey (2009). When does cognitive decline occur in the period prior to the first episode of schizophrenia?. PubMed
976. R. Walter Heinrichs (1993). Schizophrenia and the brain: Conditions for a neuropsychology of madness.. American Psychologist. https://doi.org/10.1037//0003-066x.48.3.221
977. Hirokuni Tagaya, Norio Murayama, & Yuko Hakamata (2012). [Definitions and clinical classifications of sleep disorders].. PubMed
978. Vasilenko Anna, & CM Wilson Ken (2018). Diagnosis and classification. CRC Press eBooks. https://doi.org/10.4324/9781315383576-3
979. Ronald F. Pfeiffer (2012). Intestinal Dysfunction in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_10
980. E. Maruthi Prasad, & Shih‐Ya Hung (2020). Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease. Antioxidants. https://doi.org/10.3390/antiox9101007
981. Marcela Alvarado (2021). Neuropatía Periférica en la enfermedad de Parkinson. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v83i4.3892
982. Quirino Cordeiro, Stevin Zung, & Homero Vallada (2008). Pisa syndrome induced by rapid increase and high dosage of risperidone. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2008000600026
983. Dag Aarsland (2006). DLB than those of other cholinergic agents is not known, although this is theoretically plausible. (3)
984. Ali H. Rajput, & Emma F. Rajput (2017). Octogenarian parkinsonism – Clinicopathological observations. Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2017.01.009
985. Nico J. Diederich, Glenn T. Stebbins, Christine Schiltz, & Christopher G. Goetz (2014). Are patients with Parkinson’s disease blind to blindsight?. Brain. https://doi.org/10.1093/brain/awu094
986. Amanda Caris Piccolo, Leila Maria Guissoni Campos, & Mauro Audi (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
987. Kimiko Domoto‐Reilly, Daisy Sapolsky, & Bradford C. Dickerson (2014). Mild Cognitive Impairment (MCI) Stage of the Frontotemporal Dementias: Early Diagnosis and Management. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.57
988. Jaiel Bispo dos Santos, Warlla Melo de Farias, Iago Moura Aguiar, Madson Alan Maximiano‐Barreto, André Fernando Oliveira Fermoseli, & Theresa Cristina Albuquerque Siqueira (2019). PREJUÍZO DA MEMÓRIA EPISÓDICA EM IDOSOS DEPRESSIVOS COM DOENÇA DE PARKINSON. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas
989. Cynthia L. Comella (2006). Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview. https://doi.org/10.1007/978-3-211-45295-0_53
990. G. Swarupa Rani, & Pooja Mehta (2020). Identification and Early Intervention of Bipolar Disorder in Adolescence and Adults. International Journal of Engineering and Advanced Technology. https://doi.org/10.35940/ijeat.b3637.029320
991. Derman Ozdemir, & Sonu Sahni (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
992. W R Gibb (1990). Cortical Lewy Body Dementia. Behavioural Neurology. https://doi.org/10.1155/1990/235953
993. A. Mesejo, E. Pérez-Sancho, & E. Moreno (2006). [Clinical consequences of neuromuscular impairments in critically ill patients].. Nutrición Hospitalaria
994. Monique H.M. Timmer, M.H.C.T. van Beek, Bas R. Bloem, & Rianne A.J. Esselink (2017). What a neurologist should know about depression in Parkinson’s disease. Practical Neurology. https://doi.org/10.1136/practneurol-2017-001650
995. Alessandra Musso (2014). Exploring the pathological interaction between LRRK2 and alpha-synuclein. https://doi.org/10.5075/epfl-thesis-6335
996. Beverley Tabernacle, Marie Honey, & Annette Jinks (2009). Chapter 10 Idiopathic Parkinson's disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199213283.003.0010
997. Kenji Ikeda (2004). [Anterior type dementia from the viewpoint of neuropathology].. PubMed
998. Yoshikuni Mizuno (2014). Recent Research Progress in and Future Perspective on Treatment of Parkinson's Disease. Integrative Medicine International. https://doi.org/10.1159/000365571
999. Huang Xing-hu (2013). Non-motor Symptoms in Parkinson's Disease(review). Zhongguo kangfu lilun yu shijian
1000. Pedro Clavero, & María Rodríguez‐Oroz (2007). [Sleep disorders in Parkinson's disease and other movement disorders].. PubMed
1001. Andrew Beaumont, & Paul Vespa (2009). Seizures in Fulminant Hepatic Failure, Multiorgan Failure, and Endocrine Crisis. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-532-3_7
1002. Yang Xin-lin (2013). New Progress of the Non-motor Symptoms of Parkinson Disease. Medical Recapitulate
1003. Ole‐Bjørn Tysnes, & Steinar T Vilming (2008). [Atypical parkinsonism].. PubMed
1004. Pauline Beusekamp (2019). Verdriet en verzoening bij de ziekte van Parkinson – Hoe liefde kan blijven bestaan als dopamineneuronen vergaan. Systeemtherapie
1005. Umer Akbar, & Joseph H. Friedman (2015). Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2015.1077703
1006. Ollari Ja (2001). [Attention systems and unilateral neglect].. PubMed
1007. T van Eimeren (2012). Spielsucht auf Rezept? Impulsivität bei der Parkinsonerkrankung. Klinische Neurophysiologie. https://doi.org/10.1055/s-0032-1301439
1008. Deborah M. Capaldi, & Hyoun K. Kim (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
1009. Hallis Freitas de Almeida (2015). A participação do radiologista na educação para a saúde da pessoa com Doença de Parkinson que necessita de estereotaxia
1010. Gioia Jacopini (2000). The Experience of Disease: Psychosocial Aspects of Movement Disorders. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-200010000-00005
1011. Alex J. Nelson, & Bryan T. Klassen (2015). Hypokinetic Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0025
1012. Chris Dodds, Chandra M. Kumar, & F. Servin (2017). Cognitive dysfunction and sleep disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198735571.003.0014
1013. I Rodríguez-Constenla, Iria Cabo, P Bellas-Lamas, & E Cebrián (2010). [Cognitive and neuropsychiatric disorders in Parkinson's disease].. PubMed
1014. Sneha Balasubramanian, Khawar Tariq Mehmood, Shahad Al-Baldawi, Gabriel Zúñiga Salazar, & Diego Zúñiga (2024). Behind the Mask: Parkinson's Disease and Depression. Cureus. https://doi.org/10.7759/cureus.52663
1015. Chuh‐Hyoun Lie, Manuel Dafotakis, S Behrens, & Gereon R. Fink (2005). Neural correlates of dysexecutive functions in Parkinson's disease. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-919274
1016. Richard Mindham, & Thomas A. Hughes (2012). Dementia in Parkinson's disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0046
1017. Douglas W. Scharre, & Michael Mähler (1994). Parkinson's disease: making the diagnosis, selecting drug therapies.. PubMed
1018. F Vázquez-Sáánchez, Estefanía Rodríguez-Martínez, & Adrián Arés-Luque (2010). [Urinary disorders, sexual dysfunction and hypersexuality in Parkinson's disease].. PubMed
1019. Özlem Özcanlı Çay, & Özlem Kemer Aycan (2023). Sudden infant death syndrome. Journal of Controversies in Obstetrics & Gynecology and Pediatrics. https://doi.org/10.51271/jcogp-0016
1020. Christopher Gillberg (1995). Neuorodevelopmental examination of the child with neuropsychiatric problems. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511570094.016
1021. Josef Finsterer, & Sounira Mehri (2023). The causality spectrum of dropped head syndrome is broad and includes myopathy, neurodegenerative disorders, and varia. Nöro Psikiyatri Arşivi. https://doi.org/10.29399/npa.28520
1022. Andi Agung Riatmojo (2022). Penurunan Fungsi Sistem Penghidu Pada Pasien Penyakit Parkinson: Epidemiologi dan Tatalaksananya. Jurnal Syntax Fusion. https://doi.org/10.54543/fusion.v2i01.144
1023. Daniel M. Corcos, & Elizabeth Skender (2020). Exercising for People with Parkinson’s Disease and Their Support Group. ACSMʼs Health & Fitness Journal. https://doi.org/10.1249/fit.0000000000000547
1024. Brigitte Schurch (2000). Blasendysfunktion nach spinalen und peripheren Nervenläsionen [Bladder dysfunction after spinal and peripheral nerve lesions].. Therapeutische Umschau. Revue thérapeutique
1025. Bert I. Beverly (1924). POSTENCEPHALITIC BEHAVIOR DISTURBANCE WITHOUT PHYSICAL SIGNS. Archives of Pediatrics and Adolescent Medicine. https://doi.org/10.1001/archpedi.1924.01920120027004
1026. Charlotte Busby, & Alistair Burns (2002). Differential Diagnosis of Dementia. https://doi.org/10.1002/0470846410.ch54
1027. Nicola Modugno, Francesco Lena, Francesca Di Biasio, Gloria Edith Cerrone, Stefano Ruggieri, & Francesco Fornai (2013). A clinical overview of non-motor symptoms in Parkinson's Disease.. PubMed
1028. Jens Carsten Möller, Raoul Schweinfurther, & Matthias Oechsner (2017). Parkinson-Syndrome in der Neurorehabilitation. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000946
1029. Diogo Cordeiro, Tchelet Stern, & Shani Stern (2023). Focusing on the tetra-partite synapse in Parkinson’s disease research using human patient-derived neurons. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.382235
1030. M Piccirilli, Gian Luigi Piccinin, & A Lamedica (1981). [Evaluation of intellectual functions in patients with Parkinson's disease. Bibliographic review].. PubMed
1031. Graeme J.A. Macphee (2018). Diagnosis and differential diagnosis of Parkinson’s disease. https://doi.org/10.1201/9781315365428-4
1032. Ajay Malhotra, & Johnny U. V. Monu (2010). Neuropathic Osteoarthropathy. Contemporary Diagnostic Radiology. https://doi.org/10.1097/01.cdr.0000369482.23981.d9
1033. Necati Serkut Bulut, Neşe Yorguner, Gresa Çarkaxhıu Bulut, & Emine Neşe Tuncer (2020). A Case of Chronic Functional Parkinsonism Treated Over 10 Years for the Diagnosis of Juvenile Parkinsonism. Turkish Journal of Psychiatry. https://doi.org/10.5080/u25540
1034. Magdalena Doręgowska, & Monika Rudzińska (2019). SLEEP DISORDERS IN PARKINSON’S DISEASE. Wiadomości Lekarskie. https://doi.org/10.36740/wlek201903120
1035. Lambros Messinis, Αθανάσιος Παπαθανασίου, Epameinondas Lyros, George Gatzounis, & Panagiotis Papathanasopoulos (2011). Neuropsychological Functions and SPECT Neuroimaging in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/17948
1036. Shin Hisahara, & Shun Shimoham (2012). Animal Models of Parkinson’s Disease Induced by Toxins and Genetic Manipulation. InTech eBooks. https://doi.org/10.5772/19860
1037. Meghana Anagani, & Terry Oroszi (2022). Fractures in Parkinson’s Disease. Health. https://doi.org/10.4236/health.2022.149070
1038. Michele Colaci, Giulia Cassone, Andreina Manfredi, Marco Sebastiani, Dilia Giuggioli, & Clodoveo Ferri (2014). Neurologic Complications Associated with Sjögren’s Disease: Case Reports and Modern Pathogenic Dilemma. Case Reports in Neurological Medicine. https://doi.org/10.1155/2014/590292
1039. Paola Presečki, & Ninoslav Mimica (2007). Involuntary emotional expression disorder - new/old disease in psychiatry and neurology.. PubMed
1040. E. Reina Robles, M. Vela-Navacerrada, & Juan Carlos Miangolarra Page (2000). Marcha y equilibrio en el enfermo de Parkinson: Descripción y terapéutica. Cuestiones de fisioterapia: revista universitaria de información e investigación en Fisioterapia
1041. Zhancai Yu, Zhenguang Li, Duanlan Ma, Pengfei Wang, Jinbiao Zhang, Hairong Sun, & Junwu Zhao (2015). 帕金森病认知功能损害的中医药治疗. 国际中西医结合杂志. https://doi.org/10.14725/gjicmwm.v3n1a1060
1042. H. Lisser, & Charles E. Nixon (1923). MENTAL RETARDATION AND DUCTLESS GLAND DISEASE. Journal of the American Medical Association. https://doi.org/10.1001/jama.1923.02650140018008
1043. Monika Biercewicz, & Klaudia Ćwiękała-Lewis (2024). Sleep Assessment in Parkinson’s Disease – An Assessment Tool. The Journal of Neurological and Neurosurgical Nursing. https://doi.org/10.15225/pnn.2024.13.3.6
1044. Elizabeth A. Disbrow, Owen Carmichael, Jing He, Kimberly E. Lanni, Elizabeth M. Dressler, Lu Zhang, Norika Malhado-Chang, & Karen A. Sigvardt (2014). Resting State Functional Connectivity is Associated with Cognitive Dysfunction in Non-Demented People with Parkinson's Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-130341
1045. Nicky Hayes, & Dawne Garrett (2016). Singing, music and dance in Parkinson’s disease. Nursing Older People. https://doi.org/10.7748/nop.28.9.12.s12
1046. Massimo Piccirilli, Patrizia D’Alessandro, Giancarlo Finali, & Gian Luigi Piccinin (1994). Neuropsychological Follow-Up of Parkinsonian Patients with and without Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000106689
1047. I S Abdulraheem, Mohammed Jimoh Saka, & Aysin Saka (2011). Postpolio syndrome: Epidemiology, pathogenesis and management. Journal of Infectious Diseases and Immunity. https://doi.org/10.5897/jidi.9000031
1048. Enrique Noé, Pablo Irimia, Eva Ma Pomares Arias, Eduardo Martínez‐Vila, & Ma Rosario Luquin Piudo (2001). Trastornos neuropsiquiátricos en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.3207.2000179
1049. Н. В. Федорова, А. В. Никитина, & Ye. N. Gubanova (2014). SLEEP DISORDERS IN NEUROLOGICAL PRACTICE: A ROLE OF MELATONIN IN THERAPY FOR PRIMARY SLEEP AND AWAKENING DISORDERS IN PATIENTS WITH PARKINSON’S DISEASE. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.17650/1818-8338-2013-1-70-75
1050. Renata Teles Vieira, Leonardo Caixeta, Sérgio Machado, & Marcelo Caixeta (2011). Dementia in Parkinson's Disease: A Clinical Review. Neuroscience International. https://doi.org/10.3844/amjnsp.2011.35.47
1051. George P. Prigatano, M. Meites Tiffany, & Brittany Walls (2022). Psychological Care of Persons with Parkinson’s disease: Neuropsychological and Jungian Perspectives. Praxis Psy. https://doi.org/10.32995/praxispsy.v23i37.185
1052. Gerhard Nijhof (2009). Interactioneel ongemak als gevolg van gezichtsverstijving bij mensen met de ziekte van Parkinson. Mens & Maatschappij. https://doi.org/10.5117/mem2009.1.nijh
1053. Wolfgang H. Jost (2017). An update on the recognition and treatment of autonomic symptoms in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2017.1345307
1054. Daniel Delgadillo-Iniguez, Jean‐Christophe Corvol, Marie-Christine Gély-Nargeot, & Lucette Lacomblez (2006). [Parkinson's disease: psychological and behavioral disorders].. HAL (Le Centre pour la Communication Scientifique Directe)
1055. Sarah Furtado, & Zbigniew K. Wszołek (2007). Olfactory Dysfunction. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:245
1056. Stuart Isaacson (2019). Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.ms18003br1c
1057. Susanne A. Schneider, & Christine Klein (2014). PINK1 Type of Young-Onset Parkinson Disease
1058. Eelco F. M. Wijdicks (2025). “Blacked Out and Slumped Down”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0007
1059. Mauricio Muleiro Álvarez, Gabriela Cano-Herrera, María Fernanda Osorio Martínez, Joaquín Vega Gonzales-Portillo, Germán Rivera Monroy, Renata Murguiondo Pérez, Jorge Alejandro Torres-Ríos, Ximena A. van Tienhoven, Ernesto Marcelo Garibaldi Bernot, Félipe Esparza Salazar, & Antonio Ibarra (2024). A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137183
1060. M. Paulig (2006). Kognitive Störungen bei idiopathischem Parkinson-Syndrom. psychoneuro. https://doi.org/10.1055/s-2006-955079
1061. Mark Stacy (2013). Management of non-motor symptoms of Parkinson‘s disease. https://doi.org/10.2217/ebo.13.122
1062. Wolfgang H. Jost, & Lisa Klingelhoefer (2022). Gastrointestinal Disturbances in Parkinson’s Disease Including the Management of Sialorrhea. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.014
1063. Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, Jaderson V. Ferreira, Elias Carvalho Padilha, Carlos Henrique Tomich de Paula da Silva, Carlton A. Taft, & Lorane Izabel da Silva Hage-Melim (2019). Parkinson’s Disease: A Review from Pathophysiology to Treatment. Mini-Reviews in Medicinal Chemistry. https://doi.org/10.2174/1389557519666191104110908
1064. Erle C.H. Lim, Amy M.L. Quek, & Raymond C.S. Seet (2024). Deep brain stimulation in Parkinson’s disease: Looking back, looking forward. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.2024260
1065. Brandon Barton, & Christopher G. Goetz (2013). Movement Disorders due to Systemic Disease. https://doi.org/10.1002/9781118414019.ch9
1066. Atsushi Takeda, Kanae Fujihara, Akio Kikuchi, Teiko Kimpara, & Yasuto Itoyama (2001). Dementia in Parkinson's Disease: Its Incidence and a Possible Relationship with Dopa‐refractory Symptoms. Psychogeriatrics. https://doi.org/10.1111/j.1479-8301.2001.tb00005.x
1067. J. Eric Ahlskog (2009). Constipation and Delayed Gastric Emptying. https://doi.org/10.1093/oso/9780195371772.003.0026
1068. Carles Vilariño‐Güell, Ángel Soto, Jessica E. Young, Sheng-Huang Lin, Ryan J. Uitti, Zbigniew K. Wszołek, & Matthew J. Farrer (2008). Susceptibility genes for restless legs syndrome are not associated with Parkinson disease. Neurology. https://doi.org/10.1212/01.wnl.0000317101.67684.e3
1069. Navneet Bains, Sara Abdijadid, & Jennifer Miller (2021). Major Depressive Disorder (Nursing)
1070. Hui-Miao Liu, Miao Chu, Na Li, Sai Zhang, Yongzhi Zhang, & Ping Gu (2018). Relationship between Sleep Quality and Cognitive Function in Patients with Mild-to-Moderate Parkinson's Disease. Chinese Medical Journal. https://doi.org/10.4103/0366-6999.229908
1071. Abdul Qayyum Rana, Uzma S Ahmed, Zishan M Chaudry, & Sai Vasan (2015). Parkinson’s disease: a review of non-motor symptoms. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2015.1038244
1072. Eduardo Arrais Rocha, Niraj Mehta, Maria Zildany P. Távora‐Mehta, Camila F. Roncari, Alan Alves de Lima Cidrão, & Jorge Elías (2021). Disautonomia: Uma Condição Esquecida – Parte 1. Arquivos Brasileiros de Cardiologia. https://doi.org/10.36660/abc.20200420
1073. Shimon Sapir, & Arnold Aronson (1987). Coexisting psychogenic and neurogenic dysphonia: A source of diagnostic confusion. International Journal of Language & Communication Disorders. https://doi.org/10.3109/13682828709088689
1074. Maria I Dalamagka (2024). Epilepsy in children and anesthesia. Magna Scientia Advanced Research and Reviews. https://doi.org/10.30574/msarr.2024.12.2.0180
1075. Viktor Bencs, János Bencze, V. László Módis, Viktória Simon, János Kálmán, & Tibor Hortobágyi (2020). A Parkinson-kórhoz társuló demencia és a Lewy-testes demencia patológiai és klinikai összehasonlítása. Orvosi Hetilap. https://doi.org/10.1556/650.2020.31715
1076. HTS Benamer (2007). Parkinsonism and Tremor Disorders: A Clinical Approach. Libyan Journal of Medicine. https://doi.org/10.4176/061222
1077. Klaus Häger (2008). Die Demenz im Erwachsenenalter und deren Prognosefaktoren. Das Gesundheitswesen. https://doi.org/10.1055/s-0028-1086458
1078. Jori Fleisher, & Nabila Dahodwala (2014). Parkinson’s disease. https://doi.org/10.2217/ebo.13.277
1079. Yu. N. Bykov, & Tamás Bender (1993). MOBILE COMPUTER TECHNOLOGIES IN PERSONIFIED THERAPY OF PARKINSON’S DISEASE PATIENTS. Acta Biomedica Scientifica (East Siberian Biomedical Journal). https://doi.org/10.29413/abs.2018-3.1.9
1080. Fulvio Lauretani, Andrea Ticinesi, Tiziana Meschi, & Marcello Maggio (2017). The key points for treatment of Parkinsonism in older persons. Geriatric Care. https://doi.org/10.4081/gc.2016.6156
1081. G. Mayer (2001). Narkolepsie. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15335
1082. Beatrice Heim, & Atbin Djamshidian (2025). Neuropsychiatric disorders in Parkinson’s disease. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/17562864251356062
1083. Beth A. Malow (1999). Waking up to the importance of sleep in neurologic disorders. Neurology. https://doi.org/10.1212/wnl.52.9.1732
1084. Yuanzheng Ma, Yi Xiao, Sirui Zhang, Jiyong Liu, & Huifang Shang (2024). Association of autoimmune diseases with the risk of Parkinson's disease. Neuroepidemiology. https://doi.org/10.1159/000539466
1085. W R Gibb, Philip J. Luthert, I. Janota, & P. L. Lantos (1989). Cortical Lewy body dementia: clinical features and classification.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.52.2.185
1086. Ella Burchill, Cameron Watson, Jack B. Fanshawe, James Badenoch, Emma Rengasamy, Dory Anthony Ghanem, Constantine Holle, Isabella Conti, Mohammed Ahmed Sadeq, Aman Saini, Abdelilah Lahmar, Benjamin Cross, Gareth McGuigan, Amar Nandrha, Edward J. Kane, Julia Wozniak, Reem Mohamed Farouk Ghorab, Jia Song, Andrew Sommerlad, ... Jonathan Rogers (2024). The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis. The Lancet Regional Health - Europe. https://doi.org/10.1016/j.lanepe.2024.100870
1087. Claire B. Joseph (2023). Parkinson Disease. Journal of Consumer Health on the Internet. https://doi.org/10.1080/15398285.2023.2212529
1088. Robert L. Rodnitzky (2012). Visual Dysfunction in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_21
1089. HBY Chan, P.Y. Pua, & CH How (2017). Physical therapy in the management of frozen shoulder. Singapore Medical Journal. https://doi.org/10.11622/smedj.2017107
1090. G. T. Revington (1888). The Neuropathic Diathesis, or the Diathesis of the Degenerate. Journal of Mental Science. https://doi.org/10.1192/s0368315x00227898
1091. David Moore (2015). Neurocognitive Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch83
1092. Jay S. Schneider, Stephanie Sendek, & Chengwu Yang (2015). Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson’s Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0123231
1093. Luigi Ferini‐Strambi, Sara Marelli, Andrea Galbiati, Fabrizio Rinaldi, & Enrico Giora (2015). REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039822014238
1094. Paul Krack, Roland Wenzelburger, & Günther Deuschl (1999). Klinische Pathophysiologie motorischer Störungen: Akinese und Bradykinese. Klinische Neurophysiologie. https://doi.org/10.1055/s-2008-1060087
1095. K. A. Welch, & Christopher P. Derry (2013). Mild traumatic brain injury and epilepsy: alcohol misuse may underpin the association. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-306267
1096. Michael Torrens, & C Collins (1975). The Urodynamic Assessment of Adult Enuresis. British Journal of Urology. https://doi.org/10.1111/j.1464-410x.1975.tb04002.x
1097. Ke Xu, Yu Zhang, Yue Shi, Yake Zhang, Chengguang Zhang, Tianjiao Wang, Peng Lv, Yan Bai, & Shun Wang (2024). Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2024.1464595
1098. Werner Poewe, & Gregor K. Wenning (2002). The differential diagnosis of Parkinson's disease. European Journal of Neurology. https://doi.org/10.1046/j.1468-1331.9.s3.3.x
1099. Teri Thomsen, & Janis M. Miyasaki (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
1100. Rayaz A. Malik, & Aristidis Veves (2005). Diabetic Neuropathy. Humana Press eBooks. https://doi.org/10.1385/1-59259-908-7:381
1101. Ye. A. Trufanov (2013). Дифференциальная диагностика болезни Паркинсона и мультисистемной атрофии. INTERNATIONAL NEUROLOGICAL JOURNAL. https://doi.org/10.22141/2224-0713.3.57.2013.85413
1102. Francesca Magrinelli, Alessandro Picelli, Pierluigi Tocco, Angela Federico, Laura Roncari, Nicola Smania, Giampietro Zanette, & Stefano Tamburin (2016). Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation. Parkinson s Disease. https://doi.org/10.1155/2016/9832839
1103. Bradley N. Axelrod (2008). Fabrication of psychiatric symptoms: Somatoform and psychotic disorders. Psychology Press eBooks. https://doi.org/10.4324/9780203890042-23
1104. Lindsey I. Sinclair, Asher Mohr, Mizuki Morisaki, Martin Edmondson, Selina Chan, A. Bone‐Connaughton, Gustavo Turecki, & Seth Love (2023). Is later-life depression a risk factor for Alzheimer’s disease or a prodromal symptom: a study using post-mortem human brain tissue?. Alzheimer s Research & Therapy. https://doi.org/10.1186/s13195-023-01299-2
1105. Tadashi Adachi, & Ritsuko Hanajima (2022). Neuropathological changes in advanced Parkinson’s disease. Neurology and Clinical Neuroscience. https://doi.org/10.1111/ncn3.12596
1106. Günther Deuschl (2006). Neuropsychiatrische Symptome bei Parkinson-Patienten. Aktuelle Neurologie. https://doi.org/10.1055/s-2006-932666
1107. Santiago Pérez-Lloret, & Francisco J. Barrantes (2016). Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson s Disease. https://doi.org/10.1038/npjparkd.2016.1
1108. Ibrahim Raoua Ouedraogo, Jiri Koschel, David Emmans, & Wolfgang H. Jost (2023). Comorbidity of impulse control disorders and major depression in Parkinson’s disease with multiple stressogenic factors: An intensive multimodal complex therapy.. Neurons and Neurological Disorders. https://doi.org/10.58489/2836-8851/013
1109. Anita Devlin (2003). Paediatric neurological examination. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.99.47
1110. 近藤智善 (2007). ＜Special Article＞ パーキンソン病の診察と鑑別診断. 内科
1111. Suzie Lavoie, Andrea Polari, Sherilyn Goldstone, Barnaby Nelson, & Patrick D. McGorry (2019). Staging model in psychiatry: Review of the evolution of electroencephalography abnormalities in major psychiatric disorders. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12792
1112. Nico J. Weerkamp, Annemiek van Ommen-Nijhof, & Gerrit Tissingh (2009). Non-Motor Symptoms of Parkinson's Disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199237234.001.0001
1113. Busra Ozturk (2024). Cardiac effects and comorbidities of neurological diseases. TURKISH JOURNAL OF MEDICAL SCIENCES. https://doi.org/10.55730/1300-0144.5928
1114. Annu Kumari, Muskan Gupta, Gaurav Rankawat, & Abhishek Rankawat (2023). Parkinson Disease: A Review. Asian Journal of Pharmaceutical Research and Development. https://doi.org/10.22270/ajprd.v11i5.1318
1115. Kevin J. Black (2017). Treatment of Parkinson’s disease psychosis. Authorea. https://doi.org/10.22541/au.151060992.24684436
1116. Safia Alia, Hanik Badriyah Hidayati, Muhammad Hamdan, Priya Nugraha, Achmad Fahmi, Agus Turchan, & Yudha Haryono (2021). Penyakit Parkinson: Tinjauan Tentang Salah Satu Penyakit Neurodegeneratif yang Paling Umum. AKSONA. https://doi.org/10.20473/aksona.v1i2.145
1117. Lawrence I. Golbe (2008). Early diagnosis of progressive supranuclear palsy. Neurology. https://doi.org/10.1212/01.wnl.0000338701.59007.ee
1118. Gregory Stores (2002). Misdiagnosing sleep disorders as primary psychiatric conditions. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.9.1.69
1119. Yi Xu, Yujia Yang, Zhengfan Zhao, Man‐Yu Xu, Yuan Zhang, Yingying Sheng, Junying Tian, & Zhiqiang Xu (2021). Serum mBDNF and ProBDNF Expression Levels as Diagnosis Clue for Early Stage Parkinson's Disease. Frontiers in Neurology. https://doi.org/10.3389/fneur.2021.680765
1120. George T. Capone, Parag Royal, William J. Ares, & Emily Lannigan (2007). Trastornos neuroconductuales en niños, adolescentes y adultos jóvenes con síndrome de Down: Segunda parte. Revista Síndrome de Down: Revista española de investigación e información sobre el Síndrome de Down
1121. Nataša Marković, Miodrag Veljkovic, & Tanja Zečević-Luković (2013). The treatment of neurogenic bladder dysfunction in patients with spinal cord injury. PONS - medicinski casopis. https://doi.org/10.5937/pons1304157m
1122. Nesren Farhah (2024). Utilizing deep learning models in an intelligent spiral drawing classification system for Parkinson’s disease classification. Frontiers in Medicine. https://doi.org/10.3389/fmed.2024.1453743
1123. Matthias Lemke, & A Ceballos-Baumann (2004). Parkinson-Syndrom und Depression. Nervenheilkunde. https://doi.org/10.1055/s-0038-1626291
1124. Kingsley Jones (1984). Psychological problems in the elderly.. PubMed
1125. Stefan Kaiser, Karsten Heekeren, & Joe J. Simon (2011). The Negative Symptoms of Schizophrenia: Category or Continuum?. Psychopathology. https://doi.org/10.1159/000325912
1126. Kate Padgett Walsh, & Gerald Bennett (2001). Parkinson’s disease and anxiety. Postgraduate Medical Journal. https://doi.org/10.1136/pmj.77.904.89
1127. Mónica Negueruela-López, María Jesús Mardomingo, & P. Gómez-Porro Sánchez (2012). Prodromal obsessive-compulsive symptoms in a case of schizophrenia.. PubMed
1128. Rabah Lassal, Marion Laurent, & Diane Purper‐Ouakil (2011). [Early signs of mental disorders in children aged 3-12 years].. PubMed
1129. Lisa Klingelhoefer, & Heinz Reichmann (2017). Aszensionshypothese beim idiopathischen Parkinson-Syndrom. Aktuelle Neurologie. https://doi.org/10.1055/s-0043-101907
1130. S Waechter (2012). Fahren mit Parkinson - Erfahrungen mit aerztlich begleiteten Kontrollfahrten in Zuerich, Schweiz. SCHRIFTENREIHE FAHREIGNUNG
1131. Kelvin L. Chou, & Andrew Ridder (2016). Managing fatigue in patients with Parkinson&amp;#39;s disease: a patient-focused perspective. Journal of Parkinsonism and Restless Legs Syndrome. https://doi.org/10.2147/jprls.s85481
1132. L. Klingelhöfer, & Heinz Reichmann (2011). Delir, Psychose und Demenz bei Morbus Parkinson. Aktuelle Neurologie. https://doi.org/10.1055/s-0031-1285869
1133. Brian F. O’Donnell (2007). Cognitive Impairment in Schizophrenia: A Life Span Perspective. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317507304745
1134. Martin Langeskov‐Christensen, Erika Franzén, Lars G. Hvid, & Ulrik Dalgas (2024). Exercise as medicine in Parkinson’s disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2023-332974
1135. Álvaro Frías, Cárol Palma, & Núria Farriols (2015). Traumatismo craneoencefálico en pacientes con síndrome psicótico: etiopatogenia y estatus nosológico. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352015000400011
1136. Peng Guo-guan (2009). Development in diagnosis of mild cognitive impairment in Parkinson′s disease. International Journal of Internal Medicine
1137. János Bencze, Viktória Simon, Erika Bereczki, Réka Majer, Gréta Varkoly, Balázs Murnyák, János Kálmán, & Tibor Hortobágyi (2017). A Lewy-testes demencia klinikai és neuropatológiai jellemzői | Clinical and neuropathological characteristics of dementia with Lewy bodies
1138. Keisuke Suzuki, Masayuki Miyamoto, Tomoyuki Miyamoto, Masaoki Iwanami, & Koichi Hirata (2011). Sleep Disturbances Associated with Parkinson's Disease. Parkinson s Disease. https://doi.org/10.4061/2011/219056
1139. Shuhua Li, & Haibo Chen (2016). Mild cognitive impairment in Parkinson's disease. DOAJ (DOAJ: Directory of Open Access Journals)
1140. M. Häfele (2001). Internistische Differenzialdiagnose bei unklaren Bewusstseinsstörungen in Verbindung mit synkopalen Zuständen oder epileptischen Anfällen. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15333
1141. Tutul Chowdhury, Padmaja Deb Roy, & Hasanul Islam Chowdhury (2021). Delusion in Parkinson’s disease: A Symptom or an Adverse Effect of Dopamine Agonist – A Case Report
1142. Sigurlaug Sveinbjörnsdóttir (2016). The clinical symptoms of Parkinson's disease. Journal of Neurochemistry. https://doi.org/10.1111/jnc.13691
1143. Chih‐Ping Chung, Wei‐Ju Lee, Li‐Ning Peng, Hiroyuki Shimada, Tzu-Hsuan Tsai, Ching‐Po Lin, Hidenori Arai, & Liang‐Kung Chen (2021). Physio-Cognitive Decline Syndrome as the Phenotype and Treatment Target of Unhealthy Aging. The journal of nutrition health & aging. https://doi.org/10.1007/s12603-021-1693-4
1144. Hubert H. Fernandez (2012). Updates in the medical management of Parkinson disease. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.78gr.11005
1145. Natalia Vasylieva, & I. I. Krychun (2021). PREGABALINS IN THE MANAGEMENT OF DIABETIC AND ALCOHOLIC POLYNEUROPATHY. Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії. https://doi.org/10.31718/2077-1096.21.2.24
1146. Débora da Luz Scheffer, Aderbal S. Aguiar, & Alexandra Latini (2018). Fadiga e prática de atividade física na doença de Parkinson: revisão de literatura. Arquivos de Ciências da Saúde. https://doi.org/10.17696/2318-3691.25.1.2018.886
1147. Stanley Fahn (2008). Clinical Aspects of Parkinson Disease. Parkinson s Disease. https://doi.org/10.1016/b978-0-12-374028-1.00001-4
1148. C R Lake (2007). Hypothesis: Grandiosity and Guilt Cause Paranoia; Paranoid Schizophrenia is a Psychotic Mood Disorder; a Review. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbm132
1149. Jolyon Meara, & Peter Hobson (2002). The nosology of involuntary movements in older people. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259802012315
1150. Gordon Parker, & Vijaya Manicavasagar (2005). Acute stress-related non-melancholic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.014
1151. Roberto Tuchman, Solomon L. Moshé, & Isabelle Rapin (2005). Trastornos del neurodesarrollo y epilepsia. Revista de Neurología. https://doi.org/10.33588/rn.40s01.2004649
1152. Jesús Gorosabel Rebolleda (2013). Estudio de los síntomas somáticos asociados a los trastornos depresivos y de ansiedad en una población de atención primaria
1153. Françoise Niessen (2000). Diagnostic et traitement du strabisme chez l'ancien prématuré. MTP. Médecine thérapeutique pédiatrie
1154. Mattia Siciliano, Rosa De Micco, Valeria Sant’Elia, Jennifer G. Goldman, Carlo Chiorri, Marcello Silvestro, Andrea G. Russo, Giuseppina Caiazzo, Fabrizio Esposito, & Alessandro Tessitore (2024). Cognitive and Morphometric Features of Mild Cognitive Impairment Reversion in Early Patients with Parkinson’s Disease. Parkinsonism & Related Disorders. https://doi.org/10.1016/j.parkreldis.2024.107077
1155. Mohammed Almannai, Rabah Almahmoud, Mohammed O. Mekki, & Ayman W. El‐Hattab (2021). Metabolic Seizures. Frontiers in Neurology. https://doi.org/10.3389/fneur.2021.640371
1156. Michele Poletti, Daniela Frosini, Cristina Pagni, Filippo Baldacci, Martina Giuntini, Sonia Mazzucchi, Gloria Tognoni, Claudio Lucetti, Paolo Del Dotto, Roberto Ceravolo, & Ubaldo Bonuccelli (2012). The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2012.751966
1157. Virginia Wong, & Brian Hon‐Yin Chung (2006). Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?. Current Pediatric Reviews. https://doi.org/10.2174/157339606776894621
1158. Edward J. Dropcho (2008). Paraneoplastic disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545900.018
1159. Anssi Saviluoto, Karolina M. Stępień, Jayati Das‐Munshi, Aaron M. Cook, Umut Ocak, & James Barnacle (2020). Advances in Respiratory Emergencies in Neurological Diseases
1160. Catherine Morin (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
1161. Yury P. Sivolap, & Anna A. Portnova (2024). Neuropsychiatry: psychoses that should not always be treated with antipsychotics. Clinical review for general practice. https://doi.org/10.47407/kr2024.5.8.00453
1162. Andrijana Gavrić (2018). Fizioterapija u rehabilitaciji osoba oboljelih od Parkinsonove bolesti
1163. Carlos Leiva Santana, & María Álvarez Saúco (2006). Levodopa y alteraciones cognitivas en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.4302.2005571
1164. Oksana Suchowersky, Stephen G. Reich, Joel S. Perlmutter, Theresa Zesiewicz, Gary Gronseth, & William J. Weiner (2006). Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) [RETIRED]. Neurology. https://doi.org/10.1212/01.wnl.0000215437.80053.d0
1165. Venkatesh Bhat, & William J. Weiner (2005). Parkinson's disease. Diagnosis and the initiation of therapy.. PubMed
1166. Aleksandar Videnović, & Lambros Messinis (2019). Enlightened PD. Neurology. https://doi.org/10.1212/wnl.0000000000007078
1167. Keisuke Suzuki, Masavuki Mivamoto, & Takeo Matsubara (2017). Detection and management of sleep disturbances in Parkinson's disease.. PubMed
1168. Aleksandra Buczek, Michał Borończyk, Patrycja Hudzińska, Hubert Bigajski, Alicja Białas, Wiktoria Balcerzak, Klaudia Marcinkiewicz, Jakub Milczarek, & Joanna Siuda (2024). Risk factors for falls in Parkinson's disease and other parkinsonisms. Archives of Gerontology and Geriatrics Plus. https://doi.org/10.1016/j.aggp.2024.100054
1169. Joseph H. Friedman, & Richard P. Millman (2008). Sleep Disturbances and Parkinson's Disease. CNS Spectrums. https://doi.org/10.1017/s1092852900017272
1170. Gilles Fénelon (2005). [Parkinson's disease: dealing with all dimensions of the disease].. La Revue du praticien
1171. Antonio Kodžoman (2020). Kineziterapija osoba s intelektualnim poteškoćama
1172. Ali H. Rajput (2001). Environmental toxins accelerate Parkinson’s disease onset. Neurology. https://doi.org/10.1212/wnl.56.1.4
1173. Stanley Fahn, Paul Greene, Blair Ford, Susan Bressman, & Steven J. Frucht (2009). Movement Disorders. https://doi.org/10.1007/978-1-57340-359-7_9
1174. Anatolii Tsarkov, & Petro Petlovanyi (2020). Use of pramipexole in neuropsychiatry. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.4317103
1175. Anatolii Tsarkov, & Petro Petlovanyi (2020). Use of pramipexole in neuropsychiatry. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2020.7.2.0283
1176. Beny Rilianto (2015). Mild Cognitive Impairment (MCI): Transisi dari Penuaan Normal Menjadi Alzheimer. Cermin Dunia Kedokteran
1177. Henrique Ballalai Ferraz, & James Henrique Yared (2013). Cerebrovascular lesions in parkinsonian patients: when do they really matter?. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20130167
1178. 孟昭义 (1994). 应用足反射法对常见病诊断和防治(一)——震颤麻痹(帕金森氏症)(Parkinsonism). 双足与保健
1179. Alistair Munro (1999). ‘Paranoid spectrum’ illnesses which should be included in the category of delusional disorder. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544095.010
1180. Nihan Hande Akçakaya, Zühal Yapıcı, & Uğur Özbek (2018). Cerebral Palsy and Genetics. Turkish Journal Of Neurology. https://doi.org/10.4274/tnd.67864
1181. D. B. Calne, & J. K. Kebabian (1980). Parkinson's disease: unanswered questions.. PubMed
1182. John V. Hindle (2010). Mood Disorders in Parkinson's Disease. https://doi.org/10.1002/9780470669600.ch76
1183. Juan Carlos Rojas Castillo, Adriana Marcela Ruíz, Claudia Lucía Moreno López, Miguel Arturo Silva Soler, & Cristian Camilo Páez Gutiérrez (2021). Parkinson genetico: Reporte de un caso clínico y revisión de la literatura. Acta neurológica colombiana. https://doi.org/10.22379/24224022379
1184. Fatemeh Nouri Emamzadeh, & Andrei Surguchov (2018). Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2018.00612
1185. Başar Bılgıç, Haşmet Hanağası, & Murat Emre (2014). Parkinson’s Disease Dementia. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-09537-0_3
1186. Yuns Lomami (2021). Patients with Parkinson's disease and Spindle Alterations
1187. Daniel Weintraub, Cynthia L. Comella, & Stacy Horn (2008). Parkinson's disease--Part 3: Neuropsychiatric symptoms.. PubMed
1188. Slobodin Tn (2010). [Characteristics of motor, cognitive, and emotional manifestations depending on the clinical variant of Parkinson's disease].
1189. A. M. Bonnet, & Virginie Czernecki (2013). Non-motor symptoms in Parkinson's disease: cognition and behavior. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2013.0423
1190. Bahjat Barakat, R. Agosti, Eugenio Ruggeri, V. Tonini, Maurizio Cervellera, Elena Guidetti, M. Cevenini, Andrea Imbrogno, Daniel Fabbri, I. Pareo, Alessandro Fucili, Roberto Corinaldesi, Vincenzo Stanghellini, Raffaele Pezzilli, & Roberto De Giorgio (2012). Atypical presentation of acute idiopathic megacolon in a 14-year-old patient. Emergency Care Journal. https://doi.org/10.4081/ecj.2012.3.5
1191. Heiner Ellgring, Stephan Seiler, B. Perleth, W Frings, Thomas Gasser, & WH Oertel (1993). Psychosocial aspects of Parkinson's disease.. PubMed
1192. Neeti Rajan Singh, & Inder Mohan Singh Sandhu (2019). Absence of Nocturnal Penile Tumescence: An Earlier Sign of Erectile Dysfunction and Its Linked Comorbid Conditions. AMEI s Current Trends in Diagnosis & Treatment. https://doi.org/10.5005/jp-journals-10055-0074
1193. Ali G. Hamedani, Danielle S. Abraham, Maureen G. Maguire, & Allison W. Willis (2020). Visual Impairment Is More Common in Parkinson’s Disease and Is a Risk Factor for Poor Health Outcomes. Movement Disorders. https://doi.org/10.1002/mds.28182
1194. Natalia Ospina-García (2019). Trastornos del sueño y dolor en la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022251
1195. Grace Bailey, Emily Hubbard, Alfonso Fasano, Marina A.J. Tijssen, Timothy Lynch, Kirstie N. Anderson, & Kathryn J. Peall (2021). Sleep disturbance in movement disorders: insights, treatments and challenges. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2020-325546
1196. Jeffrey L. Cummings, Claire Henchcliffe, S. Schaier, T. Simuni, Alan Waxman, & P. M. Kemp (2011). The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. https://doi.org/10.1093/brain/awr177
1197. Kelly Del Tredici, & Heiko Braak (2012). Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2011-301817
1198. Shahmir Sohail, Lei Yu, Julie A. Schneider, David A. Bennett, Aron S. Buchman, & Andrew Lim (2017). Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.27200
1199. George W. Paulson (1985). Early Alzheimer's disease or dementia from another cause?. Postgraduate Medicine. https://doi.org/10.1080/00325481.1985.11699069
1200. Yvonne Paelecke–Habermann, Georg Ebersbach, & Bernd Leplow (2007). Depressivität und Depression bei der Parkinson-Erkrankung. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x.18.3.207
1201. Yong You (2018). Currence pathogenic mechanism for weight loss in Parkinson disease. Zhongguo yishi zazhi. https://doi.org/10.3760/cma.j.issn.1008-1372.2018.01.007
1202. Irene Hegeman Richard (2005). Anxiety disorders in Parkinson's disease.. PubMed
1203. Kerstin Konrad, Christine Firk, & Peter J. Uhlhaas (2013). In Reply. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2013.0733b
1204. Braune (2002). Vegetative Störungen beim idiopathischen Parkinsonsyndrom: diagnostische Relevanz und therapeutische Möglichkeiten. Praxis. https://doi.org/10.1024/0369-8394.91.10.402
1205. Dag Aarsland, Uwe Ehrt, & Irena Rektorová (2011). Cognitive and psychiatric disturbances in Parkinson’s disease. Aging Health. https://doi.org/10.2217/ahe.11.3
1206. Adriana E. Olthoff (2016). Erkrankungen der Sprache und des Sprechens im Alter. Sprache · Stimme · Gehör. https://doi.org/10.1055/s-0042-107007
1207. Carlos R Méndez-Herrera (2011). El núcleo subtalámico en la fi siopatología de la enfermedad de Parkinson y su rol como diana quirúrgica The subthalamic nucleus in the pathophysiology of Parkinson's disease and its role as a surgical target
1208. Muhammad Adnan Khan, Syed A. Quadri, & Hassaan Tohid (2017). A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review. Bulletin of the Menninger Clinic. https://doi.org/10.1521/bumc.2017.81.1.53
1209. Sharon Muzerengi, Helen M. Lewis, Mark J. Edwards, Emma Kipps, Anuj Bahl, Pablo Martínez‐Martín, & К. Ray Chaudhuri (2006). Non-motor symptoms in Parkinson's disease: an underdiagnosed problem. Aging Health. https://doi.org/10.2217/1745509x.2.6.967
1210. Tommaso Beccari, Maria Michiara, Silvia Paciotti, Emanuele Persichetti, Davide Chiasserini, Anna Castrioto, Nicola Tambasco, Aroldo Rossi, Paolo Calabresi, Veronica Pagliardini, Bruno Bembi, & Lucilla Parnetti (2011). Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease. InTech eBooks. https://doi.org/10.5772/23552
1211. Semiha Akın (2006). PARKINSON VE HEMŞİRELİK YAKLAŞIMLARI. Florence Nightingale Hemşirelik Dergisi. https://doi.org/10.17672/fnhd.26242
1212. Paul E. Youssef, Kenneth J. Mack, & Kelly D. Flemming (2015). Classification and Approach to Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0024
1213. Gilad S. Segal, Sophie J Xie, Saif-ur-Rahman Paracha, & George T. Grossberg (2021). Psychosis in Parkinson’s Disease: Current Treatment Options and Impact on Patients and Caregivers. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/08919887211018280
1214. Jurek Olszewski, Hanna Zielińska‐Bliźniewska, & Piotr Pietkiewicz (2011). Zaburzenia połykania jako interdyscyplinarny problem diagnostyczny i leczniczy. Polski Przegląd Otorynolaryngologiczny. https://doi.org/10.1016/s2084-5308(11)70060-0
1215. Andrés Ceballos-Baumann (2006). Demenz bei Parkinson-Syndromen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1626803
1216. Dag Aarsland, & Uwe Ehrt (2003). Basal ganglia diseases and geriatric psychiatry: a new approach. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200311000-00004
1217. Joe Verghese (2000). PTSD, DEMENTIA, AND SLEEP DISORDER: A POSSIBLE ASSOCIATION. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2000.tb04799.x
1218. Detlev Schindler, David F. Bishop, David Wolfe, Anne M. Wang, Heinz Egge, Ray U. Lemieux, & Robert J. Desnick (1989). Neuroaxonal Dystrophy Due to Lysosomal α-N-Acetylgalactosaminidase Deficiency. New England Journal of Medicine. https://doi.org/10.1056/nejm198906293202606
1219. Jorge Garza-Ulloa (2019). Theory of Stress-Anxiety-Sleep Disorders-Neural Damage Cyclic Chain and the Progression of Parkinson’s Disease. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2019.06.001021
1220. J. M. Kellett (1993). Long term care on the NHS: a vanishing prospect.. BMJ. https://doi.org/10.1136/bmj.306.6881.846
1221. Charles Clarke (2022). Movement Disorders. Neurology. https://doi.org/10.1002/9781119235699.ch7
1222. Kaylena A. Ehgoetz Martens, & Simon J.G. Lewis (2016). Pathology of behavior in PD: What is known and what is not?. Journal of the Neurological Sciences. https://doi.org/10.1016/j.jns.2016.12.062
1223. Akira Kanazawa (2004). [The cognitive dysfunction in Parkinson's disease].
1224. Alla Timofeeva, & I I Belozertseva (2016). The issues of medical/social expertise in Parkinson’s disease. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20161169193-97
1225. M. G. Echeverria (1881). Alcoholic Epilepsy. Journal of Mental Science. https://doi.org/10.1192/bjp.26.116.489
1226. María Gabriela Echeverría (1881). Alcoholic Epilepsy. Journal of Mental Science. https://doi.org/10.1192/s0368315x00001614
1227. Imen Daly, Zied Hajaiej, & Ali Gharsallah (2018). Detection of Parkinson's Disease through Acoustic Parameters. International Journal of Advanced Computer Science and Applications. https://doi.org/10.14569/ijacsa.2018.090742
1228. Constance Ward (2006). Characteristics and Symptom Management of Progressive Supranuclear Palsy: A Multidisciplinary Approach. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-200608000-00007
1229. Akira Tamaoka (2013). [Fall risk and fracture. Falls and fractures in patients with neurological disorders].. PubMed
1230. Yang Yang, Beisha Tang, & Jifeng Guo (2016). Parkinson’s Disease and Cognitive Impairment. Parkinson s Disease. https://doi.org/10.1155/2016/6734678
1231. M. M. Alberto Pestano, Dayra Hernández Marrero, Bárbara Acosta Acosta, & José Luis Delgado Miranda (2020). La ptosis no orgánica: a propósito de un trastorno
1232. Allan Krumholz, Gene Sung, Robert S. Fisher, Erica F. Barry, Gregory K. Bergey, & Lynn M. Grattan (1995). Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. https://doi.org/10.1212/wnl.45.8.1499
1233. Samantha Gauci, Warwick Hosking, & Dorothy Bruck (2017). Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine. https://doi.org/10.1080/2331205x.2017.1312791
1234. Jon Stone, & Michael Sharpe (2020). Functional neurological symptom disorder (conversion disorder). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0133
1235. J. Eric Ahlskog (2009). Hallucinations, Delusions, and Pathologic Behaviors. https://doi.org/10.1093/oso/9780195371772.003.0024
1236. Alison J. Yarnall (2014). What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition. Neurodegenerative Disease Management. https://doi.org/10.2217/nmt.14.7
1237. Guillaume Baille (2019). Atteinte ventilatoire dans la maladie de Parkinson : du symptôme à l’atteinte objective
1238. Eileen J. McManus, Gemma Poke, Matthew Phillips, & Fredrik Asztély (2020). Perry syndrome: a case of atypical parkinsonism with confirmed DCTN1 mutation.. PubMed
1239. M. Pinho, Daniel Oliveira Martins, Paulo S. Martins, Laura Jane Gomes, & Serafim Carvalho (2023). Psychosis in Parkinson’s disease: a clinical biomarker of disease stage and prognosis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1985
1240. Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, Samuel Díaz, & Sagrario Manzano (2023). Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sciences. https://doi.org/10.3390/brainsci13020318
1241. George T. Elliot (1991). TWO CASES OF DERMATITIS HERPETIFORMIS DEVELOPING AFTER SEVERE MENTAL EMOTION AND SHOCK. Archives of Dermatology. https://doi.org/10.1001/archderm.1991.01680080062003
1242. Siobhan Lewis, & J Liddle (2012). Diagnosing non-parkinson's movement disorders.. PubMed
1243. Priya Nugraha, & Muhammad Hamdan (2020). Profil Gejala Motorik dan Non-Motorik pada Pasien Penyakit Parkinson di RSUD Dr. Soetomo Surabaya
1244. Madeleine A. Becker, Tal E. Weinberger, & Leigh J. Ocker (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
1245. Jim Lagopoulos, Gin S. Malhi, Belinda Ivanovski, Catherine Cahill, & John G. Morris (2005). A matter of motion or an emotional matter? Management of depression in Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.5.6.803
1246. Cinthya Montenegro de Vasconcelos Silva (2016). Avaliação do perfil de sono/vigilia em um modelo crônico de parkinsonismo em ratos
1247. Shahriar Nikpour (2012). Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review.. PubMed
1248. Thomas C. Britton, & К. Ray Chaudhuri (2009). REM sleep behavior disorder and the risk of developing Parkinson disease or dementia. Neurology. https://doi.org/10.1212/01.wnl.0000343502.98134.01
1249. Marc‐André Bédard, Sylvain Lemay, Jean Gagnon, Hélène Masson, & F. Paquet (1999). Induction of a Transient Dysexecutive Syndrome in Parkinson’s Disease using a Subclinical Dose of Scopolamine. Behavioural Neurology. https://doi.org/10.1155/1999/316598
1250. Daniel Jaramillo M, Miguel José Ortiz M, Sebastián Pérez C, Santiago Vasquez-Builes, & Isabel Cristina Rojas G (2022). Disfunción urinaria en la enfermedad de Parkinson: una revisión práctica.. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272022000100062
1251. Yuke Zhong, Huahua Su, Ying Liu, Hang Liu, Guohui Liu, Zhihui Liu, Jiahao Wei, Junyi Wang, Yunlang She, Changhong Tan, Lijuan Mo, Lin Han, Fen Deng, Xi Liu, & Lifen Chen (2024). Association of motor subtype and tremor type with Parkinson's disease progression: An exploratory longitudinal analysis. Journal of Parkinson s Disease. https://doi.org/10.1177/1877718x241305715
1252. Ethan Meltzer (2022). A woman who didn’t realize she couldn’t see half the world. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197576663.003.0005
1253. Rebecca D. Folkerth (2021). Cerebral Cortical Migration Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.041
1254. Weilin Xie (2011). Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease. https://doi.org/10.14711/thesis-b1155461
1255. Antônio Cavalcanti Oliveira Filho, Laura Marcelly Teixeira Gomes, Amanda Camelo Corrêa, Edna Fernanda Dias Leão, Danilo Mendes Cangussu, & Silvério de Almeida Souza Torres (2019). BRUXISMO DO SONO. Revista Intercâmbio
1256. Paul A.M. Smeets, Justine Laverdeur, Zayd Jedidi, Haroun Jedidi, & Frédérique Depierreux (2024). [Senses and dementia : sensory loss and dementia risk].. PubMed
1257. Nils G. Margraf, & Günther Deuschl (2010). Kamptokormie bei Morbus Parkinson. Aktuelle Neurologie. https://doi.org/10.1055/s-0030-1248605
1258. Guy Vingerhoets (2003). Predictors of cognitive impairment in advanced Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.74.6.793
1259. Dina Šućur (2018). Parkinsonova bolest i tjelesno vježbanje
1260. Elke Kalbe, & A. Petrelli (2014). Leichte kognitive Störungen und Demenz bei Patienten mit Morbus Parkinson. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x/a000115
1261. Mireia Costa Mallol (2016). Efecte de processos neurodegeneratius motors en els moviments oculars
1262. Javier Marco Llorente, & Esther Rojo Martínez (2010). Otros trastornos no motores en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009743
1263. A F G Leentjens, & Odile A. van den Heuvel (2015). [Dilemmas in the treatment of psychiatric symptoms in patients with Parkinson's disease].. PubMed
1264. Theresa Zesiewicz, Kelly L. Sullivan, & Robert A. Hauser (2006). Nonmotor symptoms of Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.12.1811
1265. Marios Politis, Kit Wu, Sophie Molloy, Peter G. Bain, К. Ray Chaudhuri, & Paola Piccini (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
1266. Elena Antelmi, Giuseppe Lanza, Maria P. Mogavero, Gloria Pompea Mingolla, Giuseppe Plazzi, Luigi Ferini‐Strambi, Raffaele Ferri, & Michèle Tinazzi (2024). Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14254
1267. ANA LARA SOARES BLUM MALAK (2016). SINTOMAS DE DEPRESSÃO EM PACIENTES COM DECLÍNIO COGNITIVO LEVE NA DOENÇA DE PARKINSON. https://doi.org/10.17771/pucrio.acad.27733
1268. Joseph H. Friedman (2011). Psychosis in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch16
1269. H. H. DRYSDALE (1916). CONJUGAL PARESIS. Journal of the American Medical Association. https://doi.org/10.1001/jama.1916.02590050018007
1270. K. Jendroska (1997). The relationship of Alzheimer-type pathology to dementia in Parkinson’s disease. https://doi.org/10.1007/978-3-7091-6844-8_3
1271. George W. Paulson (1997). Visual Hallucinations in the Elderly. Gerontology. https://doi.org/10.1159/000213859
1272. B. C. Shanley, V. A. Percy, & A. C. Neethling (1977). Pathogenesis of neural manifestations in acute porphyria.. PubMed
1273. Steve Jamieson (1999). Sexuality and parkinson’s disease. Nursing Older People. https://doi.org/10.7748/nop.11.1.39.s35
1274. Mei Yanliang, Xiaojing Liu, Yanpeng Yuan, Lanjun Li, Xu Yuming, & Jing Yang (2020). Transcranial sonography of substantia nigra for differential diagnosis of Parkinson's disease and other movement disorders: A Meta-analysis. https://doi.org/10.37766/inplasy2020.6.0068
1275. P. Bocquillon (2012). Approche psycho-physiologique des troubles attentionnels dans la maladie de Parkinson
1276. Lisa Klingelhoefer, & Heinz Reichmann (2017). Hypothesis of Ascension in Idiopathic Parkinson’s Disease. Neurology International Open. https://doi.org/10.1055/s-0043-102389
1277. Jacob J. Crouse, Joseph R. Phillips, Marjan Jahanshahi, & Ahmed A. Moustafa (2016). Postural instability and falls in Parkinson’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2016-0002
1278. Álvaro Cerame, & Maria Luisa Costa Ferreira Da Silva (2019). DELUSIONAL JEALOUSY IN THE CONTEXT OF PARKINSON’S DISEASE: A CASE REPORT.. https://doi.org/10.26226/morressier.5d1a037257558b317a140326
1279. Eliana Roldán Gerschcovich, & Kuei Y. Tseng (2008). Cognitive Deficits in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-252-0_19
1280. Dag Aarsland, Uwe Ehrt, & Clive Ballard (2005). Role of Neuropsychiatric Assessment in Diagnosis and Research. Humana Press eBooks. https://doi.org/10.1385/1-59259-834-x:163
1281. Pedro Augusto Barbosa Silva, Enmilly Gonçalves Pereira Luna da Silva, Maria Eduarda Corrêa Godoy, Mariana Vieira da Silva, Lucas Luiz Fitipaldi Ferreira, LEONARDO CARNINO MARCOLINA, Larissa Alves da Silva, Iago dos Reis e Silva, HENRIQUE MARQUES DA SILVA VARGE, Gabriel Barbosa de Carvalho Matos, Francisca Andreza Passos Silva, Anna Gabriely de Novaes Pereira, Alice Telles Brahm, & Vivian Kaori Orikassa (2024). O IMPACTO DA ATIVIDADE FÍSICA PARA PREVENÇÃO E TRATAMENTO DA DOENÇA DE PARKINSON. Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida. https://doi.org/10.36692/v16n2-60r
1282. Yiqiu Liu, Junyu Deng, Ye Liu, Wei Li, & Xuqiang Nie (2021). FGF, Mechanism of Action, Role in Parkinson’s Disease, and Therapeutics. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.675725
1283. G. Padmapriya, R Elakkiya, M Madhura Prakash, & Vinoth Kumar M (2021). Deep Learning Based Parkinson's Disease Prediction System. CRC Press eBooks. https://doi.org/10.1201/9781003194415-6
1284. Catherine Thomas-Antérion, & Pierre Krolak‐Salmon (2010). L'évaluation des fonctions exécutives en pratique courante dans la maladie de Parkinson et les syndromes apparentés. Revue de neuropsychologie. https://doi.org/10.3917/rne.025.0007
1285. Isidora Vásquez-Márquez, & Antonio Castellanos-Olivares (2011). Delirio postoperatorio en el paciente geriátrico. Deleted Journal
1286. T Nakamuro, Naonobu Futamura, Kohji Murata, A Suzumura, & T Takayanagi (1998). [Screaming during sleep in patients with Parkinson disease].. PubMed
1287. Lorena Cuenca‐Bermejo, Pilar Almela, Javier Navarro‐Zaragoza, Emiliano Fernández Villalba, Ana María González Cuello, M. Luisa Laorden, & María Trinidad Herrero (2021). Cardiac Changes in Parkinson’s Disease: Lessons from Clinical and Experimental Evidence. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms222413488
1288. Erik Scherder, Joukje M. Oosterman, Marius Ooms, Miel W. Ribbe, & Dick F. Swaab (2005). [Chronic pain in dementia and in disorders with a high risk for congnitive impairment].. PubMed
1289. Ada Chicharro-Ciuffardi, Mónica González-Silva, Alejandro de Marinis-Palombo, & Guillermo Gabler-Santalices (2012). Psychiatric disorders secondary to nonconvulsive status epilepticus of frontal origin. Two clinical case reports.. PubMed
1290. B. J. Snow (2003). Objective measures for the progression of Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.74.3.287
1291. Susan McPherson, & Jeffrey L. Cummings (1996). Neuropsychological Aspects of Parkinson’s Disease and Parkinsonism. https://doi.org/10.1093/oso/9780195090734.003.0013
1292. Jasmin Müller (2015). Endogene Schmerzmodulation bei Morbus Parkinson
1293. Gregory Castelli, Krishna Desai, & Rebecca E. Cantone (2020). Peripheral Neuropathy: Evaluation and Differential Diagnosis.. American family physician
1294. Tanis J. Ferman, & Bradley F. Boeve (2012). Sleep in Parkinson’s Disease and Dementia with Lewy Bodies. Advances in biological psychiatry. https://doi.org/10.1159/000331527
1295. Désiré Marie Patrice Yameogo (2002). Précarité et souffrance psychique au Burkina Faso. Sud/Nord. https://doi.org/10.3917/sn.017.0141
1296. Lawrence T. Taft (1995). Cerebral Palsy. Pediatrics in Review. https://doi.org/10.1542/pir.16.11.411
1297. Maarten J. Postma, & Cornelis Boersma (2011). Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost–effectiveness in early Parkinson’s disease. Expert Review of Clinical Pharmacology. https://doi.org/10.1586/ecp.11.69
1298. Janus Kremer, & Sergio Starkstein (2000). Affective disorders in Parkinson's disease. International Review of Psychiatry. https://doi.org/10.1080/09540260020002514
1299. Zlatko Trkanjec (2002). How to treat Parkinson's disease
1300. Hélio Afonso Ghizoni Teive, Délcio Caran Bertucci Filho, & Renato P. Munhoz (2016). Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20160126
1301. Agnieszka Dyduch, & M Załuska (2014). Depression in <scp>P</scp>arkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review. Psychogeriatrics. https://doi.org/10.1111/psyg.12078
1302. David Devos, Luc Defebvre, & Régis Bordet (2010). Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease. Fundamental and Clinical Pharmacology. https://doi.org/10.1111/j.1472-8206.2009.00798.x
1303. Harold L. Klawans, & Nina A. Paleologos (1986). Dystonia-Parkinson Syndrome. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-198606000-00008
1304. Roger J. Bick, Marie‐Françoise Doursout, & Brian J. Poindexter (2016). The Complex Cascade of Parkinson’s Disease: Sniffing out a Therapy?. Journal of nature and science
1305. Tomoyuki Mizuno, Hiyori Matsumoto, Kayo Mita, S. Kogauchi, Y Kiyono, Hirotaka Kosaka, & Naoto Omata (2019). Psychosis is an extension of mood swings from the perspective of neuronal plasticity impairments. Medical Hypotheses. https://doi.org/10.1016/j.mehy.2019.02.001
1306. Koichi Hirata, Birgit Högl, Eng King Tan, & Aleksandar Videnović (2015). Sleep Problems in Parkinson’s Disease. Parkinson s Disease. https://doi.org/10.1155/2015/507948
1307. Maria T. Nanagas (2011). Bipolar Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.32.11.502
1308. Willem J. Kop, & John S. Gottdiener (2011). The Interaction Between Psychologic Distress and Biobehavioral Processes in Cardiovascular Disease. https://doi.org/10.1002/9780470975138.ch1
1309. Karen A. Doherty, Laura Silveira‐Moriyama, Laura Parkkinen, Daniel G. Healy, Michael Farrell, Niccolò E. Mencacci, Zeshan Ahmed, Francesca Brett, John Hardy, Niall Quinn, Timothy J. Counihan, Timothy Lynch, Zoë Fox, Tamás Révész, Andrew J. Lees, & Janice L. Holton (2013). PARKIN DISEASE–A CLINICOPATHOLOGICAL ENTITY?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-306573.13
1310. H. C. Hopf (1988). Negative Symptome des Parkinson-Kranken. Versuch einer Differenzierung. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-1020625
1311. Shilpa Singh (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
1312. Dinesh Selvarajah, Gordon Sloan, & Solomon Tesfaye (2020). Diabetic Neuropathy. https://doi.org/10.1002/9781119445821.ch5
1313. J. Pearce (1987). Symptom Management in Multiple Sclerosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.50.9.1247
1314. Roy O. Weller, Michael Swash, D L McLellan, & Carl L. Scholtz (1983). The Interpretation of Neurological Symptoms and Signs. Clinical Neuropathology. https://doi.org/10.1007/978-1-4471-1335-5_3
1315. Naheed L. Khan, Elizabeth Graham, Peter Critchley, Anette Schrag, Nicholas Wood, Andrew J. Lees, Kailash P. Bhatia, & Niall Quinn (2003). Parkin disease: a phenotypic study of a large case series. Brain. https://doi.org/10.1093/brain/awg142
1316. Joshua S Helali, Anuj Mahindra, Yashasvi Rajeev, & Nelson Hwynn (2025). Autonomic Dysfunction in a Patient Initially Diagnosed With Parkinson’s Disease Who Subsequently Developed Systemic Amyloidosis. Cureus. https://doi.org/10.7759/cureus.87116
1317. Charles H. Adler (2005). Nonmotor complications in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.20460
1318. Christopher H. Hawkes, & Jacquie Deeb (2006). Predicting Parkinson's disease: worthwhile but are we there yet?. Practical Neurology. https://doi.org/10.1136/jnnp.2006.101238
1319. Jelena Stamenović, Saša Đurić, M. Jolić, Biljana Živadinović, & Vanja Đurić (2005). Examination of cognitive functions in patients with Parkinsons disease
1320. Imre Szirmai (2011). [Vascular or "lower body Parkinsonism": rise and fall of a diagnosis].. PubMed
1321. N Yanagisawa (1997). [Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan].. PubMed
1322. Rodger J. Elble (2016). The essential tremor syndromes. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000347
1323. Antoine M. Hakim, & G. Mathieson (1979). Dementia in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.29.9_part_1.1209
1324. Coralie de Hemptinne, & Nicole C. Swann (2016). Treating Parkinson’s Disease with Brain-Controlled Electrical Stimulation. Frontiers for Young Minds. https://doi.org/10.3389/frym.2016.00010
1325. Bari MM, Shahidul Islam, Shetu Nh, Mahfuzer Rahman, & Mofakhkharul Bari (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
1326. Ornit Chiba‐Falek, & Robert L. Nussbaum (2003). Regulation of -Synuclein Expression: Implications for Parkinson's Disease. Cold Spring Harbor Symposia on Quantitative Biology. https://doi.org/10.1101/sqb.2003.68.409
1327. Malcolm M. Kates, & Casey J. Beal (2021). Nystagmus. JAMA. https://doi.org/10.1001/jama.2020.3911
1328. Hubert H. Fernandez, & Tanya Simuni (2007). Anxiety. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:13
1329. Kasia Gustaw Rothenberg (2022). Neuropsychiatric (Behavioral) Symptoms in Parkinson’s Disease. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.009
1330. Stein Opjordsmoen (1991). [Is there any connection between structural brain changes and schizophrenia?].. PubMed
1331. J. Eric Ahlskog (2005). Testing: Blood Tests, X rays, and Scans. https://doi.org/10.1093/oso/9780195171938.003.0007
1332. M. C. de Rijk, & Monique M.B. Breteler (2001). Parkinson's disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511526909.014
1333. Heinz Reichmann, & Werner Martin Michael Schüpbach (2008). Pramipexole in the management of Parkinson’s disease. Aging Health. https://doi.org/10.2217/1745509x.4.3.225
1334. N. Dissanayaka (2021). Anxiety in Parkinson’s Disease. Cambridge University Press eBooks. https://doi.org/10.1017/9781139087469.009
1335. Aylin Akçalı, & Lütfü Savaş (2008). Malignant Syndrome of Two Parkinson Patients due to Withdrawal of Drugs. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v37n1p77
1336. J. Kornhuber, & M. Weiler (1997). Das maligne neuroleptische Syndrom. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-1017796
1337. Aliza K. Fink (1995). Anticholinergic drugs are not contraindicated after iridotomy. BMJ. https://doi.org/10.1136/bmj.310.6995.1668a
1338. З. В. Салій, Svitlana Shkrobot, & М. І. Салій (2025). Atypical forms of motor neuron disease: a review of the problem and clinical cases. INTERNATIONAL NEUROLOGICAL JOURNAL. https://doi.org/10.22141/2224-0713.21.5.2025.1206
1339. Selikhova Mv, Piatnitskiĭ An, Aristova Ra, Serkin Gv, & Gusev Ei (2004). [Clinical features of an early stage of Parkinson's disease].. PubMed
1340. Kazuko Hasegawa (2004). Sleep Disorders in Parkinson’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780203508596-31
1341. Aanchal Ajit Jain (2021). Narcolepsy: A Chronic Neurological Disorder - A Review. Bioscience Biotechnology Research Communications. https://doi.org/10.21786/bbrc/14.6.61
1342. Julián Benito‐León (2012). ‘When Did My Tremor Start’: Can Essential Tremor Patients Pinpoint Their Disease Onset. Neuroepidemiology. https://doi.org/10.1159/000342312
1343. Aurelie Pascal (2020). Early identification and intervention for infants at high risk of neurodevelopmental disorders
1344. Antonio Daniele, & Alberto Albanese (2012). Early visual memory deficits. Neurology. https://doi.org/10.1212/wnl.0b013e318253d67b
1345. Dipl.-Biol. Ulrich Frommberger (2014). In Reply. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489c
1346. David Meagher (2001). Delirium episode as a sign of undetected dementia among community dwelling elderly subjects. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.70.6.821
1347. Kailash P. Bhatia, Ioana Cociasu, Chiara Sorbera, Antonino Tuttolomondo, Francesca Morgante, & Jennifer Friedman (2021). Commentary: <scp>Anderson‐Fabry</scp> Disease: A Rare Cause of Levodopa‐Responsive Early Onset Parkinsonism. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13297
1348. Alfred L. Scherzer (2015). Think ‘neurodevelopmental syndrome’. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.12757
1349. Vincent Ongko Wijaya (2019). Impact of Pain on Stroke and Hypertension as Comorbidities In Parkinson’s Disease. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2019.01.000519
1350. Himal Bikram Bhattarai, Bibhusan Basnet, Madhur Bhattarai, Ayush Shrestha, Swotantra Gautam, Saral Lamichhane, Manish Uprety, Bidushi Pokhrel, Sanjit Sah, & Jayant Kumar Yadav (2023). Diagnostic pitfalls in young onset parkinsonism and its unique challenges: A case report from rural Nepal. SAGE Open Medical Case Reports. https://doi.org/10.1177/2050313x231197062
1351. Brit Mollenhauer, Sascha Wenzel, & Claudia Trenkwalder (2008). Schwerpunktthema: Medikamentöse Behandlung des Morbus Parkinson mit Demenz und anderen neuropsychiatrischen Störungen. Zeitschrift für Psychiatrie Psychologie und Psychotherapie. https://doi.org/10.1024/1661-4747.56.1.13
1352. Michael W. Hayes, Victor S.C. Fung, Thomas Kimber, & John D. O’Sullivan (2010). Current concepts in the management of Parkinson disease. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2010.tb03453.x
1353. Eve Blair (1996). Obstetric antecedents of cerebral palsy. Fetal and Maternal Medicine Review. https://doi.org/10.1017/s0965539596000022
1354. Marcelo Rezende Young Blood, Marcelo Machado Ferro, Renato P. Munhoz, Hélio Afonso Ghizoni Teive, & Carlos Henrique Ferreira Camargo (2016). Classification and Characteristics of Pain Associated with Parkinson’s Disease. Parkinson s Disease. https://doi.org/10.1155/2016/6067132
1355. Alfonso Sanz Cid (1990). El deterioro neuropsicologico y neurofisiologico en la esquizofrenia
1356. Jörn Peter Sieb, & Thomas Günnewig (2004). M. Parkinson im hohen Lebensalter. psychoneuro. https://doi.org/10.1055/s-2004-833662
1357. Krzysztof Pękala, Monika Ponichtera-Kasprzykowska, & Tomasz Sobów (2015). Depression diagnosis in patients with Parkinson’s disease using various diagnostic tools. Aktualności Neurologiczne. https://doi.org/10.15557/an.2015.0028
1358. John C.M. Brust (1988). Vascular Dementia Is Overdiagnosed. Archives of Neurology. https://doi.org/10.1001/archneur.1988.00520310117026
1359. Henning Vollmann, N Hübner-Kosney, Matthias L. Schroeter, Thomas Hans Fritz, Joseph Claßen, & Dorothee Saur (2013). EEG-Neurofeedback bei Patienten mit M. Parkinson. Klinische Neurophysiologie. https://doi.org/10.1055/s-0033-1337241
1360. Ellen Poliakoff (2013). Representation of action in Parkinson's disease: Imagining, observing, and naming actions. Journal of Neuropsychology. https://doi.org/10.1111/jnp.12005
1361. Hiroshi Shibasaki, & Mark Hallett (2016). Psychogenic Neurologic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190240974.003.0026
1362. Vedad Delic, Kevin D. Beck, Kevin Pang, & Bruce A. Citron (2020). Biological links between traumatic brain injury and Parkinson’s disease. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-020-00924-7
1363. Mark Lew (2007). Overview of Parkinson's Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.27.12part2.155s
1364. Dominique Flügel (2019). Schlafstörungen im Alter. Praxis. https://doi.org/10.1024/1661-8157/a003171
1365. Masayuki Yokochi (2007). [Mesolimbic and mesocortical pathways in Parkinson disease].. Brain and nerve
1366. Liliam Iris Escariz Borrego, Katiuska Mederos Mollineda, Víctor Modesto Chávez Guerra, & Esvieta Calvo Guerra. (2018). Diagnóstico temprano de la Parálisis Supra Nuclear Progresiva.. Dilemas contemporáneos Educación Política y Valores
1367. Andrew J. Lees (2003). Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. Movement Disorders. https://doi.org/10.1002/mds.10560
1368. Davor Lasić, Maja Mustapić, & Boran Uglešić (2015). Dopamine and cytokines in psychiatric disorders
1369. Bekir Enes Demiryürek, Mustafa Ceykan, Bilgehan Atılgan Acar, Aybala Neslihan Alagöz, & Esra Demiryürek (2016). Progresif Supranükleer Palsi: İki Olgu Sunumu. Journal of Human Rhythm
1370. Ramon Lugo, & Hervé Hubert (2012). Dystonia in Parkinsonian Syndromes. InTech eBooks. https://doi.org/10.5772/31385
1371. Vrutangkumar V. Shah, Gaurav Singh, Sachin Goyal, & Harish J. Palanthandalam‐Madapusi (2014). A Control-System Perspective on Parkinsonian Tremor with Implications on Diagnosis and Disease Monitoring. arXiv (Cornell University)
1372. Iris E. Sommer, Sanne Koops, & Jan Dirk Blom (2012). Comparison of auditory hallucinations across different disorders and syndromes. Neuropsychiatry. https://doi.org/10.2217/npy.12.2
1373. C Njiokiktjien (1994). [Pediatric dysphasia. II. The current concepts of its neurobiological mechanisms].. PubMed
1374. Susan Baser, Timothy Leichliter, Donald Whiting, & Michael Oh (2023). Movement Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.021
1375. Deepak Shrivastava (2022). Is There a Complaint of Depression, Anxiety, Stress, etc.?. CRC Press eBooks. https://doi.org/10.1201/9781003093381-13
1376. Pariwat Thaisetthawatkul, & P. James B. Dyck (2023). Asymmetric Diabetic Neuropathy: Radiculoplexus Neuropathies, Mononeuropathies, and Cranial Neuropathies. Contemporary diabetes. https://doi.org/10.1007/978-3-031-15613-7_10
1377. David Okai, M. Samuel, Sally Askey‐Jones, Anthony S. David, & Richard G. Brown (2011). Impulse control disorders and dopamine dysregulation in Parkinson’s disease: a broader conceptual framework. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2011.03432.x
1378. ECH Lim, Einar Wilder‐Smith, BKC Ong, & Rcs Seet (2005). Adult-onset Re-emergent Stuttering as a Presentation of Parkinson’s Disease. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v34n9p579
1379. Erinne Defriani (2023). Parkinson Disease: Pathophysiology and Histopathological Overview. Sriwijaya Journal of Neurology. https://doi.org/10.59345/sjn.v1i2.81
1380. J. Knoll (1993). The Pharmacological Basis of the Therapeutic Effect of (—)-Deprenyl in Age-Related Neurological Diseases. Milestones in drug therapy. https://doi.org/10.1007/978-3-0348-6348-3_7
1381. Kazushi Takahashi (2013). Non-motor symptoms in premotor phase of Parkinson disease. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.53.974
1382. Nicolas Nicastro (2021). Molecular imaging in degenerative parkinsonisms: windows into the brain. https://doi.org/10.13097/archive-ouverte/unige:148477
1383. Brian Hainline, Lindsey Gurin, & Daniel M. Torres (2019). Unmasking Neuropsychiatric Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0035
1384. Michael I. Good (1989). Substance-Induced Dissociative Disorders and Psychiatric Nosology. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198904000-00003
1385. Zhong Zheng, Ke Zou, Wanjun Guo, Gongshun Tang, & Bo Zheng (2013). A case of early onset Parkinson&amp;#39;s disease after major stress. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s48455
1386. Katsuya Urakami (2016). [Prevention of dementia].. PubMed
1387. John V. Hindle, Siôn Jones, & Glesni Davies (2017). Parkinsonism, Parkinson’s disease, and related conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198701590.003.0116
1388. Marte‐Helene Bjørk, & Malin Eberhard‐Gran (2018). Perinatal Depression in Neurological Disease and Disability. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190667351.003.0034
1389. Hülya Apaydın, J. Eric Ahlskog, Joseph E. Parisi, Bradley F. Boeve, & Dennis W. Dickson (2002). Parkinson Disease Neuropathology. Archives of Neurology. https://doi.org/10.1001/archneur.59.1.102
1390. Freek Nieuwhof (2017). The complexity of walking. Cognitive control of gait in aging and Parkinson's disease
1391. Giulia Menculini, Elena Chipi, Federico Paolini Paoletti, Lorenzo Gaetani, Pasquale Nigro, Simone Simoni, Andrea Mancini, Nicola Tambasco, Massimiliano Di Filippo, Alfonso Tortorella, & Lucilla Parnetti (2021). Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22094440
1392. William W. Ireland (1872). On the Classification and Prognosis of Idiocy. Journal of Mental Science. https://doi.org/10.1192/bjp.18.83.333
1393. David E. Hartman (1984). Neurogenic Dysphonia. Annals of Otology Rhinology & Laryngology. https://doi.org/10.1177/000348948409300114
1394. Т. М. Оstroumova, О. Д. Остроумова, & A. S. Soloveva (2021). Drug-induced parkinsonism. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2021-6-91-97
1395. Rebecca McKnight, Jonathan Price, & John Geddes (2019). Introduction to psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0005
1396. Ritu Soni, Prashant Delvadia, Amit Joharapurkar, & Jigna Shah (2023). Uncovering Novel Therapeutic Targets for Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00084
1397. Julie A. Fields (2017). Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acx085
1398. ‌Barry Reisberg, Steven H. Ferris, Alan Kluger, Emile Franssen, Jerzy Węgiel, & Mony J. de Leon (2007). Mild cognitive impairment (MCI): a historical perspective. International Psychogeriatrics. https://doi.org/10.1017/s1041610207006394
1399. Alfonso González (2005). Fisiopatología y diagnóstico de la anorexia nerviosa y la bulimia
1400. Jonathan Homans, & Katharine J. Nelson (2016). Psychoticism Due to Personality Disorders or Stress-Related Phenomena. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199378067.003.0006
1401. Toshimasa Yamamoto, & Naotoshi Tamura (2012). [Autonomic features in Parkinson disease].. PubMed
1402. Walter Maetzler (2014). Comment: Why do nondopaminergic features in Parkinson disease matter?. Neurology. https://doi.org/10.1212/wnl.0000000000000095
1403. Iva Menjak (2018). Liječenje seksualne disfunkcije
1404. Ying Jiang (2013). Inflammation in Parkinson's Disease (review). Zhongguo kangfu lilun yu shijian
1405. Aubyn Marath, Priya Treesa Thomas, Gargi S. Kumar, Nitish L Kamble, Vikram V. Holla, Ravi Yadav, & Pramod Kumar Pal (2024). Profile, benefits, and barriers in disability certificate for Parkinson’s disease (PD): Insights from a tertiary care center. Annals of Movement Disorders. https://doi.org/10.4103/aomd.aomd_56_24
1406. Verónica Pérez, & Claudia C. Velásquez (2006). Trastorno psicótico compartido en una madre y su hijo de 13 años. Universitas Médica
1407. Ari Bitnun, & Susan E. Richardson (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
1408. Chiara Baston (2015). Motor control system in Parkinson’s disease: a modeling approach. https://doi.org/10.6092/unibo/amsdottorato/7147
1409. Richard Mayeux, Yaakov Stern, Jeffery Rosen, & D. Frank Benson (1983). Is ?subcortical dementia? a recognizable clinical entity?. Annals of Neurology. https://doi.org/10.1002/ana.410140305
1410. 林燕华, 铁璐, 吕爱刚, 姚小皓, 谢文宁, & 李学军 (2006). 脑胰相关蛋白（BPRP）的生物学研究及药物的作用. 中国药理通讯
1411. Alice Cronin‐Golomb (2013). Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: Introduction to the special section on nonmotor dysfunctions in Parkinson's disease.. Behavioral Neuroscience. https://doi.org/10.1037/a0032142
1412. Rakesh Kumar, Meenu Gupta, & Simarpreet Singh (2023). Early Prediction of Parkinson’s Disease using Multiple SVM Classifiers. https://doi.org/10.1109/icscss57650.2023.10169162
1413. Leyi Huang, Renxi Lin, Chunying Zhang, & Ling Lin (2022). Effect of magnesium sulfate on retinal dopaminergic neurons in rats with 6-OHDA-induced Parkinson’s disease. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-1660469/v1
1414. Szabolcs Szatmári, Ben Min-Woo Illigens, Timo Siepmann, Alexandra Pintér, Annamária Takáts, & Dániel Bereczki (2017). Neuropsychiatric symptoms in untreated Parkinson&amp;rsquo;s disease. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s130997
1415. Unknown (1921). TREATMENT. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.s1-2.7.301
1416. Amit Arora (2021). Common neurological diseases in children. Journal of Pediatric Neurological Disorders
1417. N Nagaratnam, & N Pathma‐Nathan (1997). BEHAVIOURAL AND PSYCHIATRIC ASPECTS OF SILENT CEREBRAL INFARCTION. International Journal of Clinical Practice. https://doi.org/10.1111/j.1742-1241.1997.tb11416.x
1418. Stephen G. Kahler, & Michael Fahey (2003). Metabolic disorders and mental retardation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.10018
1419. Bernard Ravina, Karen Marder, Hubert H. Fernandez, Joseph H. Friedman, William M. McDonald, Declan Murphy, Dag Aarsland, Debra Babcock, Jefferey Cummings, Jean Endicott, Stewart A. Factor, Wendy R. Galpern, Andrew J. Lees, Laura Marsh, Mark Stacy, Katrina Gwinn, Valerie Voon, & Christopher G. Goetz (2007). Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group. Movement Disorders. https://doi.org/10.1002/mds.21382
1420. S. Roychowdhury, & Duncan R. Forsyth (2012). Sleep disturbance in Parkinson disease. Journal of Clinical Gerontology and Geriatrics. https://doi.org/10.1016/j.jcgg.2012.04.002
1421. 陈中美, & 彭国光 (2011). 帕金森病的神经精神异常症状. 中华内科杂志. https://doi.org/10.3760/cma.j.issn.0578-1426.2011.03.029
1422. Barbara S. Connolly, & Susan H. Fox (2012). Drug treatments for the neuropsychiatric complications of Parkinson’s disease. Expert Review of Neurotherapeutics. https://doi.org/10.1586/ern.12.142
1423. Timothy R. Nicholson (2018). 10 Functional neurological symptoms. https://doi.org/10.1136/postgradmedj-2018-fpm.10
1424. N. Quinn (1997). Parkinson's disease: clinical features.. PubMed
1425. Laura Pina‐Camacho (2016). Aplicación de técnicas de resonancia magnética al estudio de los trastornos del espectro autista y los trastornos psicóticos
1426. Mehmet Taylan Peköz, Duygu Kurt Gök, Hacer Bozdemir, & Kezban Aslan (2017). Diagnostic Criteria of Parasomnias and Other Paroxysmal Events in Sleep. Turkish Journal of Family Medicine & Primary Care. https://doi.org/10.21763/tjfmpc.318059
1427. W. J. Burke (2010). ASSOCIATION OF ANOSMIA WITH AUTONOMIC FAILURE IN PARKINSON DISEASE. Neurology. https://doi.org/10.1212/wnl.0b013e3181e793fa
1428. Ellie Borrell (2000). Hypokinetic Movement Disorders. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-200010000-00003
1429. Laura Osona-Núñez, Juan A. Guisado, & Marusa Pons (2011). Cognition and Lewy body disease.. PubMed
1430. M. A. Qamar, Anna Sauerbier, Marios Politis, Harry James Carr, Philipp Alexander Loehrer, & К. Ray Chaudhuri (2017). Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?. npj Parkinson s Disease. https://doi.org/10.1038/s41531-016-0006-9
1431. 李文咏 (2009). 精神分裂症的临床识别与社区康复管理. BMJ. https://doi.org/10.3760/cma.j.issn.1671-7368.2009.02.004
1432. Hitoshi Mochizuki, & Yoshikazu Ugawa (2012). Truncal Symptoms and Signs in Parkinson's Disease. Spinal Surgery. https://doi.org/10.2531/spinalsurg.26.293
1433. B. Robottom, William J. Weiner, & Stewart A. Factor (2011). Movement Disorders Emergencies Part 1. Archives of Neurology. https://doi.org/10.1001/archneurol.2011.84
1434. Ruth H. Walker, Harry Spiera, Mitchell F. Brin, & C. Warren Olanow (1999). Parkinsonism associated with Sj�gren's syndrome: Three cases and a review of the literature. Movement Disorders. https://doi.org/10.1002/1531-8257(199903)14:2<262::aid-mds1011>3.0.co;2-6
1435. Florence Thibaut (2018). Psychiatric disorders: neurodevelopmental disorders, neurodegenerative disorders, or both?. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2018.20.4/fthibaut
1436. Leora L. Borek, Melissa M. Amick, & Joseph H. Friedman (2006). Non-Motor Aspects of Parkinson's Disease. CNS Spectrums. https://doi.org/10.1017/s1092852900013560
1437. Craig M. Rodner, Brian A. Tinsley, & Michael O’Malley (2013). Pronator Syndrome and Anterior Interosseous Nerve Syndrome. Journal of the American Academy of Orthopaedic Surgeons. https://doi.org/10.5435/jaaos-21-05-268
1438. Craig M. Rodner, Brian A. Tinsley, & Michael O’Malley (2013). Pronator Syndrome and Anterior Interosseous Nerve Syndrome. Journal of the American Academy of Orthopaedic Surgeons. https://doi.org/10.5435/00124635-201305000-00003
1439. Reijo J. Marttila, & Urpo K. Rinne (1976). DEMENTIA IN PARKINSON'S DISEASE. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1976.tb04375.x
1440. Johannes Hätscher (2015). 2 Die Parkinson-Krankheit und mögliche Therapieformen – eine neurologische Bestimmung. Velbrück Wissenschaft eBooks. https://doi.org/10.5771/9783845277295-23
1441. Patrick McNamara (2011). The Cognitive Neuropsychiatry of Parkinson's Disease. The MIT Press eBooks. https://doi.org/10.7551/mitpress/9780262016087.001.0001
1442. Jeffrey L. Cummings, & Kate Zhong (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
1443. D. Nzamba Nzamba, K. Benallel, J. Salim, M. Gartoum, & M. Kadiri (2022). PSYCHOTIC SYMPTOMS AND PARKINSONS DISEASE: CLINICAL AND THERAPEUTIC ASPECTS. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/15221
1444. Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, & Anastasia Bougea (2023). Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches. Medicina. https://doi.org/10.3390/medicina59101756
1445. David J. Brooks (2022). Neuroimaging Studies in Non-Motor Parkinson’s Disease Symptoms. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.006
1446. A Elavarsi, & Garima Shukla (2017). Sleep Disorders in Parkinson\'s Disease. Indian Journal of Sleep Medicine. https://doi.org/10.5005/jp-journals-10069-0009
1447. Balan Louis Gaspar (2023). Classification of Immune-Mediated Neuropathies. https://doi.org/10.1007/978-981-19-8421-1_16
1448. Barbara Borodziuk, Filip Borodziuk, Katarzyna Ciuba, Paulina Dąbrowska, Michał Żuber, Karol Bochyński, Katarzyna Molenda, Michał Dacka, Kamila Giżewska, & Konrad Białogłowski (2024). Preventing Progression: A Comprehensive Approach to Managing Parkinson's Disease. Quality in Sport. https://doi.org/10.12775/qs.2024.15.52254
1449. Vabren Watts (2013). Depression May Be Linked to Onset of Parkinson’s. Psychiatric News. https://doi.org/10.1176/appi.pn.2013.11b7
1450. Tara L. Lauriat, & J Samson (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
1451. Unknown (2011). Mucopolysaccharidosis type II. SpringerReference. https://doi.org/10.1007/springerreference_41863
1452. Mea A. Weinberg, Stuart L. Segelnick, Joseph S. Insler, & Samuel Kramer (2015). Diseases of the neurological system. https://doi.org/10.1002/9781118991473.ch8
1453. Norman Sartorius (2009). Disability and mental illness are different entities and should be assessed separately. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2009.tb00220.x
1454. Deborah Dewey (2015). Motor Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp562
1455. ChristopherH Hawkes (1995). Diagnosis and treatment of Parkinson's disease. BMJ. https://doi.org/10.1136/bmj.310.6995.1668
1456. Luísa Eugênio Farias, & Esther Serman Castro e Silva (2021). O PRECONCEITO SOFRIDO POR PACIENTES COM DOENÇA DE PARKINSON. Anais do II Congresso Brasileiro de Saúde On-line. https://doi.org/10.51161/rems/1452
1457. Seungbeom Seo, S W Kim, Sung-Phil Kim, Jaeho Kim, Suk Yun Kang, & Dongil Chung (2024). Low-frequency EEG power and coherence differ between drug-induced parkinsonism and Parkinson’s disease. Clinical Neurophysiology. https://doi.org/10.1016/j.clinph.2024.10.013
1458. Elvira Bramon, & Robin Murray (2001). A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2001.3.4/ebramon
1459. Adeel Ilyas, Mariel Szapiel, & Paul M. Foreman (2022). Kernohan’s notch phenomenon: A paradoxical neurological finding. Journal of Clinical Images and Medical Case Reports. https://doi.org/10.52768/2766-7820/1939
1460. H.‐M. Meinck, & P Ringleb (2007). B 2.9.1 Vorbemerkung
1461. Ioana Zosin (2004). POLYGLANDULAR AUTOIMMUNE SYNDROMES (PGA)
1462. Aleksandra Gałuszka (2021). Znaczenie wsparcia dla funkcjonowania psychofizycznego osób opiekujących się bliskimi z chorobą Alzheimera. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2021.11.12.016
1463. Marc R. Del Bigio (2021). Neuronal Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.030
1464. Silvana Riggio, Zorica Filipovic‐Jewell, & Devendra S. Thakur (2016). Neuropsychiatric Illnesses. https://doi.org/10.1002/9781118654231.ch19
1465. Júlia Ballester Plané (2018). Beyond the motor impairment in dyskinetic cerebral palsy: neuropsychological and connectome-based approach. TDX (Tesis Doctorals en Xarxa)
1466. Marie Saint‐Hilaire, & Theresa Ellis (2013). A prescription for physical therapy and exercise in Parkinson’s disease. Advances in Parkinson s Disease. https://doi.org/10.4236/apd.2013.24023
1467. Carlotta Spagnoli, Carlo Fusco, & Francesco Pisani (2023). Pediatric-Onset Epilepsy and Developmental Epileptic Encephalopathies Followed by Early-Onset Parkinsonism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043796
1468. Stephen L. Brown (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
1469. Stanley Fahn, Paul Greene, Blair Ford, & Susan Bressman (2003). Movement Disorders. https://doi.org/10.1007/978-1-4757-4552-8_9
1470. David Booth (1981). Hunger and satiety as conditioned reflexes.. PubMed
1471. Ankit Anand, Nithin Bolishetti, Boyapati.Sri Navya Teja, Sharadindu Adhikari, Ikramuddin Ahmed, & Janani Natarajan (2022). Neurodegenerative Disorder of Ageing using Neural Networks. 2022 International Conference on Applied Artificial Intelligence and Computing (ICAAIC). https://doi.org/10.1109/icaaic53929.2022.9793136
1472. W. A. Sibley (1974). Diagnosis and Treatment of Epilepsy: Overview and General Principles. PEDIATRICS. https://doi.org/10.1542/peds.53.4.531
1473. R. A. Marriott (2018). Relationship between physical illness and affective disorders. CRC Press eBooks. https://doi.org/10.1201/9781315382913-9
1474. Monique Giroux (2007). Parkinson disease: managing a complex, progressive disease at all stages.. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.74.5.313
1475. William A. Smith (1926). RESPIRATORY DISTURBANCES FOLLOWING EPIDEMIC ENCEPHALITIS. Archives of Neurology And Psychiatry. https://doi.org/10.1001/archneurpsyc.1926.02200230082008
1476. Minqing Jiang (2022). Neural circuits underlying motor and non-motor defects of Parkinson’s disease. The Innovation. https://doi.org/10.1016/j.xinn.2022.100308
1477. Sílvia Alonso-Lana (2016). El Trastorno Bipolar: Cambios cerebrales asociados con el estado de ánimo y el deterioro cognitivo. TDX (Tesis Doctorals en Xarxa)
1478. Longping Yao, Jiayu Wu, Sümeyye Koç, & Guohui Lu (2021). Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2021.655819
1479. Unknown (2005). Cognitive impairment. CRC Press eBooks. https://doi.org/10.1201/b14478-9
1480. Pippa Medcalf (2005). Good practice in the assessment and management of nocturnal Parkinson’s disease symptoms. Age and Ageing. https://doi.org/10.1093/ageing/afi157
1481. N Ogawa, & A. Mori (1995). Parkinson’s disease, dopamine and free radicals. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7337-6_28
1482. Poluéktov Mg (2011). [Primary and secondary insomnias and sleep related breathing disturbances].. PubMed
1483. Andrew Beaumont (2008). Seizures in Renal and Hepatic Failure and Endocrine Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-841-0_6
1484. Józef Kocur, & Wiesława Trendak (2009). Double diagnosis and forensic psychiatric opinion. Psychiatria Polska
1485. Douglas A. Thom (1927). INFANTILE CONVULSIONS: THEIR FREQUENCY AND IMPORTANCE. American Journal of Psychiatry. https://doi.org/10.1176/ajp.83.4.613
1486. Sara Bakay, Sophie Béchet, Aude Barjona Morgado De Moura, Valérie Delvaux, Éric Salmon, & Gaëtan Garraux (2011). La demence chez le patient parkinsonien: facteurs de risque, diagnostic et traitement.. RMLG. Revue médicale de Liège
1487. Clémence Leung (2019). Evaluation de la plainte cognitive dans la maladie de Parkinson
1488. Jean-Émile Vanderheyden, & Dominique-Jean Bouilliez (2010). Traiter le Parkinson. Questions de personne. https://doi.org/10.3917/dbu.vande.2004.01
1489. Natália Pessoa Rocha, Helton José Reis, Pieter Vanden Berghe, & Carla Cirillo (2014). Depression and Cognitive Impairment in Parkinson's Disease: A Role for Inflammation and Immunomodulation?. NeuroImmunoModulation. https://doi.org/10.1159/000356531
1490. Christian Derouesné (2006). Dementia with Lewy bodies: third report of DLB consortium. Gériatrie et Psychologie Neuropsychiatrie du Viellissement
1491. Golubtsova Li, Vasil'chenko Gs, & Polishchuk IuI (1988). Sexual disorders in women with slowly progressing schizophrenia. Zhurnal Nevropatologii I Psikhiatrii Imeni S S Korsakova
1492. Kazutaka Jin, N Sato, Kinya Hisanaga, Hidekazu Suzuki, & Hiroshi Mochizuki (2000). [Diffuse Lewy body disease searched out from 114 patients with parkinsonism].. PubMed
1493. Dmitry M. Arbuck (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 1). Current psychiatry. https://doi.org/10.12788/cp.0242
1494. Margaret E. Flanagan, Joshua A. Sonnen, C. Dirk Keene, Robert F. Hevner, & Thomas J. Montine (2017). Molecular Basis of Diseases of the Nervous System. Molecular Pathology. https://doi.org/10.1016/b978-0-12-802761-5.00029-8
1495. Dr Adam Darowski (2008). How does neurological disease cause falls?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199541287.003.0013
1496. C P Jedynak, Evelyne Diarra, & Marc Verny (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
1497. Muniba Fayyaz, Syeda S Jaffery, Fatima Anwar, Ahsan Zil‐E‐Ali, & Ibrar Anjum (2018). The Effect of Physical Activity in Parkinson’s Disease: A Mini-Review. Cureus. https://doi.org/10.7759/cureus.2995
1498. C. Krause, S. Henschel, J. Höppner, & D. Schläfke (2004). Das maligne neuroleptische Syndrom (Rostock). Steinkopff eBooks. https://doi.org/10.1007/978-3-7985-1957-2_61
1499. J. L. Juncos (1999). Management of psychotic aspects of Parkinson's disease.. PubMed
1500. Ohoud Turkistani, Ali Albalawi, Razan Khalid Thabit, Hatim Alamri, Norah Alshehri, Shahad Alsufyani, Alia Al Qahtani, Nazik Mohammed, Alaa Althemairi, Laila Ashour, & Osamah Alsuwilem (2023). Relationship Between Sleep Disorders and Mental Health. Journal of Healthcare Sciences. https://doi.org/10.52533/johs.2023.30601
1501. D E Baxter (1993). Functional nerve disorders in the athlete's foot, ankle, and leg.. PubMed
1502. Rao Fu, & Xiaoguang Luo (2013). Mild cognitive impairment in Parkinson's disease. Zhongguo xiandai shenjing jibing zazhi. https://doi.org/10.3969/cjcnn.v13i8.780
1503. Aimé Parra Legarreta (2025). Evolución clínica del síndrome depresivo anhedónico secundario a disfunción metabólica cerebral sin diagnóstico ni tratamiento. https://doi.org/10.31234/osf.io/6e7uj_v1
1504. Díaz Garrido, & Luis David (2019). Neurocirugía funcional y estereotáxica en la enfermedad de Parkinson
1505. Sujata Das, Amar Kumar Misra, Aparna Dutt, & Shyamal Kumar Das (2004). Cognition In Parkinsonian Syndromes : A Review. Annals of Indian Academy of Neurology
1506. Pradeep C. Bollu, & Pradeep Sahota (2018). Sleep and Parkinson Disease.. PubMed
1507. 葛原 茂樹 (1994). Parkinson's disease.Advance in diagnosis and treatment.2.Advance in pathosis and diagnosis.5.Various diseases presenting parkinsonism.. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.83.559
1508. Dag Aarsland, Kenn Freddy Pedersen, Uwe Ehrt, Kolbjørn Brønnick, Michaela D Gjerstad, & Jan Larsen (2008). [Neuropsychiatric and cognitive symptoms in Parkinson disease].. PubMed
1509. Bruce L. Miller (2013). Related Disorders: FTD-ALS. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380491.003.0005
1510. Marni J. Falk, & Megan A. Moreno (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
1511. Unknown (2019). Dysautonomia. Definitions. https://doi.org/10.32388/267274
1512. Tanja Kuhlmann (2013). Relapsing–remitting and primary progressive MS have the same cause(s)- the neuropathologist’s view: 2. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458513476563
1513. Günther Deuschl (2008). Notfälle bei Patienten mit Bewegungsstörungen - Komplikationen auf dem Gebiet extrapyramidaler Erkrankungen. Notfall & Hausarztmedizin. https://doi.org/10.1055/s-2008-1061614
1514. Patricia A. Trimmer, Jeremy B. Tuttle, Jason P. Sheehan, & James P. Bennett (1996). Mechanisms of Selective Neuronal Vulnerability to 1-Methyl-4-Phenylpyridinium (MPP+) Toxicity. Neurodegenerative Diseases. https://doi.org/10.1007/978-1-4899-0209-2_53
1515. H. Doose (1992). Myoclonic-astatic epilepsy.. PubMed
1516. Adel Ekladious, & Ramana Waran (2022). Emergencies in Parkinsonism. Annals of Clinical and Medical Case Reports. https://doi.org/10.47829/acmcr.2022.8901
1517. 王小川, & 张家兴 (2007). 帕金森病记忆功能障碍及机制. Chin J Neurol. https://doi.org/10.3760/j.issn:1006-7876.2007.12.024
1518. Peter Bekkhus‐Wetterberg, Anne Brækhus, Ebba Gløersen Müller, Monica Irene Norvik, Ingvild Elisabeth Winsnes, & Torgeir Bruun Wyller (2022). Primary progressive aphasia. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.22.0100
1519. 田丸 冬彦 (1994). Parkinson's disease.Advance in diagnosis and treatments.2.Advance in pathosis and diagnosis.4.Dementia and mental disorder in Parkinson's disease and pathophysiology.. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.83.555
1520. Ricardo Kaempf de Oliveira, Rafael Pêgas Praetzel, Leohnard Roger Bayer, Paulo Henrique Ruschel, Augusto Heinen, & Pedro J. Delgado (2017). Lesión del nervio cubital tras fractura cerrada de antebrazo – dos casos clínicos. Revista Iberoamericana de Cirugía de la Mano. https://doi.org/10.1055/s-0037-1606284
1521. G Himaja, C R Nagarathna, A Jayasri, & K M Kundan (2024). Prediction of Parkinson’s Disease using Handwriting Analysis and Voice Dataset- A Review. Journal of Innovative Image Processing. https://doi.org/10.36548/jiip.2024.2.004
1522. Jonathan H. Pincus, & G Tucker (2002). Disorders of Cognitive Function. Behavioral Neurology. https://doi.org/10.1093/oso/9780195137811.003.0004
1523. Sahil Mehta (2022). Cardiovascular autonomic dysfunction in idiopathic Parkinson's disease. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_704_22
1524. Нодель Марина Романовна, & Н Н Яхно (2009). Нервно-психические нарушения при болезни Паркинсона. Неврология, нейропсихиатрия, психосоматика
1525. Lawrence T. C. Ong, Gary Galambos, & David A. Brown (2017). Primary Sjogren’s Syndrome Associated With Treatment-Resistant Obsessive–Compulsive Disorder. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2017.00124
1526. Georgina Casey (2013). Parkinson's disease: a long and difficult journey.. PubMed
1527. Inmaculada Peñuelas‐Calvo, J. Sevilla Llewellyn-Jones, Chiara Cervesi, Aditya Sareen, & A. González Moreno (2016). The importance of establishing a good differential diagnosis in bipolar disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1182
1528. Nuno Zarcos Palma, Mariana da Cruz, Lígia Rodrigues Santos, Margarida Cruz, Filipe Cunha, Vítor Fagundes, Lindora Pires, & Mari Mesquita (2020). Autoimmune polyendocrine syndrome type II: After adrenal crisis. Case Reports in Internal Medicine. https://doi.org/10.5430/crim.v7n2p3
1529. Rajesh Pahwa, & William C. Koller (1993). Is There a Relationship Between Parkinsonʼs Disease and Essential Tremor?. Clinical Neuropharmacology. https://doi.org/10.1097/00002826-199302000-00003
1530. P. Mounika, & S Govinda Rao (2021). A Study On Deep Learning And Machine Learning Techniques On Detection Of Parkinson’s Disease. E3S Web of Conferences. https://doi.org/10.1051/e3sconf/202130901008
1531. Richard A. Hughes (2008). Peripheral nerve diseases: THE BARE ESSENTIALS. Practical Neurology. https://doi.org/10.1136/jnnp.2008.162412
1532. 長谷川一子 (2007). ≪パーキンソン病に伴う非運動障害とその治療≫ Braak 分類とパーキンソン病周辺症状. 内科
1533. M.J. Gordillo Montaño, S. Ramos Perdigues, C. Merino del Villar, Carine Roy, S. Latorre, M. Guisado Rico, A. Bravo Romero, S.V. Boned Torres, & Mariela Rincón (2017). Confusion between symptom and disease. Parkinson vs meningioma. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.605
1534. A.–S. Kiang, & Andrea Amalfitano (2007). Progress and problems when considering gene therapy for GSD-II.. PubMed
1535. Daniel O. Claassen, Keith A. Josephs, J. Eric Ahlskog, Michael H. Silber, Maja Tippmann‐Peikert, & Bradley F. Boeve (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. https://doi.org/10.1212/wnl.0b013e3181ec7fac
1536. Byeong-Jun Park (2009). A Research on 7 Cases of the Treatment Process for Patients with Idiopathic Parkinson's Disease or Parkinsonism. Journal of Oriental Neuropsychiatry
1537. Takashi Nomura, Yuki Nomura, Masayoshi Oguri, Yasuaki Hirooka, & Ritsuko Hanajima (2020). Olfactory function deteriorates in patients with Parkinson's disease complicated with REM sleep behavior disorder. eNeurologicalSci. https://doi.org/10.1016/j.ensci.2020.100261
1538. Gabriel González-Medina, & Alfredo Cerisola (2002). Primera convulsión en apirexia. Archivos de Pediatría del Uruguay
1539. Monali Sardar (2021). Samprapti of Kampavata. National Journal of Research in Ayurved Science. https://doi.org/10.52482/ayurlog.v9i02.847
1540. Eric Molho, & Stewart A. Factor (2007). Psychosis. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:49
1541. Susan H. Fox, & Marina Picillo (2016). “I See Them Sitting on My Bed, Doctor”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190607555.003.0012
1542. Jorge Cuevas‐Esteban (2018). Parkinsonismo, depresión, demencia: Un reto clínico y terapeútico. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús
1543. Анжела Шупрович, & О.В. Zinych (2022). Nervous-mental stress and cognitive disorders as components of stress state in type 2 diabetic patients. Clinical endocrinology and endocrine surgery. https://doi.org/10.30978/cees-2022-2-61
1544. Giuseppe Bellelli, Rosamaria Moresco, Paola Panina–Bordignon, Beatrice Arosio, Cecilia Gelfi, Alessandro Morandi, & Matteo Cesari (2017). Is Delirium the Cognitive Harbinger of Frailty in Older Adults? A Review about the Existing Evidence. Frontiers in Medicine. https://doi.org/10.3389/fmed.2017.00188
1545. Richard L. Doty, & Christopher H. Hawkes (2022). Olfactory Dysfunction in Parkinson’s Disease and Related Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.011
1546. Unknown (2019). Epilepsy. Definitions. https://doi.org/10.32388/025983
1547. Francisco de Assis Muniz de Oliveira, Ricardo Frederico Gadelha Néo Filho, Layra Christina de Souza Rabelo, Ellen Vitória Rodrigues de Lima Freire, Kaline Malu Gerônimo Silva dos Santos, Ana Karolina Alves Brito, Nágela de Oliveira Mendes, Diogo dos Santos Viotti Bernardes, & Douglas Ribeiro de Sá (2024). CORRELAÇÃO ENTRE O DECLÍNIO COGNITIVO E ANSIEDADE EM PACIENTES COM DOENÇA DE PARKINSON. Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida. https://doi.org/10.36692/v16n2-109r
1548. Patricia Mulero, Elisa Cortijo García, & Javier Marco Llorente (2012). Abordaje terapéutico de los síntomas no motores de la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.54s05.2012536
1549. Belinda Lennox (2008). Neurocognition of depression. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198569275.003.0021
1550. Andy J. Wills (2006). The neurology of enteric disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.085365
1551. Dr P. Kishore (2019). Sleep Disorders in Parkinson’s Disease. Journal of Medical Science And clinical Research. https://doi.org/10.18535/jmscr/v7i11.24
1552. Masayuki Tani, & Akira Iwanami (2013). [Disorder of train of thought in the elderly].. PubMed
1553. Wawan Nurmansyah, & Sri Hartati (2014). Prototipe Sistem Pakar Penentu Jenis Gangguan Psikologi Klinis Menggunakan Forward Chaining dan Formula Bayes
1554. Nataliya Titova, Pablo Martínez‐Martín, Е А Катунина, & К. Ray Chaudhuri (2017). Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed. Journal of Neural Transmission. https://doi.org/10.1007/s00702-017-1799-3
1555. Thamara De Lima Benjamim, Adelina Amorim, Evelyn Soares Tenreiro, Nathalia Da Silva Araujo Mendes, Vanessa Santos, & Leila Darwichi Abbud Mustaphá (2024). CONDUTAS FISIOTERAPÊUTICAS NA MARCHA DOS PACIENTES COM DOENÇA DE PARKINSON: REVISÃO DE LITERATURA. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. https://doi.org/10.47820/recima21.v5i1.6048
1556. Emanuele Spina, Paolo Barone, Lucia Luciana Mosca, Rosanna Forges Davanzati, Agnese Lombardi, Katia Longo, Alessandro Iavarone, & Marianna Amboni (2016). Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single‐Blinded Study. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.14295
1557. Rok Berlot, Anđela Pavlović, & Maja Kojović (2024). Secondary parkinsonism associated with focal brain lesions. Frontiers in Neurology. https://doi.org/10.3389/fneur.2024.1438885
1558. E. Roulet, Thierry Deonna, Frank Gaillard, Claire Peter-Favre, & Paul‐André Despland (1991). Acquired Aphasia, Dementia, and Behavior Disorder with Epilepsy and Continuous Spike and Waves During Sleep in a Child. Epilepsia. https://doi.org/10.1111/j.1528-1157.1991.tb04683.x
1559. Steven Lehrer, & Peter H. Rheinstein (2022). Shingles vaccination reduces the risk of Parkinson's disease. Chronic Diseases and Translational Medicine. https://doi.org/10.1002/cdt3.50
1560. Solveig E J Dalbro, & Emı́lia Kerty (2024). Synsvansker ved Parkinsons sykdom. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.23.0716
1561. Youlin Zhu (2012). Advance of Susceptible Genes of Parkinson Disease. Medical Recapitulate
1562. Ulla Ellfolk (2014). Neurocognitive changes in early-stage Parkinson's disease : functional and structural brain correlates of memory and verbal functions
1563. Richard Mayeux, Yaakov Stern, Jeffery Rosen, & D. Frank Benson (1983). Elongated styloid process.. Annals of Neurology. https://doi.org/10.1111/j.1365-2044.1959.tb02436.x
1564. Shi Jian-shen (2012). Role of Neuronal Apoptosis in Parkinson Disease. Medical Recapitulate
1565. Johan Hagman, & Pernilla Hansson (2005). Parkinsons sjukdom - Inte bara ett fysiskt funktionshinder
1566. Β.N. Brooke, & David R. Cave (1973). Radiological pseudotumour in chronic ulcerative colitis.. BMJ. https://doi.org/10.1136/bmj.1.5848.293-c
1567. Casper Skjærbæk, Karoline Knudsen, Jacob Horsager, & Per Borghammer (2021). Gastrointestinal Dysfunction in Parkinson’s Disease. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10030493
1568. Franklin S. Dubois (1949). COMPULSION NEUROSIS WITH CACHEXIA (ANOREXIA NERVOSA). American Journal of Psychiatry. https://doi.org/10.1176/ajp.106.2.107
1569. João Vitor Martins Bernal da Silva, & Isabella Helena Ferreira Duarte (2022). RELEVÂNCIA DO TRATAMENTO FISIOTERAPÊUTICO EM PACIENTES PORTADORES DE PARKINSON. Anais do I Congresso Brasileiro de Saúde Pública On-line: Uma abordagem Multiprofissional. https://doi.org/10.51161/rems/3307
1570. Akio Kikuchi (2023). Dysphagia in Parkinsonʼs Disease. Higher Brain Function Research. https://doi.org/10.2496/hbfr.43.200
1571. Vicente Arturo López Cortés (2018). Características neuropsicológicas de pacientes con enfermedad de Parkinson sin demencia. https://doi.org/10.14201/gredos.139596
1572. Shin-Yuan Chen, & Sheng‐Tzung Tsai (2010). The Epidemiology of Parkinson's Disease. Tzu Chi Medical Journal. https://doi.org/10.1016/s1016-3190(10)60044-4
1573. Jess G. Fiedorowicz, & Donald W. Black (2010). Borderline, Bipolar, or Both? Frame Your Diagnosis on the Patient History. Current psychiatry
1574. Dariusz Wieczorek, Emilia J. Sitek, Jan Wójcik, & Jarosław Sławek (2013). Łagodne zaburzenia funkcji poznawczych i otępienie w chorobie Parkinsona — obraz kliniczny i aktualne kryteria diagnostyczne. Polski Przegląd Neurologiczny
1575. Hiroshi Fujioka, T Uozumi, Yasushi Miyagi, & Eiichirou Urasaki (2019). Off‐period status dystonicus in Parkinson’s disease treated with deep brain stimulation: A case report. Neurology and Clinical Neuroscience. https://doi.org/10.1111/ncn3.12352
1576. Paul E. Youssef (2022). Childhood Neurologic Conditions: Movement Disorders.. PubMed
1577. Heiko Braak, & Kelly Del Tredici (2005). Presymptomatic and Symptomatic Stages of Intracerebral Inclusion Body Pathology in Idiopathic Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-852-6_20
1578. Barry Oken (2003). Non-prescription and non-pharmacological therapies for dementia. CRC Press eBooks. https://doi.org/10.3109/9780203494578-29
1579. Dana Končelíková (2022). Sleep disorders in affective disorders. Psychiatrie pro praxi. https://doi.org/10.36290/psy.2022.030
1580. Andrea M. Auther, Dodie A. Gillett, & Barbara A. Cornblatt (2008). Expanding the Boundaries of Early Intervention for Psychosis: Intervening During the Prodrome. Psychiatric Annals. https://doi.org/10.3928/00485713-20080801-02
1581. D Perk (1956). The heart, the physician and the psychiatrist.. PubMed
1582. J.M. Léger, & François Salachas (2001). Diagnosis of motor neuropathy. European Journal of Neurology. https://doi.org/10.1046/j.1468-1331.2001.00136.x
1583. Holger Ejgil Pedersen, & Erik Birket-Smith (2009). NEUROLOGICAL ABNORMALITIES IN PHENYLKETONURIA. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1974.tb02804.x
1584. Khurana N Kaur Kumar R (2023). THERAPEUTIC POTENTIAL OF VARIOUS PHYTOCHEMICALS IN THE MANAGEMENT OF PARKINSON'S DISEASE. International Journal of Biology Pharmacy and Allied Sciences. https://doi.org/10.31032/ijbpas/2023/12.2.6828
1585. Mitsutoshi Yamamoto (2004). [Depression in Parkinson's disease].. PubMed
1586. Robert D. Nass (1992). Developmental Dyslexia: An Update. Pediatrics in Review. https://doi.org/10.1542/pir.13-6-231
1587. Nobuko Kawakami, & Shigenori Kanno (2023). 原発性進行性失語 (PPA) と聴覚障害─自験例をふまえて─. Higher Brain Function Research. https://doi.org/10.2496/hbfr.43.161
1588. Bonnie Levin, & Heather Katzen (2005). Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease.. PubMed
1589. Jill Parnham (2008). Diagnosis and management of Parkinson's disease: what the NICE guidelines say, and why
1590. Adriana E. Groisman, & Martha L. Seminatore (2003). Children and Adolescents Who Have Schizophrenia. Pediatrics in Review. https://doi.org/10.1542/pir.24.10.356
1591. Isabel Pareés, Tabish A. Saifee, Maja Kojović, Panagiotis Kassavetis, Ignacio Rubio‐Agusti, Anna Sadnicka, Kailash P. Bhatia, & Mark J. Edwards (2013). Functional (psychogenic) symptoms in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.25544
1592. Saucier Rp (1984). Panic attacks and generalized anxiety states.. PubMed
1593. Margaret Prenger, Racheal Madray, Kathryne Van Hedger, Mimma Anello, & Penny A. MacDonald (2020). Social Symptoms of Parkinson’s Disease. Parkinson s Disease. https://doi.org/10.1155/2020/8846544
1594. Ilia Bountouni, Panagiotis Zis, К. Ray Chaudhuri, & Anette Schrag (2014). Psychosis in Parkinson’s Disease. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-09537-0_6
1595. Peter J. Nestor (2010). 007 Mild cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.217554.7
1596. J. Eric Ahlskog (2005). Thinking, Memory, and Dementia. https://doi.org/10.1093/oso/9780195171938.003.0023
1597. Alexandra M. Villagran, & Michael K. Scullin (2019). Sleep Disorders and Neurocognition. https://doi.org/10.1093/oxfordhb/9780190664121.013.16
1598. Ángel de Jesús Laureani Fierro, Sandra Yasbeth Lara Aparicio, Consuelo Morgado‐Valle, Luis Beltrán‐Parrazal, Luis I. García, María Elena Hernández‐Aguilar, Jorge Manzo, & César Antonio Pérez-Estudillo (2022). Trastornos de las neuronas motoras: causas, síntomas, factores de riesgo, diagnósticos y tratamientos. eNeurobiología. https://doi.org/10.25009/eb.v13i31.2599
1599. Jeffrey Alexander (2001). Depressed men: an exploratory study of close relationships. Journal of Psychiatric and Mental Health Nursing. https://doi.org/10.1111/j.1365-2850.2001.00354.x
1600. Jeffrey Alexander (2001). Depressed men: an exploratory study of close relationships. Journal of Psychiatric and Mental Health Nursing. https://doi.org/10.1046/j.1365-2850.2001.00354.x
1601. Dan Ziegler (2024). Peripheral neuropathy in diabetes (part 1). Deleted Journal. https://doi.org/10.1007/s11428-023-01137-x
1602. Olivier Rascol, Pierre Payoux, Fabienne Ory, Joaquim J. Ferreira, Christine Brefel‐Courbon, & Jean‐Louis Montastruc (2003). Limitations of current Parkinson's disease therapy. Annals of Neurology. https://doi.org/10.1002/ana.10513
1603. 小路純央, & ほか (2009). 第二世代抗精神病薬の脳器質性・症状性精神障害への応用―せん妄・高次脳機能障害などへの適応拡大の可能性―. 臨床精神薬理
1604. Cláudia Theis, Gabriela Schelle, Isaac F. Correa Neto, K. F. Viana, Lia Nishikawa, Gabriel Fiorot Cruz Sperandio, & Laércio Robles (2022). USO DA LUBIPROSTONA EM PACIENTES PORTADORES DE DOENÇA DE PARKINSON. Journal of Coloproctology. https://doi.org/10.1055/s-0043-1764845
1605. 李琳, & 李备 (2013). 治疗帕金森病 应充分发挥中医特色——记广东省中医院神经内科连新福主任. 中国科技成果
1606. M. M. Alberto Pestano, Dayra Hernández Marrero, Bárbara Acosta Acosta, & José Luis Delgado Miranda (2021). La ptosis no orgánica; a propósito de un trastorno conversivo
1607. Daniela Berg, & Alexandra Gaenslen (2010). Place Value of Transcranial Sonography in Early Diagnosis of Parkinson’s Disease. Neurodegenerative Diseases. https://doi.org/10.1159/000314494
1608. Eldbjørg Hustad, & Jan Aasly (2020). Clinical and Imaging Markers of Prodromal Parkinson's Disease. Frontiers in Neurology. https://doi.org/10.3389/fneur.2020.00395
1609. Tamara Diesch, & David Mellor (2013). Birth transitions: Pathophysiology, the onset of consciousness and possible implications for neonatal maladjustment syndrome in the foal. Equine Veterinary Journal. https://doi.org/10.1111/evj.12120
1610. Habib Rehman (2000). Progressive supranuclear palsy. Postgraduate Medical Journal. https://doi.org/10.1136/pmj.76.896.333
1611. Norlinah Mohamed Ibrahim, Kailash P. Bhatia, Karen Østergaard, Robin Howard, Gennarina Arabia, & Niall Quinn (2007). Primary lateral sclerosis mimicking atypical parkinsonism. Movement Disorders. https://doi.org/10.1002/mds.21645
1612. Pedro Chaná, & Carlos Júri (2007). Déficit de la olfacción en la enfermedad de Parkinson: Un síntoma a considerar en la práctica clínica. REVISTA MÉDICAS UIS
1613. Rohit K B Dinesh, P Surya, & B. Priya (2022). Detection Approach Using Machine Learning for Parkinson's Disease. 2022 1st International Conference on Computational Science and Technology (ICCST). https://doi.org/10.1109/iccst55948.2022.10040313
1614. Luciano Magalhães Melo, Egberto Reis Barbosa, & Paulo Caramelli (2007). Declínio cognitivo e demência associados à doença de Parkinson: características clínicas e tratamento. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832007000400003
1615. Mary-Frances E. Hall, & Frank Church (2020). Integrative Medicine and Health Therapy for Parkinson Disease. Topics in Geriatric Rehabilitation. https://doi.org/10.1097/tgr.0000000000000278
1616. Umar Shuaib, Adam Margolius, & Hubert H. Fernandez (2022). Non-Motor Symptoms in Late-Stage Parkinson’s Disease. Cambridge University Press eBooks. https://doi.org/10.1017/9781009039291.004
1617. William C. Koller (1983). Alcoholism in essential tremor. Neurology. https://doi.org/10.1212/wnl.33.8.1074
1618. José Luiz Pedroso, Clécio Godeiro‐Júnior, André C. Felício, Antônio Carlos Martins Maia, Camila Aquino, Larissa Teles de Souza, & Orlando Graziani Póvoas Barsottini (2008). Multi-lacunar strokes mimicking atypical parkinsonism with an unusual neuroimaging presentation: état criblé. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2008000600030
1619. J. Lobo-Antunes, & Carlos A. Macedo (1971). Psychiatric aspects inParkinsonism treated withL-dopa
1620. J. Eric Ahlskog (2020). Considerations for trials of disease modifying treatments in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0000000000009127
1621. Douglas S. Goodin (2006). Physical Trauma, Psychological Stress, and Multiple Sclerosis. https://doi.org/10.1093/oso/9780195170320.003.0037
1622. Caroline Moreau (2008). Etude des troubles axiaux dans la maladie de Parkinson évoluée, Effet des fréquences de stimulation des noyaux subthalamiques sur les troubles de la marche
1623. Henry A. Nasrallah (2009). Diagnosis 2.0 Are Mental Illnesses Diseases, Disorders, or Syndromes? A Major Challenge for the DSM-V Committees as They Revise the Diagnostic "Bible" of Psychiatric Disorders Is to Determine Whether Mental Illnesses Are Diseases, Disorders, or Syndromes. Current psychiatry
1624. Hélène Verdoux, & Anne‐Laure Sutter (2002). Perinatal risk factors for schizophrenia: Diagnostic specificity and relationships with maternal psychopathology. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.10906
1625. Mariavittoria Favaro, Sofia Mauri, Greta Bernardo, Mauro Agostino Zordan, G. Mazzotta, & Elena Ziviani (2024). Usp14 down-regulation corrects sleep and circadian dysfunction of a Drosophila model of Parkinson’s disease. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1410139
1626. 유영경 (2017). 파킨슨병에서 환삼덩굴 추출물의 효능에 관한 연구
1627. Giovanna Barros Gonçalves, & João Santos Pereira (2013). Trastorno de la marcha en la enfermedad de Parkinson: freezing y perspectivas actuales. Revista médica de Chile. https://doi.org/10.4067/s0034-98872013000600010
1628. David J. Burn, & Alexander I. Tröster (2004). Neuropsychiatric Complications of Medical and Surgical Therapies for Parkinson’s Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988704267466
1629. Raudah Novita Putri, & Intan Sahara Zein (2023). Parkinson Disease. Jurnal Lmu Farmasi dan Kesehatan/. https://doi.org/10.59841/an-najat.v1i4.556
1630. David Maltête, Lou Grangeon, Floriane Le Goff, Gülden Özel, Damien Fetter, Patrick Ahtoy, Olivier Temgoua, Audrey Rouillé, & Romain Lefaucheur (2017). Four Cases of Parkinson Disease Diagnosed During the Postpartum Period. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000002066
1631. Kenichi Kashihara (2015). IV. Management of Dementia in Parkinson's Disease. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.104.1565
1632. Geert Jan Biessels (2023). Brain Changes in Diabetes and Cognitive Dysfunction. Contemporary diabetes. https://doi.org/10.1007/978-3-031-15613-7_21
1633. B Jorge Michalland, & Artículo De Investigación (2008). Estudio del deterioro cognitivo temprano entre enfermos de Mal de Parkinson sin demencia Study of early cognitive deterioration between Parkinson disease patients without dementia
1634. Unknown (2014). Melatonin’s Neuroprotective Role in Parkinson’s Disease. CRC Press eBooks. https://doi.org/10.1201/b17448-21
1635. Sarah‐Naomi James, Anna‐Sophie Rommel, Frühling Rijsdijk, Giorgia Michelini, Gráinne McLoughlin, Daniel Brandeis, Tobias Banaschewski, Philip Asherson, & Jonna Kuntsi (2018). Is Association of Preterm Birth with Cognitive-Neurophysiological Impairments and ADHD Symptoms Consistent with a Causal Inference or Due to Familial Confounds?. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3234868
1636. Sarah‐Naomi James, Anna‐Sophie Rommel, Frühling Rijsdijk, Giorgia Michelini, Gráinne McLoughlin, Daniel Brandeis, Tobias Banaschewski, Philip Asherson, & Jonna Kuntsi (2018). Is Association of Preterm Birth with Cognitive-Neurophysiological Impairments and ADHD Symptoms Consistent with a Causal Inference or Due to Familial Confounds?. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3228917
1637. David K. Johnson, James E. Galvin, & Martha Storandt (2012). P3‐080: Mild cognitive impairment in Parkinson's disease dementia. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.1299
1638. Daiva Milmantienė (2024). Treatment Tactics for Psychosis in Parkinson’s Disease: A Literature Review. Neurologijos seminarai. https://doi.org/10.15388/ns.2024.28.99.4
1639. Maud Ranchet, Isabelle Hoang, Maxime Cheminon, Romain Derollepot, Hannes Devos, Stéphane Perrey, Jacques Luauté, Téodor Danaila, & Laurence Paire‐Ficout (2019). Mesure de l'activité cérébrale pendant la marche dans la maladie de Parkinson
1640. Elan D. Louis (2013). ‘Essential Tremor' or ‘the Essential Tremors': Is This One Disease or a Family of Diseases?. Neuroepidemiology. https://doi.org/10.1159/000356351
1641. Margaret M. Hoehn, & Melvin D. Yahr (1967). Parkinsonism. Neurology. https://doi.org/10.1212/wnl.17.5.427
1642. Mohammed T. Abou‐Saleh (2002). Neuro‐imaging. Neuro‐imaging Studies of Depression. https://doi.org/10.1002/0470846410.ch73
1643. D. Nzamba Nzamba, Khadija Benallel, A. Kaddaf, M. Gartoum, & Maryeme Kadiri (2022). Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1194
1644. Itaru Kimura, Ayumu Ohnuma, HARUAKI SEKI, Shunichi Saso, & Kyuya Kogure (1990). Cognitive Impairment in Parkinson's Disease Assessed by Visuomotor Performance System and P300 Potential. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.161.supplement_155
1645. J. Moll, J. C. Antoine, H. Robert Brashear, Jean‐Yves Delattre, M. Drlicek, Edward J. Dropcho, Bruno Giometto, Francesc Graus, John Greenlee, Jérôme Honnorat, K. A. Jaeckle, Kunio Tanaka, & Ch.J. Vecht (1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology. https://doi.org/10.1212/wnl.45.10.1937
1646. Esor Balkan (2023). Initial Approach to Patients with Balance Disorders. IntechOpen eBooks. https://doi.org/10.5772/intechopen.111837
1647. Joseph Jankovic (2007). Pathophysiology and Clinical Assessment. CRC Press eBooks. https://doi.org/10.3109/9781420019995-8
1648. Miho Murata, & Ichiro Kanazawa (1997). [Clinical classifications of Parkinson's disease].. PubMed
1649. Russell N. DeJong (1969). Memory Loss due to Hippocampal Lesions. Archives of Neurology. https://doi.org/10.1001/archneur.1969.00480100015001
1650. Nobuo Yanagisawa, Sadakazu Fujimoto, & F Tamaru (1989). Bradykinesia in Parkinson’s Disease: Disorders of Onset and Execution of Fast Movement. European Neurology. https://doi.org/10.1159/000116449
1651. Yasuyuki Okuma (2014). Practical approach to freezing of gait in Parkinson's disease. Practical Neurology. https://doi.org/10.1136/practneurol-2013-000743
1652. Mingzhu Feng, & Lifang Zhang (2019). Research progress of freezing of gait in parkinson’s disease. https://doi.org/10.3877/cma.j.issn.2095-123x.2019.04.012
1653. Daphne Kos, Eric Kerckhofs, Guy Nagels, Marie D’hooghe, & S Ilsbroukx (2007). Origin of Fatigue in Multiple Sclerosis: Review of the Literature. Neurorehabilitation and neural repair. https://doi.org/10.1177/1545968306298934
1654. Marco Orsini (2021). Oral Health in Parkinson’s Disease: How Long are we Going to Neglect it?. Archives in Neurology & Neuroscience. https://doi.org/10.33552/ann.2021.10.000749
1655. K. M. Yacob (2020). The pyrexia temperatures never damage the cells of brain or harm the body. Current Pediatric Research
1656. A. Friedman, & J. Sienkiewicz (1991). Psychotic complications of long-term levodopa treatment of Parkinson's disease. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1991.tb04918.x
1657. Hubert Daude, Nathalie Bousquet-Jacq, Karine Von Kanel, Nicole Boulay, M. Faye, Mathieu Coquery, Sylvie Tronel, & Magali Beltran (2015). Repérage et prise en charge multidisciplinaire des troubles du développement cognitif et relationnel de l’enfant né prématurément. Contraste. https://doi.org/10.3917/cont.041.0151
1658. D. Frank Benson, & Alfredo Ardila (1996). Brain Damage in Aphasia. https://doi.org/10.1093/oso/9780195089349.003.0005
1659. Priyadarshi Prajjwal, Nikhil Deep Kolanu, Yeruva Bheemeswara Reddy, Aneeqa Ahmed, Mohammed Dheyaa Marsool Marsool, Krupanagram Santoshi, Himani Harshad Pattani, Jobby John, Kiran Kishor Chandrasekar, & Omniat Amir Hussin (2024). Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia. Health Science Reports. https://doi.org/10.1002/hsr2.2019
1660. Lee X. Blonder, & John T. Slevin (2011). Emotional Dysfunction in Parkinson’s Disease. Behavioural Neurology. https://doi.org/10.1155/2011/143857
1661. Zach Monahan, J. Heath, Alexis Ditren Santos, Alicia Ito Ford, & Micah Hartwell (2023). Comorbidities associated with symptoms of subjective cognitive decline in individuals aged 45–64. Journal of Osteopathic Medicine. https://doi.org/10.1515/jom-2023-0230
1662. S E Starkstein (2009). Neuropsychiatric disorders in early untreated Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2008.171231
1663. Naglis Vičkačka, Revaldė Vasiliauskaitė, & Erlandas Paulėkas (2024). Fizinio aktyvumo nauda sergant Parkinsono liga. Lithuanian General Practitioner. https://doi.org/10.37499/lbpg.1349
1664. Quentin Salardaine (2024). Typology of sexual disorders in idiopathic Parkinson's disease, a systematic review. Deleted Journal. https://doi.org/10.1016/j.fjurol.2024.102796
1665. Keith A. Josephs (2011). Neuronal intranuclear inclusion disease. Neurology. https://doi.org/10.1212/wnl.0b013e3182166ead
1666. Koji Fukuda, Tomoyasu Wakuda, Michiyo Kageyama, KINIO KITAMURA, Masaki Tanaka, YASUHIDE TAWATA, T. Miyauchi, & Shiro Ishida (2007). Psychotic symptoms, epilepsy, mental retardation, and brain malformation in a patient with 45,XO/46,XX mosaicism: Detection of mutation of ARX molecule. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2007.01626.x
1667. Hagai Bergman, & Günther Deuschl (2002). Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back. Movement Disorders. https://doi.org/10.1002/mds.10140
1668. Margot R.F. Reijnders, Richard J. Leventer, Bo Hoon Lee, Diana Baralle, Paulo Selber, Alex R. Paciorkowski, & David Hunt (2017). PURA-Related Neurodevelopmental Disorders. University of Washington, Seattle eBooks
1669. Raffaele Nappo, & Roberta Simeoli (2024). Il contributo dell'intelligenza artificiale nella diagnosi dei disturbi neurodegenerativi. RIVISTA SPERIMENTALE DI FRENIATRIA. https://doi.org/10.3280/rsf2024-003008
1670. Anna T. Magnante, Anna S. Ord, Jamie Holland, & Scott W. Sautter (2022). Neurocognitive functioning of patients with early-stage Parkinson’s disease. Applied Neuropsychology Adult. https://doi.org/10.1080/23279095.2022.2106865
1671. Rahul Arora, & Yusuf S. Khan (2021). Motor Neuron Disease
1672. Florindo Stella, Márcia Radanovic, Márcio Luiz Figueredo Balthazar, Paulo Renato Canineu, Leonardo Cruz de Souza, & Orestes Vicente Forlenza (2014). Neuropsychiatric symptoms in the prodromal stages of dementia. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000050
1673. Adolfo M. Bronstein, & T. Lempert (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
1674. Keith Isenberg, & Keith S. Garcia (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
1675. Kelly Clanchy (2013). Promoting Physical Activity in People with Brain Impairments
1676. Cynthia L. Comella (2007). Sleep disorders in Parkinson's disease: An overview. Movement Disorders. https://doi.org/10.1002/mds.21682
1677. E. Anthony Jones, & Karin Weißenborn (1997). Neurology and the liver. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.63.3.279
1678. A. Laurell, Emily Watson, Catherine Hatfield, & Robert B. Dudas (2023). Violence and delusional jealousy in Parkinson’s disease. BMJ Case Reports. https://doi.org/10.1136/bcr-2023-256682
1679. Sotirios A. Parashos (2000). Post-traumatic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-410-8_34
1680. Barbara E. McDermott (2015). Factitious Disorder. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp234
1681. Yvonne Kaußner, & Hans‐Peter Krüger (2009). Drugs, driving and traffic safety in Parkinson’s disease. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-7643-9923-8_20
1682. Raheev Yadav, & Charles Pinto (2000). Mania in Parkinson's disease with treatment emergent dyskineisa : a case report.. PubMed
1683. Zeinab Rezaee, Mohammad Marandi, Hojjatallah Alaei, & Fahimeh Esfarjani (2019). Molecular Mechanisms of Parkinson's Disease. The Neuroscience Journal of Shefaye Khatam. https://doi.org/10.29252/shefa.8.1.120
1684. Andrea C. Adams (2018). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190206895.003.0012
1685. R Landwehr, B Endres, C Wittig, R Wössner, R Fink, & J Treib (2009). Der pupillographische Schläfrigkeitstest bei neurologischen Erkrankungen. Aktuelle Neurologie. https://doi.org/10.1055/s-0029-1238642
1686. Hannah J. Bruce, Yorghos Tripodis, Michael D. McClean, Monica Korell, Caroline M. Tanner, Brittany Contreras, Joshua Gottesman, L. Kirsch, Yasir Karim, Brett Martin, Joseph Palmisano, Bobak Abdolmohammadi, Ludy C. Shih, Thor D. Stein, Robert A. Stern, Charles H. Adler, Jesse Mez, Chris Nowinski, Ann C. McKee, & Michael L. Alosco (2023). American Football Play and Parkinson Disease Among Men. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.28644
1687. José Ramón Valdizán Usón (2005). Aspectos neurofisiológicos de las disfasias. Revista de Neurología. https://doi.org/10.33588/rn.41s01.2005378
1688. Unknown (2018). Neuropsychiatry. https://doi.org/10.1002/9781119554639.ch4
1689. M A Jenike (1996). Psychiatric Illnesses in the Elderly: A Review. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198879600900202
1690. Naira F. Aripova, & Umida T. Omonova (2024). CLINICAL CASE OF MULTISYSTEM ATROPHY WITH PARKINSONISM. The American Journal of Medical Sciences and Pharmaceutical Research. https://doi.org/10.37547/tajmspr/volume06issue07-05
1691. Marc Lenaerts (2022). Parkinson’s Disease, Headache and Pain. IntechOpen eBooks. https://doi.org/10.5772/intechopen.103051
1692. Sunita Potgieter (1959). Elongated styloid process. Anaesthesia. https://doi.org/10.1111/j.1365-2044.1959.tb13786.x
1693. Hideyuki Sawada, Tomoko Oeda, Atsushi Umemura, Satoshi Tomita, Masayuki Kohsaka, Kwiyoung Park, & Kenji Yamamoto (2018). Risks and Triggers of Psychosis in Parkinson Disease. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.1000413
1694. Yamirka de la Caridad Revilla Ortiz, María de la Caridad Castellón García, Marisela Chaviano Castillo, Sarababel Taño Rodríguez, & Ariel Osmani Gómez García (2012). Síndrome de Guillain Barré en edad pediátrica. Presentación atípica.. Gaceta Médica Espirituana
1695. Malco Rossi, Néstor Wainsztein, & Marcelo Merello (2021). Cardiac Involvement in Movement Disorders. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13188
1696. Ling Li, & Terry L. Lewis (2009). Alzheimer’s Disease and Other Neurodegenerative Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-385-5_25
1697. Doungporn Ruthirago, Parunyou Julayanont, Supannee Rassameehiran, & M Abstract (2016). Acute porphyrias and porphyric neuropathy. The Southwest Respiratory and Critical Care Chronicles. https://doi.org/10.12746/swrccc2016.0415.197
1698. Doungporn Ruthirago, Parunyou Julayanont, & Supannee Rassameehiran (2016). Acute porphyrias and porphyric neuropathy. DOAJ (DOAJ: Directory of Open Access Journals)
1699. William C. Koller (1984). Sensory symptoms in Parkinson's disease. Neurology. https://doi.org/10.1212/wnl.34.7.957
1700. Buchholz Dw (1994). Dysphagia associated with neurological disorders.. PubMed
1701. Magdalena Boczarska‐Jedynak, & Grzegorz Opala (2005). [Sleep disturbances in Parkinson's disease].. PubMed
1702. Manish Ramani B., P L Muthalagappan, & Roger Kurlan (2014). Postoperative and Postpartum Onset of Chronic Parkinsonism: Four Case Reports. International Journal of Medical Students. https://doi.org/10.5195/ijms.2014.71
1703. Khaled Radad, Rudolf Moldzio, Christopher Krewenka, Barbara Kranner, & Wolf‐Dieter Rausch (2023). Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation. Exploration of Neuroprotective Therapy. https://doi.org/10.37349/ent.2023.00036
1704. Naia Sáez Francàs (2012). Percepción de fatiga central en la enfermedad de parkinson: factores clínicos, psicopatológicos y neuropsicológicos. TDX (Tesis Doctorals en Xarxa)
1705. Tanvi Dasharath Choukekar, Shilpa Laxman Mestry, & Akanksha Prakash Phondke (2020). Parkinson’s Disease: An Overview of Various Treatments. International Journal of Research
1706. Tarja Saaresranta, Päivi Polo‐Kantola, & Olli Polo (2007). Menopausal Insomnia. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-042-7_9
1707. Emil D. W. Hauser (1934). SCIATIC NEURALGIA: A CLINICAL ENTITY. Journal of the American Medical Association. https://doi.org/10.1001/jama.1934.02750180017006
1708. Reint H. Geuze (2016). Motorische ontwikkelingsstoornissen: DCD en dyspraxie
1709. Xiao‐Qi Yu, Yi Jia, & Yuan Dong (2024). Research progress on the cannabinoid type-2 receptor and Parkinson’s disease. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2023.1298166
1710. Amita (2024). A review study on Parkinson’s disease: An old age disorders. International Journal of Unani and Integrative Medicine. https://doi.org/10.33545/2616454x.2024.v8.i1b.266
1711. Geralyn Spollett, & Belinda P. Childs (2017). Peripheral and Autonomic Neuropathy. American Diabetes Association eBooks. https://doi.org/10.2337/9781580405690.ch16
1712. Patrick J. McNamara (2011). Mood Disorders and Apathy in Parkinson’s Disease. The MIT Press eBooks. https://doi.org/10.7551/mitpress/9780262016087.003.0010
1713. Filipe Sarmento, Griffin Lamp, Venkat Srikar Lavu, Achyutha S Madamangalam, Jagan Mohan Reddy Dwarampudi, Qingqi Yuan, Alfonso Enrique Martinez-Nunez, Julia T. Choi, Kara A. Johnson, Coralie de Hemptinne, & Joshua K. Wong (2024). Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factors. Clinical Parkinsonism & Related Disorders. https://doi.org/10.1016/j.prdoa.2024.100288
1714. L. I. Kopylova, A.A. Tappakhov, T. Ya. Nikolaeva, L. R. Zhozhikov, & Polina I. Golikova (2025). Сlinical and genetic predictors of anxiety in patients with Parkinson's disease. Vestnik of North-Eastern Federal University Medical Sciences. https://doi.org/10.25587/2587-5590-2025-2-23-31
1715. William V. Bernard (2018). Neurologic Disorders. CRC Press eBooks. https://doi.org/10.1201/9781315154787-10
1716. Jacob D. Jones, Holly Timblin, & Fawn Baxter (2022). Cumulative Effect of Head Injuries on Nonmotor Outcomes in Parkinson’s Disease. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.21100257
1717. Eugenia Mamikonyan, & Daniel Weintraub (2015). Neuropsychiatric symptoms in Parkinson’s disease dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199681648.003.0005
1718. Camila Aquino, Tiago Mestre, & Anthony E. Lang (2014). Restless Genital Syndrome in Parkinson Disease. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2014.1326
1719. Rajput Ah, & Rajput EF (2017). Parkinson's Disease in the Very Old - Clinicopathological Observations. Journal of Neuroscience and Neuropsychology. https://doi.org/10.18875/2577-7890.1.104
1720. Richard Hunter, Alan Ridley, & Andrew Malleson (1969). Meissner Corpuscles in Skin Biopsies of Patients with Presenile Dementia: A Quantitative Study. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.115.520.347
1721. Eduard E. Vasilevskis, & E. Wesley Ely (2016). Causes and epidemiology of agitation, confusion, and delirium in the ICU. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199600830.003.0226
1722. Etienne Goubault de Brugière (2019). L'impact des dyskinésies sur le répertoire moteur des patients atteints de la maladie de Parkinson
1723. Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, & Anastasia Bougea (2023). Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches. https://doi.org/10.20944/preprints202308.1550.v1
1724. Daniela Berg, & Oliver Bandmann (2013). Biomarkers for PD. Neurology. https://doi.org/10.1212/wnl.0b013e3182825184
1725. Margherita Grasso, Paola Piscopo, Annamaria Confaloni, & Michela A. Denti (2011). 17 Neurodegenerative Disorders. Georg Thieme Verlag eBooks. https://doi.org/10.1055/b-0034-75424
1726. Sung Jin Park, In‐Uk Song, Sung‐Woo Chung, & YoungSoon Yang (2015). Clinical Implication of High Sensitivity C-Reactive Protein for the Development of Dementia in Parkinson's Disease. Dementia and Neurocognitive Disorders. https://doi.org/10.12779/dnd.2015.14.3.123
1727. Sara Isáis‐Millán, Dan Piña‐Fuentes, Christian an Guzmán-Astorga, Amin Cervantes‐Arriaga, & Mayela Rodríguez‐Violante (2016). [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].. PubMed
1728. E. Reina Robles, M. Vela-Navacerrada, & Juan Carlos Miangolarra Page (2000). Marcha y equilibrio en el enfermo de Parkinson. Cuestiones de fisioterapia: revista universitaria de información e investigación en Fisioterapia
1729. Long Wang, & Zhibin Liu (2022). Analysis of Massage Treatment Mechanism of Parkinson’s Disease. Journal of Innovations in Medical Research. https://doi.org/10.56397/jimr/2022.12.05
1730. Juan Camilo Suárez-Escudero (2014). Discapacidad y neurociencias: la magnitud del déficit neurológico y neuro psiquiátrico. Acta neurológica colombiana
1731. Philip S. Bergman (1957). Cerebral Blindness. A M A Archives of Neurology & Psychiatry. https://doi.org/10.1001/archneurpsyc.1957.02330420028004
1732. Yun Chen, Gregory E. Garcia, Wei Huang, & Shlomi Constantini (2014). The Involvement of Secondary Neuronal Damage in the Development of Neuropsychiatric Disorders Following Brain Insults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00022
1733. Carlijn D.J.M. Borm, Bastiaan R. Bloem, Carel B. Hoyng, Nienke M. de Vries, & Thomas Theelen (2022). The Many Faces of Blurry Vision in Parkinson’s Disease: An Illustrative Case Series. Case Reports in Neurology. https://doi.org/10.1159/000523987
1734. Richard Lévy, & B. Pillon (2006). [Cognitive disorders in Parkinson's disease without dementia].. PubMed
1735. Kari O. Raivio (1991). Prevention and Treatment of Postasphyxial Cerebral Damage. International Journal of Technology Assessment in Health Care. https://doi.org/10.1017/s0266462300012617
1736. Olga Kopach, & Tatyana Pivneva (2018). Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration: neurophysiological insights into stem progenitor cell neurogenesis within a host environment. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.235224
1737. Nishikata Hiroaki, & Chiharu Kubo (2001). [The characteristics and mechanism of onset of abnormal eating behavior due to stress or psychosomatic diseases].. PubMed
1738. David M. A. Mann, & P. O. Yates (1983). PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.1983.tb00320.x
1739. Marco Onofrj, Cristina Paci, & Adam G. Thomas (1998). Sudden appearence of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.65.4.605
1740. Ernesto Simón Pérez, Idoris Núñez Lahera, & Osvaldo Ramón Aguilera Pacheco (2016). Caracterización de los síntomas no motores en la enfermedad de Parkinson. Revista cubana de neurología y neurocirugía
1741. Gordon Parker, & Vijaya Manicavasagar (2005). Identifying the constructs to non-melancholic depression: stress. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.011
1742. Р. В. Магжанов, А И Давлетова, Robert Ibatullin, V. F. Tunik, R. F. Idrisova, & K. Z. Bakhtiyarova (2016). Challenges with the differential diagnosis of progressive supranuclear palsy and Parkinson’s disease. Annals of Clinical and Experimental Neurology. https://doi.org/10.17816/psaic22
1743. Werner Poewe (2012). The Clinical Definition of Parkinson's Disease -Time for a Change?. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.52.825
1744. Archana Arya, K Shilpa, & Bindu PR (2024). Effect of udwarthana and vamana in rigidity predominant Parkinson’s disease. -Case report. Kerala Journal of Ayurveda. https://doi.org/10.55718/kja.339
1745. Карась Антонина Юрьевна, Кабанова Лидия Алексеевна, & Глухова Лариса Юрьевна (2010). Пароксизмальные состояния неэпилептического генеза. Саратовский научно-медицинский журнал
1746. Tryggve Nevéus (2017). Pathogenesis of enuresis: Towards a new understanding. International Journal of Urology. https://doi.org/10.1111/iju.13310
1747. Manuel Riklan, Constance Reynolds, & Stanley Stellar (1989). Correlates of Memory in Parkinson??s Disease. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-198904000-00008
1748. Ane Murueta‐Goyena, Ane Andikoetxea, Juan Carlos Gómez‐Esteban, & Iñigo Gabilondo (2019). Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01294
1749. Anni Karoline Balbino Amaral, Erika Aline Queiroz Nobre, & Frederico Kauffmann Barbosa (2015). PARALISIA CEREBRAL: SEUS PARADIGMAS, AVANÇOS E RETROCESSOS. UNILUS Ensino e Pesquisa
1750. Lisa M. Shulman (2000). Apathy in patients with Parkinson’s disease. International Review of Psychiatry. https://doi.org/10.1080/09540260020002523
1751. Charlotte Spay (2018). Les troubles de l’initiation du mouvement dans la maladie de Parkinson : au-delà des symptômes moteurs de la dopamine
1752. Ratna Kirani, Pratiwi Hendro Putri, Tessa Sjahriani, & Fitriyani Fitriyani (2025). Gambaran Karakteristik Demografi Pasien Parkinson Di Rumah Sakit Pertamina Bintang Amin Periode 2022-2024. JURNAL ILMU KEDOKTERAN DAN KESEHATAN. https://doi.org/10.33024/jikk.v12i6.19674
1753. Steven Herskovitz (2008). Disorders of Peripheral Nerve Hyperexcitability. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195183269.003.0020
1754. Feng Jieyin (2013). The resting state fMRI study of patients with Parkinson's disease associated with cognitive dysfunction. International Journal of Medical Radiology
1755. Allan H. Young (2008). Management commentary. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544187.025
1756. Magaret T. M. Prenger, Racheal Madray, Kathryne Van Hedger, Mimma Anello, & Penny A. MacDonald (2020). Social Symptoms of Parkinson’s Disease. https://doi.org/10.20944/preprints202007.0604.v1
1757. Maria Carmen Martínez (1999). [Clinical symptoms of generalized peroxisomal disorders].. PubMed
1758. Sanja Kovačić, Siniša Roginić, Johann Nemrava, Ksenija Gospocic, Maida Seferović Šarić, & Krešimir Luetić (2017). Acute pancreatitis in two patients with Parkinson’s disease. Cogent Medicine. https://doi.org/10.1080/2331205x.2017.1312802
1759. Mark Stacy, & Joseph Jankovic (2011). Overview of the Medical Treatment of the Non‐Motor and Non‐Dopaminergic Features of Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch35
1760. Douglas H.C.L Chin, & Roy A. Meals (2001). Anterior interosseous nerve syndrome. Journal of the American Society for Surgery of the Hand. https://doi.org/10.1053/jssh.2001.28806
1761. Jesús Taboada (2005). El diagnóstico por imagen en el niño con problemas neuropsicológicos. Parte 2. Plasticidad y Restauración Neurológica
1762. Stewart A. Factor (2007). Levodopa. CRC Press eBooks. https://doi.org/10.3109/9781420019995-23
1763. 一民 清田 (1991). 正常な「老い」と異常な「老い」 : 晩年を美しく生きるために. 星和書店 eBooks
1764. Arthur Kümmer (2007). Transtornos depressivos na doença de Parkinson de início precoce
1765. Chris Frith (1987). The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychological Medicine. https://doi.org/10.1017/s0033291700025873
1766. Deborah J. Walder, Marta Statucka, Maureen Daly, & Beril Yaffe (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
1767. Toru Baba (2023). 嗅覚検査と脳画像でせまるパーキンソン病の認知機能障害. Higher Brain Function Research. https://doi.org/10.2496/hbfr.43.207
1768. Christos Bakirtzis, Maria Lima, S. Lorenzo, Artemios Artemiadis, Paschalis Theotokis, Evangelia Kesidou, Natalia Konstantinidou, Styliani-Aggeliki Sintila, Marina Boziki, Dimitrios Parissis, Panagiotis Ioannidis, Theodoros Karapanayiotides, Georgios M. Hadjigeorgiou, & Nikolaos Grigoriadis (2023). Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review. Healthcare. https://doi.org/10.3390/healthcare11152126
1769. Robert E. Hales, & Stuart C. Yudofsky (1996). Synopsis of psychiatry
1770. Marina Mata, Katerina Dorovini‐Zis, Mary E. Wilson, & Anne B. Young (1983). New form of familial Parkinson‐dementia syndrome. Neurology. https://doi.org/10.1212/wnl.33.11.1439
1771. Keisuke Suzuki, Masayuki Miyamoto, Tomoyuki Miyamoto, Masaoki Iwanami, Hideki Sakuta, & Koichi Hirata (2012). [Sleep disturbances in patients with Parkinson disease].. PubMed
1772. Jian Yun Zhang, Piu Chan, & Er he Xu (2017). Attention must be paid to cognitive dysfunction in Parkinson's disease. DOAJ (DOAJ: Directory of Open Access Journals)
1773. Felix-Martin Werner, & Rafael Coveñas (2018). Comparison of Mono-dopaminergic and Multi-target Pharmacotherapies in Primary Parkinson Syndrome and Assessment Tools to Evaluate Motor and Non-motor Symptoms. Current Drug Therapy. https://doi.org/10.2174/1574885513666181115104137
1774. Frédéric Assal, & Joseph Ghika (2016). [Dementia with motor and language disorders].. PubMed
1775. Svetlana Masgutova, Susan Wenberg, & Mary Retschler (2008). MASGUTOVA METHOD OF REFLEX INTEGRATION FOR CHILDREN WITH CEREBRAL PALSY
1776. Mônica Lima Diniz, Alanna Michely Batista de Morais, & Milena Nunes Alves de Sousa (2024). Influência da síndrome do intestino irritável sobre a depressão e outras comorbidades psiquiátricas. Revista Eletrônica Acervo Científico. https://doi.org/10.25248/reac.e13512.2024
1777. Shyamal H. Mehta, John C. Morgan, & Kapil D. Sethi (2008). Sleep Disorders Associated with Parkinson's Disease:<i>Role of Dopamine, Epidemiology, and Clinical Scales of Assessment</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900017260
1778. Jiaxin Xu (2023). Detection methods of Parkinson's Disease based on physiological signals and machine learning methods. Highlights in Science Engineering and Technology. https://doi.org/10.54097/hset.v36i.6105
1779. Eun Joo Choi (2022). Management of patients with neuropathic pain. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2022.65.8.505
1780. Joseph R. Duffy, Edythe A. Strand, & Keith A. Josephs (2014). Motor speech disorders associated with primary progressive aphasia. Aphasiology. https://doi.org/10.1080/02687038.2013.869307
1781. Nicole Chambers, Kathryn Lanza, & Christopher Bishop (2020). Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01494
1782. Ruth Nass (1992). Developmental Dyslexia: An Update. Pediatrics in Review. https://doi.org/10.1542/pir.13.6.231
1783. Richárd, & Awad (2011). Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson＇s disease. 世界胃肠病学杂志：英文版
1784. Teiko Kimpara, & Atsushi Takeda (2020). [Parkinson's Disease in the Oldest-Old].. Brain and nerve. https://doi.org/10.11477/mf.1416201691
1785. Daniel Ortíz Morales (2019). Muerte encefálica en pediatría.
1786. Alessandra Ferreira Barbosa, Janini Chen, Fernanda Freitag, Débora Francato Valente, Carolina de Oliveira Souza, Mariana Callil Voos, & Hsin Fen Chien (2016). Gait, posture and cognition in Parkinson's disease. Dementia & Neuropsychologia. https://doi.org/10.1590/s1980-5764-2016dn1004005
1787. Alessandra Ferreira Barbosa, Janini Chen, Fernanda Freitag, Débora Francato Valente, Carolina de Oliveira Souza, Mariana Callil Voos, & Hsin Fen Chien (2018). Gait, posture and cognition in Parkinson's disease. Figshare. https://doi.org/10.6084/m9.figshare.7518644
1788. Pierre Césaro (1997). Maladie de Parkinson sévère : l’ère des thérapeutiques interventionnelles. Médecine thérapeutique
1789. Janet M. Torpy (2004). Parkinson Disease. JAMA. https://doi.org/10.1001/jama.291.3.390
1790. Mate Mihanović, Davor Bodor, Slobodanka Kezić, Branka Restek-Petrović, & Ante Silić (2009). Differential diagnosis of psychotropic side effects and symptoms and signs of psychiatric disorders.. PubMed
1791. Soheyl Noachtar, & Jan Rémi (2010). Vegetative seizures. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511781780.015
1792. Charles M. Poser, Milton Alter, Robert D. Currier, & S. E. Hunter (1979). Common Demyelinating and Degenerative Diseases and Extrapyramidal Disorders--Panel 4. Archives of Neurology. https://doi.org/10.1001/archneur.1979.00500480033006
1793. Susana Beatriz Plúas Burgos, & Andrea Marina Zuñiga Vinueza (2018). Análisis de la calidad de vida en pacientes diagnósticos con enfermedad de Parkinson y su asociación con síntomas depresivos en consulta externa de neurología del Hospital Teodoro Maldonado Carbo; julio 2017 a enero 2018.
1794. Anumeha Mishra, & Sanjay Pandey (2022). Functional Neurological Disorders. The Neurologist. https://doi.org/10.1097/nrl.0000000000000453
1795. Eric Molho, & Stewart A. Factor (2012). Psychosis. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_5
1796. Doina Nițescu, Adriana Nicolau, Simona Caraiola, Denisa Predețeanu, R. Ionescu, & C Tănăsescu (2011). Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?. PubMed
1797. Stephany Fulda (2011). Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders. The EPMA Journal. https://doi.org/10.1007/s13167-011-0096-8
1798. Rashmi Singh, & Sanjay Pandey (2022). Movement Disorder in Demyelinating Disease. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_64_22
1799. Lieve Lemey, Jan Godderis, & Hans van den Ameele (2001). Psychiatric complications of drug treatment of Parkinson's disease. Acta Neuropsychiatrica. https://doi.org/10.1017/s092427080003533x
1800. Mohd Miharbei Mf, Ahmad Zafri Ab, & Suhaila Mz (2018). A Diagnostic Dilemma: Catatonia, Serotonin Syndrome and Parkinsonism. The Malaysian journal of psychiatry
1801. Erfan Sanaei, Reza Bidaki, Mohammad Pashmchi, & Hamid Jalalifard (2025). Challenging Diagnosis of Fahr's Disease Mimicking Parkinson's Disease: A Case Report. Clinical Case Reports. https://doi.org/10.1002/ccr3.70250
1802. Bonnie M. Scott, & Jared F. Benge (2024). Lewy Body Disease and Atypical Parkinsonian Conditions. Dementia. https://doi.org/10.1093/med/9780197690024.003.0012
1803. John G. Nutt (1990). Abnormalities of Posture and Movement. Geriatric medicine. https://doi.org/10.1007/978-1-4757-2093-8_35
1804. Kun-Woo Park (2024). Neuropsychiatric Manifestations in Parkinson’s Disease and Other Lewy Body Diseases. https://doi.org/10.1007/978-981-97-1821-4_16
1805. Gilberto Levy, & Karen Marder (2003). Prevalence, Incidence, and Risk Factors for Dementia in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_20
1806. Ruth B. Schneider, Julia Iourinets, & Irene Hegeman Richard (2017). Parkinson’s Disease Psychosis: Presentation, Diagnosis and Management. Neurodegenerative Disease Management. https://doi.org/10.2217/nmt-2017-0028
1807. Ouafae Messouak, Saı̈d Boujraf, S. Chaouki, & Faouzi Belahsen (2008). Delayed onset dystonia secondary to neonatal anoxia.
1808. Joseph E. Moore (1929). THE RELATION OF NEURORECURRENCES TO LATE SYPHILIS. Archives of Neurology And Psychiatry. https://doi.org/10.1001/archneurpsyc.1929.02210190120007
1809. Ebele Joan Ajagun, Abraham Olufemi Asuku, Maryam Tayo Ayinla, Taoheed Adedeji Abdulsalam, Ayodeji Johnson Ajibare, Tobiloba Samuel Olajide, Yusuf Olamilekan Hamza, & Kaosara Oyinola Ganiyu (2024). Pharmacotherapy of Parkinson's Disease and Their Limitations. CRC Press eBooks. https://doi.org/10.1201/9781003402893-17
1810. Donald B. Calne (1995). Diagnosis and Treatment of Parkinson's Disease. Hospital Practice. https://doi.org/10.1080/21548331.1995.11443136
1811. Alison R. Yung (2011). Risk, Disorder and Diagnosis. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048674.2011.614926
1812. Aurélia Poujois, & France Woimant (2019). Challenges in the diagnosis of Wilson disease. Annals of Translational Medicine. https://doi.org/10.21037/atm.2019.02.10
1813. Salomé Mouta, Isabel Fonseca Vaz, Miguel Pires, Sara Roldán Ramos, & Diana Figueiredo (2023). What do we know about pseudodementia?. General Psychiatry. https://doi.org/10.1136/gpsych-2022-100939
1814. Justyna Morylowska-Topolska, Rafał Ziemiński, Agnieszka Molas, Jacek Gajewski, Marta Flis, Ewa Stelmach, & Hanna Karakuła‐Juchnowicz (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
1815. K. A. Jellinger (2014). Neurobiology of Non-Motor Symptoms in Parkinson Disease
1816. Olivier Rascol, & Ludwig Schelosky (2009). <sup>123</sup>I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders. Movement Disorders. https://doi.org/10.1002/mds.22499
1817. J.L. Bosboom, & E.Ch. Wolters (2004). Psychotic symptoms in Parkinson?s disease: pathophysiology and management. Expert Opinion on Drug Safety. https://doi.org/10.1517/eods.3.3.209.31071
1818. Bradley C. Hiner (2000). Autonomic Complications of Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-410-8_11
1819. Marijana Balažinec, Ljiljana Širić, Lana Maljković, & Katarina Marijan (2022). Acquired non-specific stuttering in Parkinson’s disease. Logopedija. https://doi.org/10.31299/log.12.1.4
1820. M. S. Gonzalez Bardanca, MJ Jiménez González, Eva Fontela Vivanco, M. T. Amboage Paz, & M. Diaz Allegue (2007). Distonía psicógena: un diagnóstico complejo.
1821. Gökçen Çetinel, Elif SARICA, & Alhasan ALKHATIB (2020). The Role of Dysphonia and Voice Recordings in Diagnosis of Parkinson’s Disease. International Journal of Applied Mathematics Electronics and Computers. https://doi.org/10.18100/ijamec.679038
1822. María Magdalena Martínez Llaría, Roxana Isabel Singo Guamanarca, Noelia Bueno Loraque, Ana Lorente Rubio, María Montero García, & Isabel Jiménez Lupiañez (2025). SÍNDROME DE CHARLES BONNET. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.23.73.002
1823. E. KOST SHELTON (1933). OSSEOUS DEVELOPMENT AS AN INDEX OF METABOLIC SPEED WITH SPECIAL REFERENCE TO THE MENTALLY SUBNORMAL AND EMOTIONALLY UNSTABLE CHILD*. Endocrinology. https://doi.org/10.1210/endo-17-6-667
1824. Celso Arango, Brian Kirkpatrick, & Robert W. Buchanan (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
1825. William E. Krewson (1950). DIAGNOSIS OF MULTIPLE OCULAR MUSCLE PARALYSES. Journal of the American Medical Association. https://doi.org/10.1001/jama.1950.02920070022006
1826. J. E. Lizardi, Leslie Wolfson, & Robert Whipple (1989). Review Article: Neurological Dysfunction in the Elderly Prone to Fall. Neurorehabilitation and neural repair. https://doi.org/10.1177/136140968900300301
1827. Marjo S. van der Knaap, Christel Depienne, Frédéric Sedel, & Truus E. M. Abbink (2015). CLCN2-Related Leukoencephalopathy
1828. Ennio Ongini (2003). Introduction: Adenosine A <sub>2A</sub> receptors in nonlocomotor features of Parkinson’s disease. Neurology. https://doi.org/10.1212/01.wnl.0000095217.17071.b6
1829. Muzumel A. Chaudhary, & Kiran Rabheru (2009). Síntomas paranoides en pacientes ancianos. RET: revista de toxicomanías
1830. Constantine G. Lyketsos (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
1831. Jéssica Geovana Simões Neiro, Nastia Branca Bernardelli Lacerda de Souza, Maria Emília Oliveira Leandro, Flávio Luis Ribeiro Cândido, & Sandra Cristina Catelan Mainardes (2007). A DOENÇA DE PARKINSON E O EFEITO TERAPÊUTICO DA LEVODOPA
1832. Elisabeth C. DeMarco, Zidong Zhang, Haider Al-Hakeem, & Leslie Hinyard (2022). Depression After Parkinson’s Disease: Treated Differently or Not At All?. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/08919887221090217
1833. Elena Andreea Mut, Cristina Pălădoiu, & Monica Stănescu (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
1834. Stuart McGrane, Nicklaus P. Atria, & John Barwise (2014). Perioperative implications of the patient with autonomic dysfunction. Current Opinion in Anaesthesiology. https://doi.org/10.1097/aco.0000000000000072
1835. D. A. Drachman (1969). Bell's Palsy: A Neurological Point of View. Archives of Otolaryngology - Head and Neck Surgery. https://doi.org/10.1001/archotol.1969.00770020149027
1836. Andrea Antal, Fabio Bandini, Szabolcs Kéri, & Iván Bódis-Wollner (2004). Visuocognitive Dysfunctions in Parkinson’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780203508596-33
1837. Sebastian Walther (2018). Motorische Auffälligkeiten bei Schizophrenie: Effekte auf Kommunikation und mögliche Therapieoptionen
1838. Santosha Pochiraju, & Mia Edgerton (2022). Parkinson’s Disease: An Overview on its Neurophysiologi-cal Effects and Potential Treatments. Journal of Student Research. https://doi.org/10.47611/jsrhs.v11i4.4061
1839. Pooyan Alizadeh, Cinthia Terroba‐Chambi, Blaine Achen, K Cantu Flores, & Verónica Bruno (2023). P.024 Pain in monogenic Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2023.128
1840. Pavan A. Vaswani, & Jayne Wilkinson (2023). Parkinson’s Disease and Other Movement Disorders. Geriatric medicine. https://doi.org/10.1007/978-3-030-01782-8_86-1
1841. Pavan A. Vaswani, & Jayne Wilkinson (2024). Parkinson’s Disease and Other Movement Disorders. Geriatric medicine. https://doi.org/10.1007/978-3-030-74720-6_86
1842. Henry A. Nasrallah (2014). Borderline Personality Disorder Is a Heritable Brain Disease. Current psychiatry
1843. Dennis W. Dickson (2003). Neuropathology of Parkinsonism. CRC Press eBooks. https://doi.org/10.1201/9780203912164-13
1844. Kryzhanovskiĭ Gn (1998). [The pathologic system].. PubMed
1845. Ahmad Radi Swindeh (2017). Nemotorički simptomi Parkinsonove bolesti
1846. María del Rocío García-Ramos García (2009). Validación al castellano de la escala LARS de apatía en la enfermedad de Parkinson
1847. Eiko N. Minakawa (2019). Sleep abnormality as a potential target of disease-modifying therapy for neurodegenerative diseases. Proceedings for Annual Meeting of The Japanese Pharmacological Society. https://doi.org/10.1254/jpssuppl.92.0_3-s29-3
1848. Deborah L. Renaud (2004). Leber’s hereditary optic neuropathy. https://doi.org/10.1093/oso/9780195177442.003.0042
1849. Marc Ziégler (2006). [Advanced Parkinson's disease].. PubMed
1850. Ronald F. Pfeiffer (2011). Gastrointestinal and Swallowing Disturbances in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch24
1851. Meyer A. Perlstein, & Eugene T. McDonald (1953). Nature, recognition and management of neuromuscular disabilities in children; round table discussion.. PubMed
1852. Sirwan K.L. Darweesh, Frank J. Wolters, Ronald B. Postuma, Bruno H. Stricker, Albert Hofman, Peter J. Koudstaal, M. Kamran Ikram, & M. Arfan Ikram (2017). Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2017.2248
1853. W. B. Kesteven (1881). On the Early Phases of Mental Disorder, and their Treatment. Journal of Mental Science. https://doi.org/10.1017/s0368315x00002309
1854. W. B. Kesteven (1881). On the Early Phases of Mental Disorder, and their Treatment. Journal of Mental Science. https://doi.org/10.1192/s0368315x00002309
1855. L.А. Maltseva, V.M. Lisnycha, Yu.Yu. Kobelatskyy, & N.A. Kazimirova (2021). Вплив додаткової нейропротекції Гліатиліном на перебіг септичного процесу і вираженість енцефалопатії в структурі синдрому поліорганної недостатності. EMERGENCY MEDICINE. https://doi.org/10.22141/2224-0586.17.2.2021.230634
1856. Kapil D. Sethi (2004). Movement Disorders, Phenomenology, and Differential Diagnosis. CRC Press eBooks. https://doi.org/10.1201/9780203913611-5
1857. Charles E. Gibbs (1923). RELATION OF PUBERTY TO BEHAVIOR AND PERSONALITY IN PATIENTS WITH DEMENTIA PRÆCOX. American Journal of Psychiatry. https://doi.org/10.1176/ajp.80.1.121
1858. Iracema Leroi (2017). Disrupted identities: movement, mind, and memory in Parkinson's disease. International Psychogeriatrics. https://doi.org/10.1017/s1041610217000370
1859. Michel Goedert, Ross Jakes, R. Anthony Crowther, & Maria Grazia Spillantini (2003). Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy as α-Synucleinopathies. Parkinson s Disease. https://doi.org/10.1385/1-59259-142-6:33
1860. Hong Jiang, Zhi-xiu Xu, & Li-Ke (2009). Poststroke cognitive impairment. Int J Cerebrovasc Dis. https://doi.org/10.3760/cma.j.issn.1673-4165.2009.08.011
1861. Xilma R. Ortiz-Gonzalez (2024). A Child Has Had a Progressive Decline in School Performance Over the Last Few Months. How Should This Be Evaluated?. CRC Press eBooks. https://doi.org/10.1201/9781003523659-17
1862. Lesley Crabb (2001). Sleep disorders in Parkinson's disease: the nursing role. British Journal of Nursing. https://doi.org/10.12968/bjon.2001.10.1.5401
1863. R. G. Hoskins, & Francis H. Sleeper (1929). ENDOCRINE STUDIES IN DEMENTIA PRAECOX. Endocrinology. https://doi.org/10.1210/endo-13-3-245
1864. Dragan Pavlović, & Aleksandra Pavlović (2009). Mild cognitive impairment. Srpski arhiv za celokupno lekarstvo. https://doi.org/10.2298/sarh0908434p
1865. Archibaldo Donoso, María Isabel Behrens, & Pablo Venegas (2003). Deterioro cognitivo leve: seguimiento de 10 casos. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272003000200005
1866. Maja Trošt, Matej Perovnik, & Zvezdan Pirtošek (2019). Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies. Frontiers in Neurology. https://doi.org/10.3389/fneur.2019.01204
1867. J. Jeyaram Bharathi, & Antony Justin (2021). TrkA Signalling and Parkinson’s Dementia. IntechOpen eBooks. https://doi.org/10.5772/intechopen.99106
1868. A. H. I. Abu Shehab, Simona Truglia, Ioan-Adrian Ciureanu, Doina Carina Voinescu, Lucian Ştefan Burlea, & Alexandru Bogdan Ciubară (2024). The Influence of Depression in the Evolution of Parkinson’s Disease: A Psychiatric Perspective. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.629
1869. Maria Livia Fantini (2016). Trouble comportemental en sommeil paradoxal et troubles du contrôle de l'impulsion dans la maladie de Parkinson
1870. Mary C. Townsend (2004). Nursing diagnoses in psychiatric nursing : care plans and psychotropic medications. F.A. Davis Co. eBooks
1871. Emilija Bodinovac (2016). Fizioterapijski postupci kod problema zamrzavanja pokreta u hodu kod bolesnika s Parkinsonovom bolesti
1872. Vladimir Kostić, Elka Stefanova, Nataša Dragašević, & Saška Potrebić (2003). Diagnosis and Treatment of Depression in Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_27
1873. Lydia Vela, Daniele Urso, Mireia Osuna Lopez, & Janet Hoenicka (2022). Non-Motor Symptoms in PLA2G6-Associated Dystonia-Parkinsonism: A Case Report and Literature Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11061590
1874. Rituparna Ghosh, & B.J. Liddle (2010). Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcome. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2010.104976
1875. Adele Blankfield (2013). Article Commentary: Kynurenine Pathway Pathologies: Do Nicotinamide and Other Pathway Co-Factors have a Therapeutic Role in Reduction of Symptom Severity, Including Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). International Journal of Tryptophan Research. https://doi.org/10.4137/ijtr.s11193
1876. Jeffrey Sheung Ching Ng (2018). Palliative care for Parkinson’s disease. Annals of Palliative Medicine. https://doi.org/10.21037/apm.2017.12.02
1877. Ana Clara Costa Garcia, Isadora Almeida Couto, Luiz Garcia Neto, & Marisa Costa e Peixoto (2021). Doença de Parkinson e transtorno depressivo: uma revisão bibliográfica. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n5-036
1878. Emma Tenison, & Emily J. Henderson (2020). Multimorbidity and Frailty: Tackling Complexity in Parkinson’s Disease. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-202105
1879. Hamza Karabıber, Onur Kutlu, Alpay Alkan, İsa Üzüm, & Cengiz Yakıncı (2004). Reversible Posterior Leukoencephalopathy Syndrome Secondary to Acute Hepatic Failure. TURKISH JOURNAL OF MEDICAL SCIENCES
1880. Lucas Lima Najar, Leonardo Figueira Pouchucq, Iara Louise Marques Alves, Júlio Bernardo Ferreguett, Lucas Rodrigues Diniz Rodrigues Diniz, & Marleide da Mota Gomes (2021). Parkinson's disease and periodic limb movement in sleep. Revista Brasileira de Neurologia
1881. Nicolaas I. Bohnen, Uroš Marušič, Stiven Roytman, Rebecca Paalanen, F Michalakis, Taylor Brown, Peter J. H. Scott, Giulia Carli, Roger L. Albin, & Prabesh Kanel (2024). Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patterns. Brain Communications. https://doi.org/10.1093/braincomms/fcae286
1882. J. J. Gilbert, Stephen J. Kish, Li‐Jan Chang, Caryl L. H. Morito, Kathleen Shannak, & Oleh Hornykiewicz (1988). Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates. Annals of Neurology. https://doi.org/10.1002/ana.410240518
1883. Unknown (2013). Management of anxiety and depression. CRC Press eBooks. https://doi.org/10.1201/b14361-12
1884. Christopher M. Gómez (2001). Polyglutamine aggregates in SCA6 Purkinje cells. Neurology. https://doi.org/10.1212/wnl.56.12.1618
1885. C. C. Wholey (1927). MENTAL SYMPTOMS IN RELATION TO GENERAL MEDICINE. JAMA. https://doi.org/10.1001/jama.1927.02690230028009
1886. Amanda Trigo Campoy, Magdalena Yebra Rotger, Laura Ruiz de la Hermosa Gutiérrez, & Romina Vanesa Pastorelli (2011). ¿Psicosis mental injertada o retraso mental? A propósito de un caso.. Psiquiatria.com
1887. Teofilo Lee‐Chiong (2008). Psychiatric and Behavioral Disorders. https://doi.org/10.1093/oso/9780195306590.003.0011
1888. Unknown (2008). Positive ways to assist older people in coping with symptoms of MSA. Nursing Older People. https://doi.org/10.7748/nop.20.3.18.s17
1889. Luo Xiao (2013). Mild cognitive impairment in Parkinson's disease. DOAJ (DOAJ: Directory of Open Access Journals)
1890. Anne T. Berg (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
1891. Gülçin Benbir Şenel, & Derya Karadeniz (2022). Neuroanatomical and Etiological Approaches to Secondary Narcolepsy. Neurological Sciences and Neurophysiology. https://doi.org/10.4103/nsn.nsn_5_22
1892. Mehdi Djekidel, & Walid Harb (2006). A Case of Foot Drop as an Expression of Brain Metastases?. The Neurologist. https://doi.org/10.1097/01.nrl.0000231731.90889.27
1893. U Abildgaard (1993). [Coma from cerebral and metabolic causes].. PubMed
1894. Gabrio Bassotti, Roberto De Giorgio, Vincenzo Stanghellini, Marcello Tonini, Giovanni Barbara, Beatrice Salvioli, Serafina Fiorella, & Roberto Corinaldesi (1998). Constipation: a common problem in patients with neurological abnormalities.. PubMed
1895. Alfonso Castro García, Ángel Sesar Ignacio, Begoña Ares Pensado, José Luis Relova Quinteiro, Miguel Gelabert‐González, Ramón Martínez Rumbo, & Manuel Noya García (2006). Complicaciones psiquiátricas y cognitivas de la estimulación subtalámica en la enfermedad de Parkinson. Revista de Neurología. https://doi.org/10.33588/rn.4304.2005581
1896. Morvarid Karimi, & Joel S. Perlmutter (2011). MRI measures predict progressive supranuclear palsy. Neurology. https://doi.org/10.1212/wnl.0b013e31822e14c7
1897. Michele Poletti (2008). Deficit cognitivi e disturbi neuropsichiatrici nella Malattia di Parkinson: ambiti operativi dello psicologo. PSICOLOGIA DELLA SALUTE
1898. Γεώργιος Βλάχος (2022). Η σχέση υποκειμενικής γνωστικής έκπτωσης και διατροφής στον ελληνικό πληθυσμό τρίτης ηλικίας. https://doi.org/10.12681/eadd/51347
1899. Beata Szluz (2019). Doświadczanie choroby Parkinsona (ujęcie socjologiczne). Seminare Poszukiwania naukowe. https://doi.org/10.21852/sem.2019.2.04
1900. Barbara Liptac Fabbrni, & Roberta Monterazzo Cysneiros (2018). As crises neonatais produzem efeitos neurológicos deletérios de longo prazo: evidências clínicas experimentais
1901. W F Gorman (1982). Defining malingering.. PubMed
1902. F. Leite, H. Salgado, O. Campos, P. C. L. de Carvalho, Mariana Pinto da Costa, Patrícia Queirós, & Catarina Cochat (2016). Clinical aspects of depression in Parkinson's disease. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1365
1903. Lawrence Elmer, & Robert A. Hauser (2012). Dopaminergic agents. https://doi.org/10.2217/ebo.11.375
1904. James L. Levenson (2008). Psychological Factors Affecting Medical Condition. Psychiatry. https://doi.org/10.1002/9780470515167.ch83
1905. Hilde Bruch (1962). Perceptual and Conceptual Disturbances in Anorexia Nervosa. Psychosomatic Medicine. https://doi.org/10.1097/00006842-196203000-00009
1906. Donald R. Gunn (1962). Psychiatric Recognition of Anxiety and Depression. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674376200701s01
1907. Antônio Lúcio Teixeira, Leonardo F. Fontenelle, Edward C. Lauterbach, & Sergio Starkstein (2012). Neuropsychiatry of Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1155/2012/908943
1908. Emilie Faggiani (2014). Les systèmes monoaminergiques : implication dans la physiopathologie et la thérapie de la maladie de Parkinson
1909. Jindra Svátová (2010). Vliv Parkinsonovy nemoci na schopnost řídit motorová vozidla. Interní medicína pro praxi
1910. Michiel F. Dirkx, & Rick C. Helmich (2022). Parkinson’s Disease and Parkinsonian Tremor. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197529652.003.0012
1911. Arianna Bellucci, Nicola Biagio Mercuri, Annalena Venneri, Gaia Faustini, Francesca Longhena, Marina Pizzi, Cristina Missale, & PierFranco Spano (2015). Review: Parkinson's disease: from synaptic loss to connectome dysfunction. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12297
1912. R Trèves (2015). Aux confins de la neurologie et de la rhumatologie. Bulletin de l Académie Nationale de Médecine. https://doi.org/10.1016/s0001-4079(19)30927-6
1913. Fahd Baig, Michael Lawton, Michal Rolinski, Claudio Ruffmann, Kannan Nithi, Samuel Evetts, Hugo J. R. Fernandes, Yoav Ben‐Shlomo, & Joshua Shulman (2015). Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives. Movement Disorders. https://doi.org/10.1002/mds.26281
1914. Álvaro Pascual‐Leone, & Daniel Z. Press (1999). [Cognitive and behavioral disorders in Parkinson disease].. PubMed
1915. Sara Dehanov, & Tiago Ferreira (2019). AN IMMACULATE CONCEPTION – THE DIFFERENTIAL DIAGNOSIS OF A DELUSION OF PREGNANCY. https://doi.org/10.26226/morressier.5d1a037857558b317a14085a
1916. Susanna Lopez, Claudio Del Percio, Maria Teresa Pascarelli, Roberta Lizio, Giuseppe Noce, Raffaele Ferri, Andrea Soricelli, Flavio Nobili, Dario Arnaldi, Francesco Famà, Laura Bonanni, Raffaella Franciotti, Marco Onofrj, Peter Fuhr, Ute Gschwandtner, Gerhard Ransmayr, Dag Aarsland, Lucilla Parnetti, Lucia Farotti, ... Claudio Babiloni (2020). Different abnormalities of electroencephalographic (EEG) markers in quiet wakefulness are related to motor visual hallucinations in patients with Parkinson’s and Lewy body diseases. Alzheimer s & Dementia. https://doi.org/10.1002/alz.045811
1917. Thomas Szazz (1993). Crazy talk: Thought disorder or psychiatric arrogance?. British Journal of Medical Psychology. https://doi.org/10.1111/j.2044-8341.1993.tb01726.x
1918. C.J. Mathias (1999). Can the early presence of autonomic dysfunction aid diagnosis in parkinsonism?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.5.566
1919. José Garnacho‐Montero, Juan Madrazo-Osuna, Jos Luis Garc a-Garmendia, & Carlos Ortíz-Leyba (2001). Neuromuscular Disorders of the Critically Ill Patient. Clinical Pulmonary Medicine. https://doi.org/10.1097/00045413-200111000-00008
1920. Igor Grant, Ned Sacktor, & Justin C. McArthur (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
1921. Elspeth Guthrie, & Ayanangshu Nayak (2012). Medically unexplained symptoms
1922. Joshua L. Golubovsky, Hong Li, Arbaz Momin, Jianning Shao, Maxwell Lee, Leonardo A. Frizon, Olivia Hogue, Benjamin L. Walter, André G. Machado, & Sean J. Nagel (2020). Predictors of second-sided deep brain stimulation for Parkinson’s disease. Journal of neurosurgery. https://doi.org/10.3171/2019.12.jns19638
1923. Josipa Perhoč Mrla, & Tanja Jurin (2024). Uloga depresije u razvoju blagog kognitivnog poremećaja. Socijalna psihijatrija. https://doi.org/10.24869/spsih.2023.202
1924. Unknown (2025). Neurological. https://doi.org/10.1002/9781394218844.ch8
1925. Olivier Godefroy, Mélanie Barbay, Daniela Andriuta, Mélissa Tir, & Martine Roussel (2016). Global Hypoactivity and Apathy. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_5
1926. Carlo Colosimo, & Luca Marsili (2014). Parkinson’s Disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199862924.003.0028
1927. Kan Ding, Puneet Kumar Gupta, & Ramon Diaz‐Arrastia (2016). Epilepsy after Traumatic Brain Injury. CRC Press, Taylor and Francis Group eBooks
1928. Karel Šonka (2019). Sleep and its disturbances in neurology.. PubMed
1929. Hervé Bénony, Christelle Bénony-Viodé, & Jean‐Guillaume Dumas (2012). Le retard mental. Le point sur... Psychologie
1930. R. Laraki, O Blétry, F. Agbalika, P. Bouché, & P Godeau (1994). [Do neuromyosites exist?].. PubMed
1931. S Krzymiński (1995). [Dementia in diffuse Lewy body disease].. PubMed
1932. Jee‐Young Lee (2024). Sex/Gender Differences in Parkinson’s Disease. https://doi.org/10.1007/978-981-97-0130-8_26
1933. Vegard Berge Kristensen, Margaret A. Olsen, & Alice Theilgaard (1977). Levodopa treatment of presenile dementia. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1977.tb00139.x
1934. Damien Léger (2000). Public health and insomnia: economic impact.. PubMed
1935. Ester di Giacomo, Federica Moretti, Fabrizia Colmegna, & Massimo Clerici (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
1936. William I. Rosenblum, & Nitya R. Ghatak (1979). Lewy Bodies in the Presence of Alzheimer's Disease. Archives of Neurology. https://doi.org/10.1001/archneur.1979.00500390088011
1937. Amany Sakr (2021). Recent Study on SLP and Parkinson's Disease (PD). Book Publisher International (a part of SCIENCEDOMAIN International). https://doi.org/10.9734/bpi/hmmr/v8/1939f
1938. María Dolores López Bravo (2011). Ansiedad y depresión en la vejez
1939. Christian Pehl (2012). Sekundäre Form der Obstipation aufgrund von medikamentösen Nebenwirkungen und endokrinen, neurologischen und psychiatrischen Erkrankungen  medikamentös-konservative Therapieoptionen. Viszeralmedizin. https://doi.org/10.1159/000341720
1940. Stefania Lalli, & Alberto Albanese (2010). The diagnostic challenge of primary dystonia: Evidence from misdiagnosis. Movement Disorders. https://doi.org/10.1002/mds.23137
1941. Irina Zhukova, Н. Г. Жукова, & В. М. Алифирова (2009). No-motor impairment in patients with Parkinson’s disease. Bulletin of Siberian Medicine. https://doi.org/10.20538/1682-0363-2009-1(2)-136-141
1942. Günther Thayssen, & Klaus Püschel (2024). Influence of neurological diseases on mobility and ability to drive. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. https://doi.org/10.1007/s00103-024-03920-7
1943. Carol Ewing Garber, & Joseph H. Friedman (2007). Fatigue. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:281
1944. К. Ray Chaudhuri (2011). Parkinson's disease and quality of life - a clinician's perspective
1945. Yashvi Verma (2025). Woman aged 42 years with Parkinson’s disease: a case study. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20251328
1946. Örjan Skogar, & Johan Lökk (2016). Pain management in patients with Parkinson&amp;#39;s disease: challenges and solutions. Journal of Multidisciplinary Healthcare. https://doi.org/10.2147/jmdh.s105857
1947. Diego Santos‐García, A Aneiros-Díaz, M Macías-Arribi, Miguel A Llaneza-Gonzalez, Javier Abella-Corral, & H. Santos-Canelles (2010). [Sensory symptoms in Parkinson's disease].
1948. Kenichi Kashihara (2004). [Behavioral impairments in Parkinson's disease].. PubMed
1949. Paul Maruff, & Christos Pantelis (1999). Attention and neuropsychiatric disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-199905000-00015
1950. Hamid Azadi, Mohammad-R. Akbarzadeh-T, Ali Shoeibi, & Hamid-Reza Kobravi (2021). Evaluating the effect of Parkinson's disease on jitter and shimmer speech features. Advanced Biomedical Research. https://doi.org/10.4103/abr.abr_254_21
1951. Nakesha Bradley (2003). Neuraminidase inhibitors for influenza A and B: PROSE may be as useful as POEMs. BMJ. https://doi.org/10.1136/bmj.327.7406.105-b
1952. Sarah Holder, & Navjot S Narula (2022). Common Sleep Disorders in Adults: Diagnosis and Management.. PubMed
1953. Brian Hainline, Lindsey Gurin, & Daniel M. Torres (2019). Sleep Disorder Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0013
1954. Richard A. Walsh, Robertus M. A. de Bie, & Susan H. Fox (2013). Nonmotor Symptoms in Parkinson’s Disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199927524.003.0006
1955. Beccy Oliver, & Julie Jones (2021). Exercise and Parkinson's update: are your patients getting the right dose?
1956. Jeffrey Smith, & Jennifer Seirafi (2013). Delirium and Dementia
1957. Ana Antunes, Mariana Carvalho Dias, & Ana Verdelho (2016). Neuropsychiatric Symptoms in Reversible Dementias. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_6
1958. Joyce D. Kales, Anthony Kales, Constantin R. Soldatos, K Chamberlin, & Elaine D. Martin (1979). Sleepwalking and night terrors related to febrile illness. American Journal of Psychiatry. https://doi.org/10.1176/ajp.136.9.1214
1959. Ali AL-Mayahi (2018). Early Markers for Cerebral Palsy. IntechOpen eBooks. https://doi.org/10.5772/intechopen.79466
1960. Li Zhang, Liang'e Xu, Sheng Zhang, Bin Xu, & You Wu (2018). Recent advance in pathological mechanism and treatments of dysphagia in Parkinson's disease. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2018.10.022
1961. Steno Rinalduzzi, Carlo Trompetto, Lucio Marinelli, Alessia Alibardi, Paolo Missori, Francesco Fattapposta, Francesco Pierelli, & Antonio Currà (2015). Balance Dysfunction in Parkinson’s Disease. BioMed Research International. https://doi.org/10.1155/2015/434683
1962. Juan Humberto Medina-Chávez, Salvador Fuentes-Alexandro, Irwin Bernardo Gil-Palafox, Lorena Adame-Galván, Fernando Solís-Lam, Lucía Yveth Sánchez-Herrera, & Francisco Sánchez Narváez (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed
1963. Bridget Tierney (2005). Fetal Alcohol Spectrum Disorder (FASD): Finding Information about Preventable Birth Defects. Indiana libraries
1964. Sergio Starkstein, P L Bolduc, Helen S. Mayberg, Thomas J. Preziosi, & Robert G. Robinson (1990). Cognitive impairments and depression in Parkinson's disease: a follow up study.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.53.7.597
1965. Dallah Yoo, Sung‐Hye Park, Man Jin Kim, & Tae‐Beom Ahn (2022). Burning chest pain as a prodromal sign in autopsy- proven Parkinson’s disease dementia. Deleted Journal. https://doi.org/10.54029/2022tew
1966. Rainer Freynhagen, & Mike Bennett (2009). Diagnosis and management of neuropathic pain. BMJ. https://doi.org/10.1136/bmj.b3002
1967. Martin J. McKeown, & Guerry M. Peavy (2015). Biomarkers in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0000000000001692
1968. Bob Woods, Linda Clare, Holly Tuokko, & David F. Hultsch (2006). Cognition-based therapies and Mild Cognitive Impairment.. https://doi.org/10.4324/9780203782996-22
1969. Yu‐Wen Chiu, Shwu‐Hua Lee, & Tu‐Hsueh Yeh (2016). Diversified psychiatric presentation in a case of progressive supranuclear palsy. Journal of Clinical Gerontology and Geriatrics. https://doi.org/10.1016/j.jcgg.2016.05.001
1970. Urszula Kukla, Krzysztof Łabuzek, Justyna Chronowska, Marek Krzystanek, & Bogusław Okopień (2015). [Mental disorders in digestive system diseases - internist's and psychiatrist's insight].. PubMed
1971. Alessandra Costanza, Andrea Amerio, Andrea Aguglia, Andrea Escelsior, Gianluca Serafini, Isabella Berardelli, Maurizio Pompili, & Mario Amore (2020). When Sick Brain and Hopelessness Meet: Some Aspects of Suicidality in the Neurological Patient. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527319666200611130804
1972. Zhijun Zang, Fang Yang, Qu Liang, Minghui Ge, Liang Tong, Liqing Xue, Xiaoguang Sun, & Ying Hai (2025). Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson’s disease treatment. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2025.1640389
1973. Andrea Antal, Daniella Terney, & Iván Bódis-Wollner (2008). Parkinson's Disease, Aging, and Visual Cognition. Topics in Geriatric Rehabilitation. https://doi.org/10.1097/01.tgr.0000318903.80066.e7
1974. Courtney Oare (2017). Imaging Parkinson's Disease: Gray Matter Atrophy Associated With Motor Dysfunction. Journal of Purdue Undergraduate Research. https://doi.org/10.5703/1288284316395
1975. John Snowdon (1997). Epidemiologic questions on mood disorders in old age.. PubMed
1976. R. H. C. Rischbieth (1979). The support of the long term neurological cripple.. PubMed
1977. Jonathan Green, & Stewart A. Factor (2006). Nonmotor Symptoms in Dystonia. CRC Press eBooks. https://doi.org/10.3109/9781420019988-22
1978. Agnès Annic (2014). Physiopathologie des troubles de la sélectivité attentionnelle dans la maladie de Parkinson : rôle des processus de capture et de contrôle volontaire de l'attention
1979. Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony E. Lang, C. Warren Olanow, Caroline M. Tanner, & Kenneth Marek (2004). Levodopa and the Progression of Parkinson's Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa033447
1980. Jan Grace, & Ian G. McKeith (1998). Decline in cognitive function in Parkinson's disease may be due to dementia with Lewy bodies. BMJ. https://doi.org/10.1136/bmj.316.7136.1022
1981. Dirk Bäumer (2018). Diagnosis in suspected neurological disease. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0220
1982. A Guillard (1989). [Development of Parkinson's disease].. PubMed
1983. Christina E. Wierenga, & Mark W. Bondi (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations
1984. R. P. L. Andrade, N. Gil, A Costa, J. Brás, Nelson Castro, R. Sousa, R. Vaz, J. Martins, E. Almeida, J. Abreu, & Hugo Afonso (2023). Psychosis in Parkinson’s Disease: a Case Report of Diagnosis and Management. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2305
1985. Jeffrey L. Cummings (1988). Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198878800100106
1986. Cassandra Navarro-Roa, Mayela Rodríguez‐Violante, & Amin Cervantes‐Arriaga (2019). Terapias de infusión en la enfermedad de Parkinson avanzada. DELETED. https://doi.org/10.24875/rmn.m19000018
1987. K. Amar, & Ibrahim Rakha Ibrahim (2007). Mild cognitive impairment. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2007.68.10.27322
1988. Alexander Swan (2020). Clinical Improvement in a Patient with Parkinsonism and Vascular Dementia Receiving PCSK9 Inhibitor for Ischemic Heart Disease: A Case Report
1989. Zhichun Chen (2018). The identification and diagnosis of preclinical and premotor Parkinson′s disease. Chin J Neurol. https://doi.org/10.3760/cma.j.issn.1006-7876.2018.07.002
1990. Hans‐Peter Ludin (2012). Parkinson-Therapie heute. pharma-kritik. https://doi.org/10.37667/pk.2011.864
1991. Robert J. Mones, T. S. Elizan, & G. J. Siegel (1971). Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.34.6.668
1992. Marco Onofrj, Astrid Thomas, Laura Bonanni, Massimo Di Giannantonio, Francesco Gambi, & Gianna Sepede (2012). Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies Evidence Underlying Psychotic Traits. Advances in biological psychiatry. https://doi.org/10.1159/000331658
1993. Juliana Cristina de Lima (2018). Evidências de projeções indiretas da substância negra compacta para o núcleo retrotrapezóide por meio da substância cinzenta periaquedutal e as alterações respiratórias observadas nesta via em um modelo da doença de Parkinson.. https://doi.org/10.11606/t.42.2018.tde-20092018-135704
1994. Gudisa Bereda (2021). Classifying Causality of an Adverse Drug Reaction: Naranjo Algorithm. International Journal of Pharmacy and Chemistry. https://doi.org/10.11648/j.ijpc.20210706.14
1995. Leon Lack, Gorica Micic, & Nicole Lovato (2023). Circadian aspects in the aetiology and pathophysiology of insomnia. Journal of Sleep Research. https://doi.org/10.1111/jsr.13976
1996. Hrayr Attarian (2004). Differential Diagnosis of Insomnia. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_4
1997. 馬場 正之 (2004). Neuropathy associated with diabetes mellitus: Advances in diagnosis and treatment. IV. Peripheral nerve disorders: Diagnosis and treatment. 2. Polyneuropathy.. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.93.1556
1998. Jill Marjama-Lyons, & William C. Koller (2001). Parkinson's disease. Update in diagnosis and symptom management.. PubMed
1999. Eoin Mulroy, Francesca Baschieri, Francesca Magrinelli, Anna Latorre, Pietro Cortelli, & Kailash P. Bhatia (2021). Movement Disorders and Liver Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13238
2000. Μάρθα Τσαρούχη (2022). Μελέτη της εκδήλωσης αγχώδους συμπεριφοράς σε ζωικό μοντέλο Πάρκινσον. https://doi.org/10.12681/eadd/53328